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chapter i
general introduction and outline of thesis
Adapted from “Young at heart. An update on cardiac regeneration.” 
Smits AMa, Ramkisoensing AAb, Atsma DEb, Goumans MJa.
aDepartments of Molecular Cell Biology and bCardiology, Leiden University Medical 
Center, 2300 RC Leiden, The Netherlands.
Minerva Med. 2010 Aug, 101 (4). 255-70
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chapter i
10 background
Ischemic heart disease is the leading cause of morbidity and mortality in indus-
trialized countries.1 A major contributor to ischemic heart disease is myocardial 
infarction (MI). The erosion or rupture of a coronary atherosclerotic plaque can 
result in the acute obstruction of myocardial blood supply leading to massive loss 
of cardiomyocytes. Since mammals are unable to replenish the large number of 
cardiomyocytes lost as a result of MI, a fibrotic scar with a definitive nature is 
formed.2 Although the scar increases the tensile strength of the infarcted myo-
cardium and thereby prevents cardiac rupture, it impairs the contractile capacity 
of the heart which will eventually culminate in heart failure. Important advances 
have been made in prevention and treatment of the acute complications of MI 
and in reducing myocardial infarct size by reperfusion strategies.3 As a result, the 
number of patients in developed countries that acutely dies from MI has decreased 
in recent years. However, patients that do survive are prone to undergo (left) ven-
tricular remodeling and to ultimately develop heart failure. Prognosis of advanced 
heart failure is only 50% survival after two years. The only therapy for heart failure 
that addresses the fundamental problem of cardiomyocyte loss and vasculature 
damage is heart transplantation. Unfortunately, this therapy is restricted since the 
demand for donor hearts is largely exceeded by donor availability. Furthermore, 
immune rejection of the transplanted heart remains a major problem. If one could 
reconstruct the myocardium by replenishing lost cardiomyocytes and blood ves-
sels through cell-based therapy, this would provide a powerful approach to treat 
cardiovascular disease. The ideal cell population for cardiac cell therapy should be 
able to generate all major cell types in the heart including endothelial cells, peri-
cytes and smooth muscle cells to form new blood vessels. Newly formed cardio-
myocytes must integrate structurally, mechanically, electrically and metabolically 
with the host myocardium and beat synchronously to be of functional significance 
and to prevent arrhythmias. The field of cardiac regeneration was fueled by a study 
of Orlic and colleagues, who reported on the existence of a population of Lin-c-Kit+ 
bone marrow cells that appeared to cause infarct healing and partial restoration 
of cardiac function after injection into the border zone of freshly infarcted mouse 
hearts.4 (As only 44±10% [n=6] of the donor cells were eGFP-positive). Histology 
analyses revealed the expression by the engrafted donor cells of cardiomyocyte, 
smooth muscle or endothelial markers and showed that the cells in the regener-
ated areas were mainly of donor origin. Based on the findings, the authors con-
cluded that the damaged myocardium produces signals causing the donor cells to 
differentiate into cardiomyocytes, smooth muscle cells or endothelial cells instead 
of into hematopoietic cells However, in subsequent years, these spectacular results 
could not be confirmed.5,6 Nevertheless, the use of bone marrow cells to reduce 
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the loss of contractile tissue following acute MI was translated to the clinic with 
an unprecedented speed. The results from placebo-controlled randomized trials 
at 5-year follow-up show that the administration of bone marrow-derived cells is 
safe7 and on average has a very similar small positive effect on cardiac function as 
existing pharmacotherapies for heart failure. While initially the focus in cardiac cell 
therapy was on whole bone marrow or hematopoietic/endothelial subfractions of 
these cells, recently the attention has been largely directed to mesenchymal stem 
cells (MSCs; see below) and cardiac progenitor cells.
mesenchymal stem cells
characterizing mscs
MSCs are a source of cells that has received a lot of attention with regard to cardiac 
stem cell therapy due to their abundance and relatively easy isolation and handling. 
These cells were first characterized by Friendenstein et al., who described fibro-
blast-like cells derived from adult bone marrow.8 As no unique marker has been 
identified yet to distinguish MSCs from other cell types, the International Society 
for Cell Therapy has put forward a set of criteria for defining human MSCs. These 
criteria comprise (1) the ability to adhere to tissue culture plastic under standard 
culture conditions, (2) the presence of a set of surface markers (MSCs have been 
described to be positive for CD73, CD90 and CD105, but do not express CD79a, 
CD45, CD34, CD31, CD19, CD14 or CD11b or HLA-DR on their surface as deter-
mined by fluorescence-activated cell sorter analysis), and (3) the capacity to dif-
ferentiate in vitro into osteoblasts, adipocytes and chondroblasts.9 Additionally, 
MSCs have been shown to secrete pro-angiogenic and anti-apoptotic cytokines 
and possess immunomodulatory properties.10,11 Several studies propose that MSCs 
have cardiomyogenic properties, together with their pro-angiogenic and anti-apop-
totic capacities, these features have made these cells a promising therapeutic tool 
for cell-based cardiovascular repair.
origin of mscs
Since their first identification, MSCs have been demonstrated in a wide variety of 
adult, neonatal, fetal, and also embryonic tissues.12,13 However, differences exist 
between MSCs derived from various sources, but also from the same source and 
even from the same tissue isolation, which may have important clinical implica-
tions.14 MSCs were originally isolated from adult bone marrow, but their numbers 
in this tissue are low.8 It has been estimated that about 0.001% to 0.01% of cells in 
a bone marrow aspirate is able to attach and grow as fibroblast-like cells.10 Recently, 
cells with similar properties as adult bone marrow MSCs have been found in adult 
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12 adipose tissue, albeit in higher numbers.13,15 The large quantities of MSCs that can 
be derived from fat aspirates constitute an advantage over bone marrow-derived 
MSCs.13,16 MSCs have also been isolated from other adult tissue sources such as 
lymphoid organs (thymus and spleen)17, periodontal ligament18, and peripheral 
blood19, but these MSCs have not been used in clinical trials in contrast to adult 
bone marrow- and adipose tissue-derived MSCs. Recent studies have shown that 
the number and function of stem cells are depressed in older patients.20,21 More-
over, regardless of age, stem and progenitor cell number and function are impaired 
in patients suffering from various cardiovascular risk factors, such as diabetes, 
hypercholesterolemia and hypertension.20 Using younger, and likely more healthy 
sources may circumvent the limitations of adult stem cell therapy. The advantages 
of MSCs derived from young sources have been extensively described for cells 
derived from fetal and neonatal tissues, such as umbilical cord22 and blood23, amni-
otic fluid24 and membrane25, bone marrow, lung and liver.26 These “young” MSCs 
show better intrinsic homing and engraftment, greater multipotentiality, increased 
ability to self renew and lower immunogenicity.25,27 The use of young MSCs for 
cell therapy typically excludes autologous transplantation. Currently the efficacy of 
allogeneic strategies are being explored in animal models and in clinical trials to 
overcome this drawback.28-30 Strategies to modify the immunogenicity of alloge-
neic MSCs are also being investigated to improve their potential in tissue repair.31 
Recently, MSCs have been derived from human embryonic stem cells (ESCs). These 
fibroblast-like cells were obtained after co-culture of the human ESCs with the OP9 
murine bone marrow stromal cell line or directly from ESCs cultured without feeder 
cells.32,33 They resemble MSCs from various other tissue sources with respect to 
morphology, surface marker profile, immunogenicity and differentiation potential 
toward osteogenic, adipogenic and chrondrogenic lineages. Moreover, they lack 
expression of the pluripotency-associated markers and after transplantation they 
do not form teratomas.32-35 Although ESC-derived MSCs seem superior to other 
sources with regard to their differentiation potential, clinical use of embryonic stem 
cells is still surrounded by ethical issues. This makes it difficult to envision the clini-
cal application of ESC-derived MSCs in the near future.
As MSCs have been shown to differentiate towards a cardiomyocyte-like phe-
notype, the question arises whether MSCs are involved in cardiac development. 
The group of Liechty et al. has shown that human MSCs engrafted and underwent 
site-specific differentiation into various cell types including cardiomyocytes after in 
utero transplantation in a sheep model.29 Identical results were obtained by Mac-
kenzie et al., who used a similar ovine model and was also able to identify cardio-
myocytes of human origin.36 These studies suggest that transplanted MSCs could 
participate in organogenesis during fetal development. Nonetheless, the heteroge-
neity of MSC populations obtained by plastic adherence and the wide variety of cell 
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surface markers used to isolate MSCs, make identification of a MSC population in 
the heart quite difficult.
in vitro cardiac differentiation of mscs
The ability of adult human MSCs to differentiate into functional cardiomyocytes 
remains a much investigated and debated topic. This may be due to application 
of different criteria to identify adult MSC-derived cardiomyocytes. While some 
groups report expression of cardiac sarcomeric protein genes, organization of the 
encoded proteins into sarcomeres is often absent. Also intrinsic action potentials 
are rarely detected in these cells indicating that while a cardiomyocyte-like pheno-
type may be present, a functional cardiomyocyte has not been formed.37-39 In recent 
years, several groups have shown that MSCs derived from neonatal tissues can be 
induced to express cardiac proteins in a sarcomeric pattern while they also could 
generate an intrinsic action potential which suggests that young MSCs do have the 
ability to become a functional cardiomyocyte.25,40 However, these studies do not 
include the use of species-, strain- or gender-specific markers in combination with 
cardiomyocyte markers to unambiguously demonstrate that the cardiomyocyte 
is indeed derived from a stem cell. Without these specific markers heterocellular 
fusion as a mechanism in the formation of MSC-derived cardiomyocytes can not 
be excluded. Strikingly, many studies showing both expression of cardiac muscle 
genes and generation of intrinsic action potentials in MSC-derived cardiomyocytes 
involve co-cultures of MSCs and native cardiomyocytes to induce cardiomyogen-
esis. This suggests that interactions with bona fide cardiomyocytes might play an 
important role in the induction of cardiomyogenic differentiation of human MSCs. 
With regard to cardiovascular regeneration, the potential of MSCs to differentiate 
into endothelial and smooth muscle cells is also important. Tamama et al. have 
shown that bone marrow-derived human MSCs can gain molecular but also func-
tional characteristics of smooth muscle cells after treatment with a small molecular 
mitogen-activated protein kinase kinase inhibitor.41 Inducing endothelial differen-
tiation in MSCs has given inconsistent results. After exposing adult bone marrow-
derived human MSCs to endothelial cell differentiation-inducing conditions for up 
to 12 days, the MSCs were able to form capillary-like structures on Matrigel.42,43 A 
study by Roobrouck et al. also showed that human MSCs are able to differentiate 
into endothelial cells in the presence of vascular endothelial growth factor.44 The 
aforementioned results are, however, were not in line with those of Au et al. and 
Delorme et al. who showed that bone marrow-derived human MSCs are not able 
to differentiate toward the endothelial lineage even after priming the cells under 
endothelial conditions.45,46
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14 in vivo cardiac differentiation of mscs
Multiple in vivo studies have been conducted investigating the regenerative capac-
ity of MSCs in the diseased heart.25,47-50 Nevertheless, the ability of MSCs to undergo 
cardiac differentiation in vivo remains a highly controversial topic. While some stud-
ies showed expression of cardiomyocyte proteins in a sarcomeric organization after 
cardiac stem cell transplantation in an animal model, they did not use an additional 
marker to determine whether these cells were indeed of MSC origin (e.g. species-, 
strain- or gender-specific markers).25,50 Also, Toma et al. did not look into the pos-
sibility of heterologous cell fusion as an explanation for the expression of cardio-
myocyte proteins by the transplanted MSCs.50 In contrast, Quevedo et al. showed 
that male MSCs are able to differentiate into cardiomyocytes, smooth muscle cells 
and endothelial cells after allogeneic stem cell transplantation in the chronically 
infarcted myocardium of a female swine by co-localization of the Y chromosome 
with markers of cardiac muscle, vascular muscle and endothelial lineages.49 None-
theless, in all the vivo studies mentioned above, the frequency with which MSCs 
differentiated into cardiac cells was low.49,50 Furthermore, MSC engraftment rate in 
these studies is also minimal. Therefore, modest improvements in cardiac function 
observed in most animal studies have been ascribed to paracrine mechanisms. 
MSCs secrete cytokines and growth factors that can inhibit apoptosis and fibro-
sis, suppress the immune system and induce angiogenesis.48,51-53 In recent animal 
studies, genetically modified MSCs have been used to increase their therapeutic 
efficacy. For example, overexpression of chemokine receptors by MSCs have been 
shown to improve cell viability, migration, engraftment and capillary density in the 
injured myocardium.54 Furthermore, paracrine factors that are released by MSCs 
that overexpress GATA4 increase angiogenesis and cell survival.55 Also, Akt overex-
pression led to repair of the infarcted myocardium and improvement of the cardiac 
function.56 Therefore, genetic modification of MSCs may be a tool to increase their 
effectiveness in mediating cardiac repair.
clinical trials of msc therapy for cardiac repair
Clinical cardiac stem cell therapy for acute MI and ischemic cardiomyopathy using 
bone marrow-derived MSCs has been conducted.28,57,58 In these phase I/II trials 
different cell delivery routes, such as intravenous and intracoronary infusion and 
intramyocardial injection were investigated. The main objective of these studies 
was determining safety of both autologous and allogeneic MSC therapy. Chen et al. 
investigated the effects of intracoronary autologous MSC infusion in patients with 
acute MI. Compared to controls, which were infused with saline, cardiac function 
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was modestly improved in patients who received MSCs. More important, however, 
was that this study showed intracoronary autologous MSC infusions to be safe with 
regard to adverse events such as occurrence of arrhythmias after cell administra-
tion. Moreover, no deaths were reported during the 6-month follow-up period.57 
Hare et al. investigated the safety and efficacy of intravenous allogeneic human 
MSC infusion in patients with acute MI. This randomized, double-blind, placebo-
controlled dose-escalation study showed that allogeneic intravenous MSC delivery 
is safe in acute MI patients and also improves cardiac function in these patients 
compared to that in controls.28 This study is especially interesting as multiple stud-
ies have shown that functional capacities of stem cells decline with age.59,60 Use 
of allogeneic stem cells from young donors may help to increase the therapeutic 
effect of cardiac cell-based therapy.
Cardiac MSC therapy has also been initiated for patients with cardiac injury 
post-MI. Williams et al. showed that intramyocardial injection of autologous 
bone marrow-derived MSCs in patients with ischemic cardiomyopathy improved 
regional contractility of a chronic myocardial scar and led to reverse remodeling. 
Importantly, the intramyocardial cell injections did not cause sustained ventricular 
arrhythmias. This clinical trial shows that cardiac stem cell therapy in patients with 
ischemic cardiomyopathy is safe and has positive effects on cardiac structure and 
function.58 The findings of this early-phase clinical trial have led to larger studies in 
which bone marrow-derived MSCs will be compared to mononuclear cells (TAC-
HFT trial)61, autologous MSC therapy will be compared to allogeneic MSC therapy 
(POSEIDON study), MSCs will be delivered during coronary artery bypass surgery 
(PROMETHEUS trial) and MSC therapy will be investigated for treatment of idi-
opathic dilated cardiomyopathy (POSEIDON-DCM study). In addition, another 
clinical trial in which MSCs are primed ex vivo with cytokines to improve cardiac 
differentiation in vivo has been initiated.62 While the smaller clinical studies have 
shown that stem cell therapy is safe and feasible and modest improvements in car-
diac function were achieved, the outcomes of the larger double-blind, randomized-
controlled clinical trials will have to reveal whether MSC-based cardiac therapy is 
truly beneficial.
The current experience with the use of MSCs to treat cardiac diseases has pro-
vided several leads to improve their therapeutic efficacy. First of all, the option of 
using allogeneic stem cells from young donors in cardiac stem cell therapy should 
be thoroughly investigated as several studies have exposed that the functional 
capacity of stem cells declines with age.59,60 Also, another major issue regarding 
cell transplantation that deserves examination is the low survival and engraftment 
rate that have been reported in studies in which MSCs were injected.25,48,50 Recent 
studies have focused on improving engraftment rate by using biomaterials.63-65 The 
risks of adverse events (e.g. occurrence of arrhythmias) that could occur when the 
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16 engraftment rate is improved are largely unknown and future studies should also 
take these into account. Besides engraftment, alignment with the surrounding 
myocardial tissue also seems to be of importance as alignment of stem cells could 
influence the mechanical and electrical activation of the heart. Currently, cardiac 
patches have been engineered to improve structural and electrical integration in 
host myocardium after cardiac stem cell transplantation.66-68 Before MSC-based 
therapy will find widespread application in the clinic, the issues raised above should 
be answered in extensive in vitro studies, animal experiments and clinical studies.
aim and outline of the thesis
In recent years stem cell based therapies have shown to give modest improve-
ments in heart function. Most clinical trials have been conducted with autologous 
and therefore adult stem cells. However, functional capacity of stem cells decline 
with age. Therefore, chapter II of this thesis focuses on the influence of donor 
age on the in vitro differentiation potential of mesenchymal stem cells (MSCs) 
towards three cardiac lineages, namely cardiomyocytes, smooth muscle cells and 
endothelial cells. The exact mechanism behind improvement of cardiac function 
after stem cell transplantation is unknown, but functional integration with host car-
diac tissue is known to be important for therapeutic efficiency and to avoid adverse 
effects.69 The myocardium has a typical anisotropic tissue structure, which affects 
electrical and mechanical activation. Therefore, MSC-derived cardiac cells should 
align properly with native cardiac cells in order to restore tissue structure and for 
anisotropic conduction. Chapter III discusses the influence of forced alignment of 
MSCs undergoing cardiomyogenic differentiation on their functional integration 
with myocardial cells. Besides functional integration, electrical coupling with the 
surrounding host tissue is fundamental to make MSC-based therapy a safe option. 
Clinical trials in which skeletal myoblasts were transplanted in the diseased myo-
cardium emphasized the importance of gap junctional coupling with the resident 
cardiomyocytes. Transplantation of skeletal myoblasts that after differentiation 
into myotubes do not eletromechanically couple with host myocardium led to an 
increased incidence of arrhythmias in patients.70-72 Gap junctional coupling also 
seems to play an essential role in inducing cardiomyogenic differentiation. Multi-
ple studies show stem cells are able to undergo cardiomyogenesis when they are 
in close contact with native cardiomyocytes. Therefore, chapter IV evaluates the 
role of gap junctional coupling in the cardiomyogenic differentiation potential of 
human MSCs. As cardiomyogenic differentiation of stem cells is often investigated 
after intramyocardial transplantation or in co-cultures with cardiomyocytes, they 
are commonly labeled through viral transduction with a marker protein to facili-
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tate their identification. An often neglected pitfall of these studies is secondary 
transduction of cardiomyocytes by viral vector-marked stem cells and a second 
marker to distinguish stem cell-derived cardiomyoctes from native cardiomyocytes 
is rarely used. In chapter V, secondary transduction of neonatal rat cardiomyocytes 
by adult human cells that had previously been transduced with an enhanced green 
fluorescent protein-encoding lentiviral vector was studied.
The initial results of cell transplantation studies show improvement in cardiac 
function, however, therapeutic efficiency is not optimal due to low survival and 
engraftment rate of the transplanted cells. Biomaterials have been developed to 
improve survival and engraftment rate and thereby therapeutic efficiency. The pos-
sible adverse effects of a higher engraftment rate and of the pattern of distribution 
of a higher number of transplanted cells are unknown. These aspects are studied 
in chapter VI, which explores the role of engraftment patterns of MSCs on arrhyth-
micity in controlled in vitro models. Not only transplantation of exogenous cells in 
the diseased myocardium could lead to arrhythmias, proliferation of endogenous 
myofibroblasts after MI is known to cause conduction disturbances. An alterna-
tive way to minimize the negative effects of MI is described in Chapter VII of this 
thesis. In this chapter in a vitro model is used to study whether anti-proliferative 
treatment of myofibroblasts prevents arrhythmias by limitation of myofibroblast-
induced depolarization.
Chapter VIII provides the summary and conclusions of this thesis, as well as 
future perspectives related to stem cell-based therapies for the treatment of dam-
aged myocardium.
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24 abstract
Mesenchymal stem cells (MSCs) show unexplained differences in differentiation 
potential. In this study, differentiation of human (h) MSCs derived from embryonic, 
fetal and adult sources toward cardiomyocytes, endothelial and smooth muscle 
cells was investigated.
Labeled hMSCs derived from embryonic stem cells (hESC-MSCs), fetal umbili-
cal cord, bone marrow, amniotic membrane and adult bone marrow and adipose 
tissue were co-cultured with neonatal rat cardiomyocytes (nrCMCs) or cardiac 
fibroblasts (nrCFBs) for 10 days, and also cultured under angiogenic conditions.
Cardiomyogenesis was assessed by human-specific immunocytological analy-
sis, whole-cell current-clamp recordings, human-specific qRT-PCR and optical 
mapping. After co-culture with nrCMCs, significantly more hESC-MSCs than fetal 
hMSCs stained positive for α-actinin, whereas adult hMSCs stained negative. Fur-
thermore, functional cardiomyogenic differentiation, based on action potential 
recordings, was shown to occur, but not in adult hMSCs. Of all sources, hESC-MSCs 
expressed most cardiac-specific genes. hESC-MSCs and fetal hMSCs contained sig-
nificantly higher basal levels of connexin43 than adult hMSCs and co-culture with 
nrCMCs increased expression. After co-culture with nrCFBs, hESC-MSCs and fetal 
hMSCs did not express α-actinin and connexin43 expression was decreased. Con-
duction velocity (CV) in co-cultures of nrCMCs and hESC-MSCs was significantly 
higher than in co-cultures with fetal or adult hMSCs. In angiogenesis bioassays, 
only hESC-MSCs and fetal hMSCs were able to form capillary-like structures, which 
stained for smooth muscle and endothelial cell markers.
Human embryonic and fetal MSCs differentiate toward three different cardiac 
lineages, in contrast to adult MSCs. Cardiomyogenesis is determined by stimuli 
from the cellular microenvironment, where connexin43 may play an important role.
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introduction
Despite significant advances in the management of cardiovascular disease, it 
remains the predominant cause of morbidity and mortality in Western countries 
[1]. The risk of developing cardiovascular disease increases with age and is associ-
ated with progressive impairment of cardiovascular repair mechanisms, including 
the capacity of the heart to replace damaged cells [2].
In recent years, cell therapy has been studied intensively as novel therapeu-
tic option for cardiac diseases. After transplantation and engraftment of cells in 
the host myocardium, different mechanisms are thought to be responsible for the 
improvement in cardiac function, including angiogenesis and cardiomyogenesis [3]. 
Mesenchymal stem cells (MSCs) are one of the cell types studied in clinical trials 
for treatment of ischemic heart disease. However, MSCs themselves are prone to 
the effects of aging and disease and if autologous MSCs are used, may suffer from 
decreased ability to proliferate, differentiate, home, engraft and exert immunosup-
pressive effects [4,5]. Moreover, the developmental stage of tissues and different 
states of disease alter the microenvironmental regulation of stem cell behaviour 
[6]. Whether the developmental stage of MSC donor tissue also affects the car-
diac differentiation potential of MSCs is not completely understood. While the role 
of MSCs in cardiac development is largely unknown, several studies indicate that 
MSCs derived from young cell sources, like umbilical cord blood, appear to retain 
their primitive characteristics [7,8]. Also, some of these MSCs seem to possess car-
diovascular differentiation potential in vitro and in vivo [9,10]. More recently, cells 
with MSC-like characteristics have been derived from human embryonic stem cells 
(ESCs) [11–15]. These cells resemble hMSCs derived from various tissue sources 
with respect to morphology, surface marker profile, immunogenicity and differen-
tiation potential toward osteogenic, adipogenic and chrondrogenic lineages [12,14]. 
More important, they lack expression of pluripotency-associated markers, and after 
transplantation, no teratoma formation has been reported [12,16]. MSCs derived 
from human ESCs may therefore be mesoderm progenitors like primitive MSCs 
and may constitute the most primitive committed mesodermal cell type.
In this study, it was investigated whether the developmental stage of the tis-
sue, from which hMSCs were derived, had an effect on the cardiac differentiation 
potential of these cells. To this end, the ability of hMSCs derived from ESCs, fetal 
(amniotic membrane, umbilical cord and bone marrow) and adult (adipose tissue 
and bone marrow) tissue sources to differentiate towards cardiomyocytes, smooth 
muscle cells and endothelial cells was studied.
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isolation and culture of neonatal rat cardiomyocytes and fibroblasts
All animal experiments were approved by the Animal Experiments Committee of 
the Leiden University Medical Center (LUMC) and conform to the Guide for the 
Care and Use of Laboratory Animals, as stated by the US National Institutes of 
Health (permit numbers: 09012 and 10236). Neonatal rat ventricular cardiomyo-
cytes (nrCMCs) and fibroblasts (nrCFBs) were isolated and cultured as described 
previously [10].
isolation, culture and characterization of hmscs
All human-derived tissues were collected based on individual written (parental) 
informed consent, after approval by the Medical Ethics committee of the LUMC, 
where all investigations were performed. The investigation conforms with the prin-
ciples outlined in the Declaration of Helsinki. Human mesenchymal stem cells 
(hMSCs) were derived from embryonic stem cells (hESC-MSCs), fetal amniotic 
membrane (amniotic), umbilical cord (UC), bone marrow (BM), adult BM and adi-
pose tissue (adipose). Furthermore, fetal human skin fibroblasts (hSFBs) were also 
isolated and used as control cells (see Online Supplement for extensive descrip-
tion of cell isolation and culture procedures). All hMSCs were characterized by flow 
cytometry, adipogenic and osteogenic differentiation ability, immunocytological 
analyses, growth kinetics and telomere length. After characterization, cells were 
labeled with enhanced green fluorescent protein (eGFP) and put in co-culture with 
nrCMCs or nrCFBs for 10 days to study their cardiomyogenic differentiation poten-
tial. Differentiation was assessed by human-specific immunocytological analyses, 
whole-cell current-clamp recordings, human-specific quantitative reverse transcrip-
tion-polymerase chain reaction (qRT-PCR) analysis and optical mapping of action 
potential propagation. In addition, Western Blot analysis was used to study the 
expression of connexin43 (Cx43) in relation to differentiation of hMSCs. All experi-
ments described below were conducted using hMSCs from passage 3-6.
flow cytometry
Analysis of surface marker expression was carried out by flow cytometry using fluo-
rescein isothiocyanate-, phycoerythrin- or allophycocyanin-conjugated antibodies 
directed against human CD105 (Ancell, Bayport, MN, USA), CD90, CD73, CD45, 
CD34, CD31, CD24 and stage-specific embryonic antigen-4 (SSEA-4) (all from Bec-
ton Dickinson, Franklin Lakes, NJ, USA).
adipogenic and osteogenic differentiation
Adipogenesis and osteogenesis of hMSCs were induced by incubating hMSCs in 
appropriate differentiation media. Lipid accumulation was assessed by Oil Red O 
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(Sigma-Aldrich, St. Louis, MO, USA), while calcium deposits were visualized by 
staining the cells with 2% Alizarine Red S (Sigma-Aldrich).
growth kinetics
Growth kinetics of the hMSCs was analyzed by calculating population doublings 
(PDs). hMSCs were plated in triplicate and trypsinized every 5 days and sub-
jected to Trypan Blue staining to determine the viable cell concentration using a 
hemocytometer.
relative telomere length
Genomic DNA from experimental and reference samples was obtained using DNA-
zol (Invitrogen, Breda, The Netherlands). Relative telomere lengths were measured 
by SYBR Green-based (Qiagen, Valencia, CA, USA) qRT-PCR amplification of tel-
omere repeats (T) and single-copy gene 36B4 (S) in a LightCycler 480 Real-Time 
PCR System (Roche, Foster City, CA, USA).
immunocytochemical analyses
Co-cultures or monocultures were fixed in 4% paraformaldehyde, permeabilized 
with 0.1% Triton X-100, and stained with primary antibodies. Primary antibodies 
specific for human lamin A/C (Vector laboratories, Burlingame, CA, USA), SSEA-4, 
Oct3/4 (both Santa Cruz Biotechnologies, Santa Cruz, CA, USA), Nanog (R&D Sys-
tems, Minneapolis, MN, USA), CD90, CD73, and CD105 were used to characterize 
hESC-MSCs. Co-cultures were stained with α-actinin, Cx43 (both Sigma-Aldrich) 
and human lamin A/C. Primary antibodies were visualized with Alexa fluor-conju-
gated antibodies (Invitrogen). Nuclei were stained using Hoechst 33342 (Invitro-
gen). A fluorescence microscope equipped with a digital camera (Nikon Eclipse, 
Nikon Europe, Badhoevedorp, The Netherlands) and dedicated software (Image-
Pro Plus, Version 4.1.0.0, Media Cybernetics, Silver Spring, MD, USA) were used 
to analyze data. All cultures were treated equally using the same antibody dilutions 
and exposure times.
electrophysiological measurements in pharmacologically uncoupled 
hmscs in co-culture with nrcmcs
In order to study functional cardiomyogenic differentiation in hMSCs, either eGFP-
labeled fetal or adult hMSCs were put in co-culture with nrCMCs and studied as 
described previously [10]. In brief, at day 10 of co-culture, 180 µmol/L of 2-ami-
noethoxydiphenyl borate (2-APB) (Tocris, Ballwin, MO, USA) was added to the 
extracellular solution, resulting in gap junction uncoupling [17,18], which allowed 
for single-cell studies within the co-culture. Next, whole-cell current-clamp record-
ings were performed in eGFP-labeled hMSCs.
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Total cellular RNA was extracted from monocultures of hMSCs and from co-cul-
tures consisting of hMSCs and nrCMCs using the RNeasy Mini kit (Qiagen). Oligo 
(dT)-primed reverse transcription was performed on 2 µg of total cellular RNA and 
the resultant cDNA was used for PCR amplification using SYBR Green. To detect 
changes in cardiac and pluripotency gene expression levels, only human-specific 
primers were used. The expression of the genes of interest was normalized to that 
of the housekeeping gene glyceraldehyde-3-phosphate dehydrogenase (GAPDH). 
Specific primer information and annealing temperatures are provided in the Online 
Supplement. Data were analyzed using the ΔCt method.
optical mapping to determine conduction velocity in co-cultures of 
nrcmcs and different types of hmscs
Action potential conduction velocity (CV) was investigated on a whole-culture 
scale in wells of a 24-well plate by optically mapping using the voltage-sensitive 
dye di-4-ANEPPS (Invitrogen). The measurements were performed 10 days after 
seeding of either 8x105 nrCMCs (nrCMC monoculture) or 8x105 nrCMCs plus 8x104 
nrCFBs or 8x104 hMSCs (nrCMC/nrCFB or nrCMC/hMCS co-cultures) per well. The 
co-cultures were mapped using the Ultima-L optical mapping setup (SciMedia, 
Costa Mesa, CA, USA). Optical signal recordings were analyzed using Brain Vision 
Analyze 0909 (Brainvision Inc, Tokyo, Japan). The CV of all (co-)cultures was deter-
mined in a blinded manner.
assessment of angiogenesis
All types of hMSCs were were plated on Matrigel (Becton Dickinson) and cultured 
in Endothelial Growth Medium-2 (Cambrex IEP, Wiesbaden, Germany) containing 
100 ng/mL recombinant human VEGF-A165 (R&D Systems) up to 24 h to determine 
their ability to form capillary-like structures. Following culture under angiogenic 
conditions, cells were fixed and stained with antibodies specific for smooth muscle 
myosin heavy chain (smMHC; Sigma-Aldrich) and platelet/endothelial cell adhe-
sion molecule-1 (PECAM-1; Santa Cruz).
western blot analysis
Homogenates were made from at least 5 different isolations of hMSCs per source. 
Equal amounts of protein were size-fractionated in a 12% NuPage Tris-Acetate 
gel (Invitrogen) and transferred to a Hybond-P PVDF membrane (GE Healthcare, 
Waukesha, WI, USA). This membrane was incubated for 1 h with an antibody 
against Cx43 followed by incubation with horse radish peroxidase conjugated goat 
anti-rabbit secondary antibody (Santa Cruz). To check for equal protein loading, 
the housekeeping protein GAPDH (Chemicon International, Temecula, CA, USA) 
was used.
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statistics
Experimental results were expressed as mean±standard deviation (SD) for a given 
number (n) of observations. Data was analyzed by Student’s t-test for direct com-
parisons. Analysis of variance followed by the appropriate post-hoc analysis was 
performed for multiple comparisons. Statistical analysis was performed using 
SPSS 16.0 for Windows (SPSS Inc, Chicago, IL, USA). Differences were considered 
statistically significant at P<0.05.
A detailed description of the materials and methods can be found in the Supple-
mental Materials and Methods S1.
results
isolation and characterization of hmscs
All types of hMSCs displayed a spindle-shaped morphology (Supplemental Figure 
S1A1-F1). To evaluate MSC properties, their surface phenotype and adipogenic and 
osteogenic differentiation capacity were studied. All types of hMSCs were negative 
for CD31 (endothelial cell marker), CD34, CD45 (hematopoietic cell markers), and 
SSEA-4 (embryonic stem cell marker), whereas they were positive for CD90, CD73 
and CD105 (mesenchymal cell markers). Furthermore, hESC-MSCs were negative 
for CD24, indicating absence of hESCs in our cultures (Supplemental Table S1). In 
vitro differentiation assays confirmed that all types of hMSCs were able to differen-
tiate into adipocytes and osteoblasts thus confirming their multipotent differentia-
tion potential (Supplemental Figure S1A2-F2 and S1A3-F3, respectively).
growth kinetics
Comparison of the growth kinetics of hESC-MSCs with those of fetal or adult 
hMSCs showed that hESC-MSCs had a significantly larger replication capacity dur-
ing 20 days in culture (35.1 PDs) than any of the fetal hMSCs types (22.3-31.6 PDs) 
and both types of adult MSCs (6.4-12.8 PDs) (P<0.001). Fetal hMSCs also prolifer-
ated more rapidly and grew to higher densities than both types of adult hMSCs 
(P<0.001) (Supplemental Figure S1G).
telomere length
Replicative stability of hMSCs was determined by estimating their relative telomere 
lengths (i.e. telomere repeat copy number to single gene copy number [T/S] ratio). 
Relative telomere length was significantly longer in hESC-MSCs (4.87±0.7) and in 
fetal hMSCs (2.48±0.4) than in adult hMSCs (0.89±0.2) (P<0.05; n=10 samples 
from different isolations for each hMSC group). Relative telomere length was also 
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Figure 1. Characterization of hESC-MSCs: (A1) Bright field image of a hESC colony in which 
the cells at the periphery are differentiating toward spindle-shaped fibroblast-like cells and 
(A2-A3) pure cultures of hESC-MSC. (B1-B2) Confirmation of the human origin of the hMSCs 
derived from hESC colonies with the aid of a human-specific lamin A/C antibody. Incubation 
of murine MSCs (mMSCs; negative control cells) with this antibody (B1) did not produce 
signal corroborating its species specificity. (C1-E2) Immunostaining of hESC colonies and 
hMSCs derived from these colonies for the embryonic stem cell marker SSEA-4 and the 
pluripotency markers Oct-4 and Nanog. Nuclei were detected with Hoechst.
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significantly longer in hESC-MSCs than in fetal hMSCs (P<0.05; n=10 samples from 
different isolations for each hMSC group) (Supplemental Figure S1H).
immunocytological characterization of hesc-mscs
All fibroblast-like cells derived from the hESC colonies (Figure 1A1-A3) were rec-
ognized by a monoclonal antibody specific for human lamin A/C confirming the 
human origin of these cells (Figure 1B2). Murine MSCs (mMSCs), which served as 
a negative control, were negative for this marker (Figure 1B1). In addition, hESC-
MSCs were negative for the undifferentiated hESC marker SSEA-4 and the pluripo-
tency markers Oct-4 and Nanog (Figure 1C2-E2) in contrast to the hESC colonies 
from which the fibroblast-like cells were derived (Figure 1C1-E1). However, hESC-
MSCs were positive for the mesenchymal cell markers CD90, CD73 and CD105 
(Supplemental Figure S2A1-A3).
assessment of cardiomyogenic differentiation
Human-specific immunocytological evaluation
At day 10 of co-culture with nrCMCs, 7.17±0.4% eGFP-labeled hESC-MSCs (n=1,500 
cells analyzed from 5 different isolations) were positive for the sarcomeric protein 
α-actinin (Figure 2A1 and 2E), which was a significantly higher fraction than the per-
centage of fetal hMSCs staining for α-actinin (fetal amniotic MSCs 2.15±0.2%, fetal 
BM MSCs 1.8±0.3% and fetal UC MSCs 2.56±0.7%, n=1,200 cells analyzed from 
4 different isolations per type of fetal hMSC) (P<0.001) (Figure 2B and 2E). Further-
more, in some of the hESC-MSCs (30.8%), fetal amniotic MSCs (25.8%) and fetal 
BM MSCs (5.89%) α-actinin was distributed in a cross-striated pattern typical for 
CMCs. After 10 days of co-culture with nrCMCs, adult BM and adipose MSCs did 
not stain for α-actinin (n=1,200 cells analyzed from 4 different isolations per type 
of adult hMSC) (Figure 2C and 2E). eGFP-labeled fetal hSFBs in co-culture with 
nrCMCs were not positive for α-actinin (n=1,200 cells analyzed from 4 different 
isolations) (Figure 2D and 2E) indicating that not all fibroblastic human cell types 
acquire cardiomyocyte properties in co-culture with nrCMCs. To exclude fusion 
of nrCMCs with hMSCs or secondary transduction of nrCMCs with eGFP, all co-
cultures were also stained for human-specific lamin A/C. None of the eGFP posi-
tive cells were negative for human-specific lamin A/C or contained multiple nuclei 
(n≥8,500 eGFP-positive cells analyzed) confirming the validity of the assay system.
To assess the influence of the cellular microenvironment on cardiomyogenic 
differentiation of hESC-MSCs and fetal hMSCs the presence of α-actinin in these 
cells after 10 days of co-culture with nrCFBs rather than nrCMCs was determined. 
Alpha-actinin was not expressed by hESC-MSCs (Figure 3A1) or any of the fetal 
hMSC types (Figure 3A2) after co-culture with nrCFBs (n=1,200 cells analyzed from 
3 different isolation of each hMSC type) (Figure 3B).
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Figure 2. Immunocytological assessment of cardiomyogenic differentiation of different 
types of hMSCs after 10 days of co-culture with nrCMCs. (A1-B3) A fraction of eGFP-labeled, 
human-specific lamin A/C positive hESC-MSCs and fetal amniotic, BM and UC hMSCs 
expressed α-actinin (indicated as α-act), while (C1-C2) adult BM and adipose hMSCs did 
not. (D) eGFP-labeled human fetal skin fibroblasts (hSFBs; negative control cells) in co-
culture with nrCMCs did not stain positive for α-actinin. (E) Quantitative analysis of the 
cardiomyogenic differentiation of different types of hMSCs. The graph is based on a mini-
mum of 1,200 cells analyzed from 4 separate isolations per hMSC type. #P<0.001 vs all 
fetal and adult hMSC types; *P<0.05 vs adult hMSCs; ND is not detected. (F) Intracellular 
electrophysiological measurements in fetal (amniotic) and adult (adipose) hMSCs at day 10 
of co-culture with nrCMCs and after pharmacological uncoupling of gap junctions. Intrin-
sic action potentials could be recorded from eGFP-labeled fetal cells, while adult hMSCs 
showed only steady membrane potentials.
Ramkisoensing.indd   32 22-4-2014   11:51:27
33
human mesenchymal stem cells and cardiac differentiation
Figure 3. Study of cardiomyogenic differentiation in hESC-MSCs and fetal hMSCs after 
co-culture with nrCFBs for 10 days assessed by immunocytological analysis. (A1-A2) No 
α-actinin expression, indicated as α-act, was detected in eGFP-labeled, human-specific 
lamin A/C positive hESC-MSCs or fetal hMSCs after co-incubation with nrCFBs. Nuclei 
were detected with Hoechst. (B) Quantitative analysis of cardiomyogenic differentiation 
of hESC-MSCs and all of the fetal hMSC types co-cultured with nrCFBs or nrCMCs. The 
graph is based on a minimum of 1,200 cells analyzed from 3 separate isolations per hMSC 
type. #P<0.001 vs hESC-MSCs and fetal hMSCs co-cultured with nrCFBs and fetal hMSCs 
in co-culture with nrCMCs; *P<0.01 vs fetal hESC-MSCs and fetal hMSCs co-cultured with 
nrCFBs; ND is not detected.
Intracellular electrophysiological measurements in pharmacologically uncoupled 
hMSCs in co-culture with nrCMCs.
Patch-clamp recordings were obtained from eGFP-labeled fetal and adult hMSCs at 
day 10 of co-culture with nrCMCs after electrical isolation through incubation with 
the gap junction uncoupler 2-APB. Action potentials could only be measured in 
fetal hMSCs (n=5, amniotic), this in contrast to adult hMSCs (n=8, adipose), which 
only showed steady membrane potentials (Figure 2F). Selection of cells was based 
on eGFP-labeling and the presence of 2-4 nrCMCs adjacent to the cells of interest.
Human-specific qRT-PCR analysis to detect pluripotency and cardiac differentiation
qRT-PCR showed that at the mRNA level, hESC-MSCs expressed the following car-
diac markers: Nkx2.5, GATA-4, ANP, MLC2v and Cx43. These mRNAs were upregu-
lated after co-culture with nrCMCs (P<0.001 for both ANP and MLC2v; P<0.01 for 
Nkx2.5; P<0.05 for both GATA-4 and Cx43). However, Islet-1 and c-kit mRNA lev-
els were lower in co-cultured hESC-MSCs compared to hESC-MSC monocultures 
(P<0.01 and P<0.05, respectively). No significant difference in gene expression 
of VEGF was detected in hESC-MSCs before or after co-incubation with nrCMCs 
(Figure 4A). Fetal amniotic hMSCs showed an increase in Nkx2.5 (P<0.05), ANP, 
Cx43 and VEGF (all P<0.01) gene expression after co-culture with nrCMCs, while 
Islet-1 mRNA levels were decreased under these circumstances (P<0.05). No 
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34  difference in c-kit gene expression was detected in these fetal hMSCs before or 
after co-incubation with nrCMCs (Figure 4B). In fetal UC hMSCs, mRNA levels of 
GATA-4, Cx43 (both P<0.05) and VEGF (P<0.001) were significantly upregulated 
after their co-culture with nrCMCs, while Islet-1 and c-kit gene expression were 
downregulated (P<0.001 and P<0.01, respectively). No change in the expression of 
ANP was detected in fetal UC hMSCs following co-incubation with nrCMCs (Fig-
ure 4C). Fetal BM hMSCs showed an increase in ANP (P<0.001), Cx43 and c-kit 
(both P<0.05) gene expression co-incubation with nrCMCs, while no difference 
in Islet-1 and VEGF mRNA levels were detected under these circumstances (Fig-
ure 4D). At the mRNA level, ANP, Cx43, VEGF and c-kit were detected in adult BM 
and adipose hMSCs. However, after co-culture with nrCMCs, only the expression 
of ANP (P<0.05) and VEGF (P<0.01) increased in both types of adult hMSCs. In 
adult adipose hMSCs c-kit mRNA levels were also upregulated in the presence of 
nrCMCs (P<0.05) (Figure 4E-4F). Oct-4, Nanog, cTnI and β-MHC gene expression 
was not detected in any of the hMSC types. qRT-PCR analysis of RNA from appro-
priate human control samples confirmed the functionality of all human-specific 
primer pairs. The same primer pairs did not give rise to amplification products 
using nrCMC RNA as starting material. Expression of the qRT-PCR target genes 
in nrCMCs was confirmed using rat-specific primers. Quantitative differences in 
gene expression between hMSCs cultured alone or with nrCMCs are given in sup-
plemental table S2.
Optical mapping analysis to determine action potential CV in co-cultures of nrCMCs 
with different types of hMSCs
CV in nrCMC co-cultures with hESC-MSCs (25.9±0.9 cm/s) was similar to the 
CV in nrCMC cultures alone (24.8±1.2 cm/s) (Figure 5B1-B2 and 5C). However, it 
was significantly higher than in co-cultures of nrCMCs with fetal amniotic hMSCs 
(22.0±1.8 cm/s), adult adipose hMSCs (18.2±1.1 cm/s) and nrCFBs (17.0±1.2 cm/s) 
(P<0.001; n≥15 co-cultures with each cell type) (Figure 5B3-B5 and C). CV was also 
higher in co-cultures of nrCMCs with fetal amniotic hMSCs than in co-cultures with 
adult adipose hMSCs or with nrCFBs (P<0.001) (Figure 5B3-B5 and C).
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Figure 4. Analysis by qRT-PCR of expression of pluripotency and cardiac genes in hMSCs 
alone or after co-incubation with nrCMCs. (A) hESC-MSCs expressed most cardiac-specific 
genes, which were significantly upregulated after co-incubation with nrCMCs. Expression 
of the cardiac progenitor genes, Islet-1 and c-kit, was downregulated in the presence of 
nrCMCs. (B-D) The fetal hMSC types expressed a variety of cardiac-specific genes, which 
were upregulated after co-culture with nrCMCs. Islet-1 and c-kit mRNA levels decreased in 
the presence of nrCMCs with the exception of the upregulation of c-kit gene expression in 
fetal BM MSCs following their co-culture with nrCMCs. (E-F) ANP, Cx43, VEGF and c-kit 
gene expression was detected in adult hMSCs before and after co-incubation with nrCMCs. 
(A-F) hMSCs did not express the pluripotency genes Oct-4 and Nanog. #P<0.05 vs specific 
hMSC monoculture; *P<0.01 vs specific hMSC monoculture; †P<0.001 vs specific hMSC 
monoculture.
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Figure 5. Assessment of CV by optical mapping in co-cultures of nrCMCs and different types 
of hMSCs. (A) The presence of hMSCs and nrCFBs after optical mapping was confirmed 
by immunostaining for human-specific lamin A/C and collagen type I, respectively. Nuclei 
were detected with Hoechst. (B) Activation maps of the different (co-)cultures reveal signifi-
cantly higher CVs in nrCMCs monocultures and in hESC-MSCs/nrCMC and fetal amniotic 
hMSCs/nrCMC co-cultures than in co-cultures of nrCMCs with adult adipose hMSCs or 
with nrCFBs. CVs were also significantly higher in nrCMC monocultures and in hESC-MSCs/
nrCMC co-cultures than in co-cultures between nrCMCs and fetal amniotic hMSCs. Spac-
ing of isochronal lines in activation maps is 4 ms, and colors indicate temporal sequence of 
activation, starting from the red area. (C) Bar graph of the CVs in nrCMC monocultures and 
in co-cultures (+) between nrCMCs and nrCFBs or different types of hMSCs as indicated. 
#P<0.001 vs fetal amniotic hMSCs, adult adipose hMSCs and nrCFBs co-incubated with 
nrCMCs; *P<0.01 vs adult adipose hMSCs and nrCFBs co-incubated with nrCMCs.
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in vitro angiogenesis assays
hESC-MSCs and all types of fetal hMSCs were able to form capillary-like structures 
on Matrigel (n≥5 isolations of each hMSC type incubated in triplicate) (Figure 6A1-
D1). These networks stained positively for the smooth muscle marker smMHC and 
the endothelial cell marker PECAM-1 (Figure 6A2-D2). Formation of cellular net-
works was established by hESC-MSCs 12 h after incubation on Matrigel. For hMSCs 
derived from the fetal sources it took 18 h to establish capillary-like networks. Adult 
BM and adipose tissue hMSCs failed to form capillary-like structures (n≥5 isola-
tions of each hMSC type incubated in triplicate) (Figure 6E-F). Formation of vessel-
like networks was checked every hour for a total period of 24 h.
evaluation of cx43 expression levels
To further analyze mechanisms underlying differences in cardiomyogenic poten-
tial, Cx43 expression levels were evaluated. Immunocytological analysis showed 
that Cx43 protein expression was more abundant in hESC-MSCs and fetal amniotic 
MSCs than in adult adipose MSCs and nrCFBs (n=5 isolations of each hMSC type 
were assessed) (Figure 7A). These results were confirmed by Western blot analysis 
(n=5 different isolations for each cell type) (Figure 7C). Cx43 expression was also 
detected at the interfaces between nrCMCs and hESC-MSCs or fetal MSCs, while 
under equivalent staining conditions it was not present at contact-areas between 
nrCMCs and adult hMSCs or nrCFBs (Figure 7A). Moreover, Cx43 did not line bor-
ders between nrCFBs and any of the types of hMSCs (n≥1,500 cells analyzed from 
5 isolations of each cell type under each condition) (Figure 7A). qRT-PCR showed a 
significant increase in Cx43 expression following the incubation of hESC-MSCs or 
fetal amniotic hMSCs with nrCMCs (9.14±0.9 (P<0.01) and 3.94±0.5 fold (P<0.001), 
respectively), while no (hESC-MSCs) or 19.4±0.1 fold less (fetal amniotic hMSCs) 
Cx43 mRNA was detected in co-cultures with nrCFBs (P<0.05) (Figure 7B1-B2). No 
significant difference in Cx43 mRNA levels was detected between adult adipose tis-
sue hMSCs cultured alone or together with nrCMCs or nrCFBs (Figure 7B3).
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Figure 6. Angiogenic differentiation capacity of different types of hMSCs assessed by forma-
tion of capillary-like structures and expression of angiogenic markers following their culture 
on Matrigel. (A1-D1) Bright field images show that hESC-MSCs and fetal hMSCs were able to 
form stable cellular networks on a basement membrane matrix, while (E1-F1) adult hMSCs 
could not. (A2-D2) hESC-MSCs and all fetal hMSC types stained positive for the endothelial 
cell protein, PECAM-1, and the smooth muscle cell protein, smMHC, while (E2-F2) the adult 
hMSCs were negative for these markers. Nuclei were stained with Hoechst.
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Figure 7. Analysis by immunofluorescence microscopy, qRT-PCR and Western blotting of 
Cx43 expression in hMSC monocultures and in co-cultures of nrCMCs or nrCFBs with differ-
ent types of hMSCs. (A1-A2) Immunocytological analysis shows high Cx43 levels in mono-
cultures of hESC-MSCs and fetal amniotic hMSCs. Cx43 was also detected at the interfaces 
of these young hMSCs with nrCMCs but not with nrCFBs. nrCMCs were visualized by stain-
ing with ɑ-actinin (indicated as ɑ-act), while an antibody against human-specific lamin A/C 
was used to detect hMSCs. Nuclei were detected with Hoechst. (A3-A4) Adult adipose 
hMSCs contain very low amounts of Cx43 in both monocultures and co-cultures with nrC-
MCs or nrCFBs. Also in nrCFB monocultures and nrCFB/nrCMC co-cultures Cx43 is barely 
detectable. (B1-B3) Bar graphs of the assessment by qRT-PCR of Cx43 mRNA levels in hESC-
MSC, fetal amniotic hMSC and adult adipose hMSC monocultures and co-cultures (+) of 
these cells with either nrCMCs or nrCFBs as indicated. (C) Picture of representative part of 
a Western blot showing that hESC-MSCs and fetal amniotic hMSCs contain large amounts 
of Cx43 in contrast to adult adipose hMSCs and nrCFBs. The housekeeping protein glyceral-
dehyde-3-phosphate dehydrogenase (GAPDH) was used to check for equal protein loading. 
#P<0.05 vs hMSCs in co-culture with nrCFBs; *P<0.01 vs hMSC monocultures and hMSCs 
in co-culture with nrCFBs.
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Key findings of the present study are: 1) Differentiation potential of hMSCs toward 
three cardiac cell lineages depends on the developmental stage of donor tissue; 
2) Cardiomyogenesis of hMSCs is influenced by stimuli from the cellular microen-
vironment; and 3) The propensity of different types of hMSCs to acquire properties 
of heart muscle cells correlates with Cx43 expression levels.
development and stemness
During embryonic development, stem cells contribute to organ formation, while 
later in life these cells or their derivatives are involved in repair and regeneration 
of organs [6]. However, with increasing age, the potential of stem cells declines 
[19,20]. This decrease in the regenerative ability is associated with cumulative 
organ dysfunction, which may lead to increased morbidity and mortality. Consist-
ent with this developmental stage-dependent decline in function of stem cells, this 
study showed that MSCs derived from hESCs have significantly greater prolifera-
tive capacity and longer telomeres than MSCs derived from human fetal tissue, or 
adult hMSCs. The intrinsic age-associated decrease in telomere length is one of 
the mechanisms that contributes to the loss of stem cell properties with age [21]. 
The results of this first-time direct comparison of the proliferative capacity of hESC-
MSCs, fetal hMSCs and adult hMSCs are in line with previous studies [12,13,22–24]. 
All together, these findings show that MSCs derived from human ESCs are more 
immature and display greater stemness than those derived from fetal tissues.
mscs and cardiac differentiation
In the present study, it was also shown that hMSCs derived from either embry-
onic or fetal sources have the capacity to undergo cardiac differentiation, while 
those derived from adult sources do not. Our results revealed that developmental 
stage of the donor tissue not only influences the ability of hMSCs to differentiate 
into CMCs but also their capacity to undergo smooth muscle and endothelial dif-
ferentiation. This information may be of value in extending the repertoire of cells 
considered suitable for studies of cardiac repair. We showed that after co-culture 
with nrCMCs the sarcomeric protein α-actinin is expressed by a significantly higher 
percentage of hESC-MSCs than of fetal hMSCs, while it was not expressed by adult 
hMSCs. Although the cardiomyogenic potential of MSCs derived from neonatal 
sources has been described before, a direct comparison of hMSCs derived from 
embryonic, fetal and adult sources was not conducted [9,10]. Controversy still 
exists on whether MSCs actually differentiate into CMCs or whether this apparent 
cardiomyogenesis is due to fusion of MSCs with CMCs [25]. Therefore, in all our 
co-culture experiments eGFP-transduced hMSCs were stained for human-specific 
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lamin A/C. Neither multinucleated eGFP positive cells nor eGFP positive cells 
negative for human-specific lamin A/C were detected. In addition, only human-
specific primers were used in the qRT-PCR experiments to exclude detection of 
rat cardiac-specific genes expressed by nrCMCs. Accordingly, the cardiomyogenic 
differentiation of hMSCs observed in our experiments does not result from cell 
fusion. Importantly, the records of intrinsic action potentials in eGFP positive cells 
at day 10 of co-culture provides direct evidence for functional cardiomyogenic 
differentiation.
With respect to smooth muscle and endothelial differentiation, only hESC-MSCs 
and fetal hMSCs were able to form capillary-like structures on Matrigel. These net-
works stained positive for the smooth muscle marker smMHC and the endothelial 
marker PECAM-1. Previous studies showed that adult BM-derived MSCs were able 
to form capillary-like structures after priming the cells in endothelial differentiation 
medium. However, after priming, UC hMSCs had higher endothelial potential than 
adult BM hMSCs [26,27].
Concerning the underlying mechanisms why adult hMSCs do not form CMCs, 
Cx43 expression may be of importance. In this study, hMSCs are co-cultured with 
nrCMCs, resulting in physical contact between these two cell types, and allowing 
the possibility for gap junction formation. Gap junctions, which in the ventricles 
are mainly formed by Cx43, allow a low-resistant spread of chemical and electrical 
signals between adjacent cells [28]. Interestingly, hMSCs derived from adult human 
sources express very low levels of Cx43, both at mRNA and protein level, as com-
pared to hMSCs derived from embryonic and fetal sources. In addition, hMSCs, 
which underwent functional cardiomyogenic differentiation, were always adjacent 
to native CMCs, naturally containing high levels of Cx43. As hMSCs are able to 
form functional gap junctions with adjacent CMCs [29], electrical and chemical 
interaction can occur between both cell types and this was shown to play a role in 
cardiomyogenic differentiation [30]. Interestingly, co-culture of MSCs with cardiac 
fibroblasts, expressing very low levels of Cx43, did not result in cardiomyogenic 
differentiation. In fact, using human-specific primers, Cx43 expression levels in 
hMSCs were shown to decrease significantly in this microenvironment.
As Cx43 plays an essential role in myocardial electrical conduction across the 
ventricular muscle, and cardiomyogenic differentiation would make non-excitable 
MSCs become excitable, we also studied the CV across co-cultures of hMSCs with 
nrCMCs. It was shown that co-cultures with hESC-MSCs showed a significantly 
higher CV than those with fetal hMSCs and adult hMSCs, while the CV in co-cul-
tures with fetal hMSCs was also significantly higher than that in those with adult 
hMSCs. Of note, embryonic MSCs did not only show high expression of Cx43, but 
had the greatest cardiomyogenic differentiation potential. The type of MSC that 
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42 contributes to the highest CV may be preferable to accomplish functional integra-
tion with host myocardium after transplantation.
msc transplantation for cardiac diseases
Besides providing new insights into the factors that stimulate cardiac differentia-
tion, the findings of this study may also have implications for the use of MSCs in 
patients. Currently, in myocardial cell therapy studies mainly autologous cells from 
aged patients suffering from chronic diseases are used. Based on our results, it may 
be expected that the therapeutic effects of MSC transplantation, to improve cardiac 
function, are affected by intrinsic properties of the transplanted cells. Furthermore, 
the beneficial effects of stem cell therapy in the damaged heart seems to be largely 
mediated by paracrine factors promoting neo-angiogenesis and CMC survival with 
little evidence of the differentiation of transplanted cells into CMCs [3]. As these 
effects will be of limited help in case of extensive loss of myocardial tissue there 
is still a great demand for stem cells that can differentiate in vivo into new CMCs. 
In this study, we have shown that hMSCs of prenatal origin can differentiate into 
functional CMCs and that this process is dependent on instructive cues provided 
by neighboring CMCs. Therefore selection of MSCs from donor sources, such as 
the umbilical cord or amniotic membrane/fluid, may be an attractive source of 
immature or young cells for autologous cell transplantation. Even allogeneic trans-
plantation may be considered as MSCs are reported to have immunomodulatory 
properties [31–33]. However, many aspects related to transplantation of cardiomyo-
genic stem cells need to be studied in more detail before optimal therapeutic effi-
cacy and minimal hazardous potential can be achieved.
conclusions
Human MSCs of embryonic stem cell or fetal but not adult origin can differentiate 
into three cardiac lineages: cardiomyocytes, endothelial cells and smooth muscle 
cells. The ability to undergo functional cardiomyogenic differentiation is amongst 
others determined by the microenvironment of the cells, in particular their com-
munication with adjacent cell types. The gap junction protein Cx43 may play an 
important role in this differentiation process.
study limitations
It would have been more clinically relevant to co-culture the different hMSC sub-
types with adult human hCMCs, but obtaining these cells in the numbers needed 
to conduct these experiments seems not feasible. Furthermore, adult hCMCs can-
not be cultured long enough to perform some of the key experiments described in 
this paper.
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supplemental materials and methods s1
expanded materials & methods
isolation and culture of human mesenchymal stem cells (hmscs)
All human-derived tissues were collected based on individual written (parental) 
informed consent, after approval by the Medical Ethics committee of the Leiden 
University Medical Center (LUMC), where all investigations were performed. The 
investigation conforms with the principles outlined in the Declaration of Helsinki.
Derivation of MSCs from human embryonic stem cells (hESCs)
MSCs were derived from undifferentiated hESC colonies (hES3 subclones) as pre-
viously described [1,2]. Briefly, the undifferentiated hESC colonies were removed 
from their mouse embryonic fibroblast (mEF) feeder layer and propagated in gel-
atin-coated culture dishes in standard MSC culture medium (Dulbecco’s modified 
Eagle’s medium [Invitrogen, Breda, The Netherlands] containing 10% fetal bovine 
serum [FBS; Invitrogen], penicillin [100 U/mL] and streptomycin [100 µg/mL]; here-
inafter referred to as MSC-CM) at 37ºC in a humidified 5% CO2 incubator. After 
2-3 days of culture, a portion of the cells at the periphery of the hESC colonies dif-
ferentiated toward spindle-shaped fibroblast-like cells. Next, the undifferentiated 
portions of the hESC colonies were removed by physical scraping and suctioning. 
Consecutive enzymatic passaging as single cell suspensions led to a reproducible 
derivation of morphologically homogeneous fibroblast-like cells from cultures of 
pluripotent undifferentiated hESCs within 2-3 passages (n=5 different isolations). 
Medium was replaced twice a week until the primary cultures were 60-80% conflu-
ent, after which the so-called hESC-MSCs were amplified by serial passage using a 
buffered 0.05% trypsin-0.02% ethylenediaminetetraacetic acid/EDTA solution (TE; 
BioWhittaker, Vervier, Belgium) for cell detachment.
Fetal hMSC isolation and culture
Human fetal tissues (gestational age between 17-22 weeks) were collected through 
legal interventions by the Department of Obstetrics. Fetal umbilical cords (UCs) 
and amniotic membranes were washed twice with phosphate-buffered saline (PBS) 
and were finely minced into 1-2 mm fragments using scissors and scalpels. Cells 
were released by treatment with 0.1% collagenase type I (Worthington, Lakewood, 
NJ, USA) for 3 h. Thereafter, 10 mL MSC-CM was added. The cell suspension was 
transferred to a 25-cm2 culture flask (Becton Dickinson, Franklin Lakes, NJ, USA) 
and incubated for 3-4 days at 37ºC in a humidified 5% CO2 atmosphere to allow the 
cells to adhere. Fetal UC and amniotic membrane (amniotic) hMSCs were subcul-
tured as described in the previous section. Single cell suspensions of fetal bone 
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46 marrow (BM) were obtained by punching fetal femora and tibiae with a 23-gauge 
needle and flushing them with culture medium. The cell suspension was centri-
fuged at 330 g for 10 min after which the same culture methods were applied as for 
the other fetal hMSCs. To obtain human fibroblasts, sections of human fetal skin 
(5×5 mm) were transferred to 25-cm2 culture flasks containing 5 ml MSC-CM and 
maintained in a humidified 5% CO2 incubator at 37°C. Fetal human skin fibroblasts 
(hSFBs) were allowed to migrate from the skin sections for 7 days. Thereafter, the 
skin sections were removed and the remaining hSFBs were cultured using standard 
procedures.
Adult MSC isolation and culture
Adult hMSCs were purified from leftover BM samples derived from adult donors 
undergoing orthopedic surgery (n=8 donors, mean donor age 72±2.4 yrs). Briefly, 
the mononuclear cell fraction of the BM was isolated by Ficoll density gradient cen-
trifugation. Twenty-four hours after seeding of the BM mononuclear cell fraction in 
75-cm2 culture flasks (Becton Dickinson), the non-adherent cells were removed and 
the remaining hMSCs were expanded by serial passage using standard methods.
Adult adipose tissue (adipose) hMSCs were derived from subcutaneous adb-
dominal fat tissue (n= 10 donors, mean donor age 39.6±1.1 yrs). Tissue samples 
were washed twice with PBS containing penicillin (100 U/mL) and streptomycin 
(100  µg/mL). For tissue disruption 0.1% collagenase type I solution was added 
and tissue samples were finely minced. Next, samples were incubated at 37°C in 
a humidified 5% CO2 incubator for 1 h. Collagenase type I activity was quenched 
by adding excess MSC-CM. Samples were then centrifuged at 330 g for 10 min. 
After centrifugation the layer of primary adipocytes could be removed and the col-
lagenase type I-containing solution was aspirated. The cell pellet was resuspended 
in MSC-CM, filtered through a 70 mm cell strainer (Becton Dickinson) and the cells 
were once again collected by centrifugation. This step was repeated twice, after 
which the cell pellet was resuspended in 5 ml culture medium. The resulting cell 
suspension was transferred to a 25-cm2 culture flask and these adult adipose tissue 
(adipose) hMSCs were propagated as all the other hMSCs.
isolation and culture of neonatal rat (nr) cardiomyocytes (cmcs) and 
cardiac fibroblasts (cfbs)
All animal experiments were approved by the Animal Experiments Committee of 
the LUMC and conform to the Guide for the Care and Use of Laboratory Animals, 
as stated by the US National Institutes of Health (permit numbers: 09012 and 
10236) [3].
nrCMCs and nrCFBs were dissociated from ventricles of 2-day old male Wistar 
rats, separated from each other by differential plating and maintained in nrCMC 
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culture medium containing 5% horse serum (Invitrogen), penicillin (100 U/mL; Bio-
Whittaker) and streptomycin (100 µg/mL; BioWhittaker), as previously described 
[4]. nrCFBs were cultured in MSC-CM and passaged at least three times before they 
were used in co-culture experiments.
Five hundred thousand or one million nrCMCs were plated on collagen type 
I -coated (Sigma-Aldrich) glass coverslips in 6-well culture dishes and incubated 
in a humidified incubator at 37 C and 5% CO2. Proliferation of residual nrCFBs in 
nrCMC cultures was inhibited by incubation of the cells with 100 mmol/L 5-bromo-
2-deoxyuridine (Sigma-Aldrich) during the first 24 h after culture initiation.
For optical mapping experiments, 8×104 nrCMCs were plated on fibronectin 
-coated (Sigma-Aldrich) glass coverslips in 24-well culture dishes. As the conduc-
tion velocity (CV) through monolayers of nrCMCs is inversely related to their CFB 
content, prior to their use in co-incubation experiments with hMSCs, the nrCMC 
cultures were treated for 2 h with 10 mg/mL mitomycin-C (Sigma-Aldrich) to stop 
proliferation of residual nrCFBs present in these cultures [12].
characterization of hmscs
Flow cytometry
Analysis of surface marker expression was carried out by flow cytometry. hMSCs 
(passage³3) were detached using TE, resuspended in PBS containing 1% bovine 
serum albumin fraction V (BSA; Sigma-Aldrich) and divided in aliquots of 2×105 
cells. Cells were then incubated for 30 min at 4°C with fluorescein isothiocyanate-, 
phycoerythrin- or allophycocyanin-conjugated antibodies directed against human 
CD105 (Ancell, Bayport, MN, USA), CD90, CD73, CD45, CD34, CD31, CD24 and 
stage-specific embryonic antigen-4 (SSEA-4) (all from Becton Dickinson). Labeled 
cells were washed three times with PBS containing 1% BSA and analyzed using an 
LSR II three-laser, 12-color, flow cytometer (Becton Dickinson). Isotype-matched 
control antibodies (Becton Dickinson) were used to determine background fluores-
cence. At least 104 cells per sample were acquired and data were processed using 
FACSDiva software (Becton Dickinson).
Adipogenic and osteogenic differentiation of hMSCs
The hMSCs were characterized by established differentiation assays [5]. Briefly, 
5x103 hMSCs per well were plated in a 12-well culture plate and exposed to adi-
pogenic or osteogenic differentiation medium. Adipogenic differentiation medium 
consisted of MEM-plus (i.e. α-minimum essential medium [Invitrogen] containing 
15% FBS, 100 U/L penicillin and 100 µg/mL streptomycin) supplemented with insu-
lin, dexamethason, indomethacin and 3-isobutyl-1-methylxanthine (all from Sigma-
Aldrich) to final concentrations of 5 µg/mL, 1 µM, 50 µM and 0.5 µM, respectively, 
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48 and was refreshed every 3-4 days for a period of 3 weeks. Lipid accumulation was 
assessed by Oil Red O (Sigma-Aldrich) staining of the cultures (15 mg of Oil Red O/
mL of 60% isopropanol) and light microscopy. Osteogenic differentiation medium 
consisted of MEM-plus containing 10 mM b-glycerophosphate, 50 µg/mL ascorbic 
acid and 10 nM dexamethason (all from Sigma-Aldrich) and was refreshed every 
3-4 days for a period of 3 weeks. Afterwards, the cells were washed with PBS and 
calcium deposits were visualized by staining of the cells for 5 min with 2% Alizarine 
Red S (Sigma-Aldrich) in 0.5% NH4OH (pH 5.5).
Immunocytological characterization of hESC-MSCs
hESC colonies were originally grown on a feeder layer of mEFs. To verify the human 
origin of the fibroblast-like cells derived from the hESC colonies, the cells were 
incubated with a monoclonal antibody (MAb) specific for human lamin A/C (clone 
636; Vector laboratories, Burlingame, CA, USA) at a dilution of 1:200, as previously 
described [6]. Binding of the primary antibody to its target antigen was visualized 
using Alexa 568-linked donkey anti-mouse IgG secondary antibodies (Invitrogen; 
dilution 1:200). Murine MSCs (mMSCs) were not labeled with the human lamin 
A/C-binding MAb, confirming its species specificity.
In addition, hESC-MSCs were stained with antibodies directed against the hESC 
marker SSEA-4 (MAb MC813; Santa Cruz Biotechnologies, Santa Cruz, CA, USA) 
or against the pluripotency-associated transcription factors Oct-3/4 (MAb N-19; 
Santa Cruz) and Nanog (goat polyclonal antibody [PAb]; R&D Systems, Minneapo-
lis, MN, USA). Each of these primary antibodies was applied at a dilution of 1:100. 
As secondary antibodies we used Alexa 568-conjugated donkey anti-mouse IgG or 
donkey anti-goat IgG (both from Invitrogen) at a dilution of 1:200. hESC colonies 
from which the hESC-MSCs were derived, were used as a positive control in these 
stainings. Lastly, hESC-MSCs were stained with fluorescein isothiocyanate- and 
phycoerythrin- conjugated antibodies directed against the mesenchymal stem cell 
markers CD90, CD73 and CD105 at a dilution of 1:200.
Growth kinetics
Growth kinetics of the hMSCs was analyzed by calculating population doublings 
(PDs). Each type of hMSC was plated in triplicate at a concentration of 2x103 hMSCs 
per cm2 in 25-cm2 culture flasks (n=3 isolations for each type of hMSC). After every 
5 days of culture at 37°C in 95% humidified air-5% CO2, the cells were trypsinized 
and resuspended in 5 mL. Subsequently, a part of each cell suspension was sub-
jected to Trypan Blue staining to determine the viable cell concentration using a 
hemocytometer. This information was used to initiate the next cell passage in a 
new culture flask and to determine the number of PDs during the previous culture 
period.
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Relative telomere length using quantitative real-time polymerase chain reaction 
(qRT-PCR)
Genomic DNA from experimental (n³6 samples of ESC-derived, fetal or adult MSCs 
cultured for the same period of time) and reference samples was obtained using 
DNAzol (Invitrogen) according to the recommendations of the manufacturer. Rel-
ative telomere lengths were measured by SYBR Green-based (QuantiTect SYBR 
Green PCR kit; Qiagen, Valencia, CA, USA) qRT-PCR amplification of telomere 
repeats (T) and single-copy gene 36B4 (S) in a LightCycler 480 Real-Time PCR Sys-
tem (Roche, Foster City, CA, USA). The 36B4 gene was analyzed to normalize for 
differences in DNA amount between samples. The primers, primer concentrations 
and thermal cycling profiles were identical to those of Cawthon et al [7]. T and S 
standard curves were generated using serial dilutions (100 to 20 ng) of the DNA 
from the reference sample. The telomere- and 36B4-specific qPCRs were carried 
out in separate plates and a standard curve was produced in each run to allow 
relative quantification between samples (50 ng per sample). The T/S ratio of one 
sample relative to that of another corresponds to the relative telomere lengths of 
their DNA. Since the amount of PCR product approximately doubles during each 
amplification cycle, the T/S ratio is approximately [2Ct(telomeres)/ 2Ct(36B4)]-1 = 2-ΔCt. The 
relative T/S ratio is 2-(ΔCt1-ΔCt2) = 2-ΔΔCt.
cardiac differentiation potential of hmscs derived from different 
sources
To facilitate the identification of hMSCs in co-cultures with nrCMCs or nrCFBs, 
these cells were transduced with enhanced green fluorescent protein (eGFP) using the 
vesicular stomatitis virus G protein-pseudotyped self-inactivating human immuno-
deficiency virus type 1 (HIV-1) vector CMVPRES [8], essentially as described by van 
Tuyn et al [9]. Before being used in co-culture experiments, the eGFP- transduced 
hMSCs were subcultured for several passages to avoid undesired secondary trans-
ductions of nrCMCs or nrCFBs by infectious HIV-1 particles carried over by the 
hMSCs. Cardiomyogenic differentiation was studied in co-cultures of 5x104 eGFP-
labeled hMSCs and 5x105 nrCMCs or 5x105 nrCFBs. As a control group, 5x104 
eGFP-labeled fetal hSFBs were co-incubated with 5x105 nrCMCs. The eGFP-labeled 
hMSCs and fetal hSFBs were added to the nrCMCs two days after they had been 
isolated and put into culture. All experiments described below were conducted 
using hMSCs from passage 3-6.
Human-specific immunocytochemical analysis of cardiomyogenic differentiation 
potential
Co-cultures of 5x105 nrCMCs and 5x104 eGFP-labeled hMSCs or eGFP-labeled fetal 
hSFBs and co-cultures of 5x105 nrCFBs with 5x104 eGFP-labeled hMSCs were stained 
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50 with a MAb recognizing the sarcomeric protein α-actinin (clone EA53; Sigma-
Aldrich; dilution 1:400) on day 10 after culture initiation, as previously described [6]. 
The primary antibody was visualized using Alexa 568-coupled donkey anti-mouse 
IgG secondary antibodies at a dilution of 1:200. The human lamin A/C-specific 
MAb mentioned above was used to detect hMSCs in the co-cultures. Lamin A/C 
staining was visualized with Qdot 655-streptavidin conjugates (Invitrogen) after 
incubation of the cells with biotinylated goat anti-mouse IgG2b secondary antibod-
ies (Santa Cruz). Nuclei were stained using a 10 µg/mL solution of Hoechst 33342 
(Invitrogen) in PBS containing 1% FBS. The percentage of eGFP-labeled cells show-
ing positive staining for α-actinin was determined by analyzing at least 3 cultures 
(100 cells per culture, at 100x magnification) of at least 4 hMSC isolations per type 
of hMSC). The presence of well-organized sarcomeres in eGFP-labeled hMSCs was 
assessed by comparing the α-actinin staining pattern in these cells with that of the 
native nrCMCs in each culture.
A fluorescence microscope equipped with a digital camera (Nikon Eclipse, 
Nikon Europe, Badhoevedorp, The Netherlands) and dedicated software (Image-
Pro Plus, Version 4.1.0.0, Media Cybernetics, Silver Spring, MD, USA) were used to 
analyze data. All co-cultures were treated equally using the same antibody dilutions 
and exposure times.
Electrophysiological measurements in pharmacologically uncoupled hMSCs in 
co-culture with nrCMCs
Whole-cell patch-clamp measurements were performed in co-cultures of 5x104 
eGFP-labeled fetal (amniotic) or adult (adipose) hMSCs and 5x105 nrCMCs, plated 
on collagen-coated glass coverslips, at day 10 of culture. To perform single-cell 
measurements from eGFP-labeled cells in a field of beating nrCMCs, cells were 
pharmacologically uncoupled by incubation with 180 µmol/L of 2-aminoethoxy-
diphenyl borate (2-APB) (Tocris, Ballwin, MO, USA) for 15 min [6]. This agent 
blocks gap junctional intercellular coupling by Cx40, Cx43, and Cx45 [10,11]. Whole-
cell current-clamp recordings were performed at 25°C using a L/M-PC patch-clamp 
amplifier (3 kHz filtering) (List-Medical, Darmstadt, Germany). Pipette solution 
contained (in mmol/L) 10 Na2ATP, 115 KCl, 1 MgCl2, 5 EGTA, 10 HEPES/KOH 
(pH 7.4). Tip resistance was 2.0 - 2.5 MW, and seal resistance >1 GW. The bath solu-
tion contained (in mmol/L) 137 NaCl, 4 KCl, 1.8 CaCl2, 1 MgCl2, 10 HEPES (pH 7.4). 
For data acquisition and analysis pClamp/Clampex8 software (Axon Instruments, 
Molecular Devices, Sunnyvale, CA, USA) was used. Current-clamp recording were 
performed in eGFP-labeled cells which were adjacent to 2-4 nrCMCs, and from 
these cells the data were analyzed and compared between the two different groups.
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Human-specific quantitative reverse transcription-PCR (qRT-PCR) to detect mRNAs 
associated with pluripotency and cardiac differentiation
Total cellular RNA was extracted from monocultures of hMSCs (n³4 samples from 
each type of hMSC) and from co-cultures consisting of 105 hMSCs and 106 nrCMCs 
using the RNeasy Mini kit (Qiagen). Oligo (dT)-primed reverse transcription was 
performed on 2 µg of total cellular RNA and the resultant cDNA was used for PCR 
amplification using SYBR Green. To detect changes in cardiac and pluripotency 
gene expression levels, the following human-specific primers: gap junction protein, 
alpha 1 (Cx43/GJA1; QT00012684), vascular endothelial growth factor A (VEGF/
VEGFA; QT01682072), GATA-binding protein 4 (GATA-4/GATA4; QT00031997), 
Nanog homeobox (Nanog/NANOG; QT01844808), octamer-binding protein 3/4 
(Oct-3/4/POU5F1; QT00210840), NK2 transcription factor related, locus 5 (Dros-
ophila) (Nkx2.5/NKX2-5; QT00010619), v-kit Hardy-Zuckerman 4 feline sarcoma 
viral oncogene homolog (c-kit/KIT; QT01844549), natriuretic peptide precur-
sor A (ANP/NPPA; QT00203322), myosin, light chain 2, regulatory, cardiac, slow 
(MLC2v/MYL2; QT00012999), ISL LIM homeobox 1 (Islet-1/ISL1; QT00000294), 
troponin I type 3 (cardiac) (cTnI/TNNI3; QT00084917) (all with an annealing tem-
perature of 55°C; all from Qiagen) and myosin heavy chain 7, cardiac muscle, beta 
(b-MCH/MYH7; forward primer: 5’-TGTGTCACCGTCAACCCTTA-3’, reverse primer: 
5’-TGGCTGCAATAACAGCAAAG-3’; annealing temperature 63°C; Invitrogen). The 
expression of the genes of interest was normalized to that of the housekeeping 
gene glyceraldehyde-3-phosphate dehydrogenase (GAPDH, forward primer: 5́ -GAA-
GGTGAAGGTCGGAGTC-3́ , reverse primer: 5́ -GAAGATGGTGATGGGATTTC-3́ ; 
annealing temperature 60°C; Invitrogen). Agarose gel electrophoresis was used to 
ensure that each primer pair yielded a single PCR product of the expected size. 
PCR primers were checked for human specificity with the aid of appropriate posi-
tive human right atrium and hESC control and negative nrCMC control samples, 
while rat-specific primers were used to detect expression of the cardiac genes in the 
nrCMC control samples. Data were analyzed using the ΔCt method.
Optical mapping to determine CV in co-cultures between nrCMCs and different types 
of hMSCs
Action potential propagation was investigated on a whole-culture scale in wells 
of a 24-well plate by optically mapping using the voltage-sensitive dye di-4-AN-
EPPS ( Invitrogen). The measurements were performed 10 days after seeding of 
either 8x105 nrCMCs (nrCMC monoculture) or 8x105 nrCMCs plus 8x104 nrCFBs or 
8x104 hMSCs (nrCMC/nrCFB or nrCMC/hMCS co-cultures) per well (n³15 cultures 
per cell type or combination of cell types). Co-cultures were loaded with 16 μmol/L 
di-4-ANEPPS for 30 minutes. After which medium was refreshed and the co- 
cultures were mapped using the Ultima-L optical mapping setup (SciMedia, Costa 
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52 Mesa, CA, USA). Throughout mapping experiments, cultures were kept at 37ºC. 
Optical signal recordings were analyzed using Brain Vision Analyze 0909 (Brainvi-
sion Inc, Tokyo, Japan). For more details regarding the optical mapping protocol 
see Askar et al [12]. The CV of all (co-)cultures was determined in a blinded manner.
in vitro angiogenesis assays
hMSCs of different origin (n³5 isolations for each type of hMSC) were plated 
on Matrigel (Becton Dickinson) to determine their ability to form capillary-like 
structures. Ninety microliters of gel matrix solution was applied to each well of 
a 24-well plate on top of a glass coverslip and the plate was incubated for 1 h 
at 37°C. After trypsinization, 1.5x104 cells were suspended in 1 mL of Endothelial 
Growth Medium-2 (Cambrex IEP, Wiesbaden, Germany) containing 100 ng/mL 
recombinant human VEGF-A165 (R&D Systems), plated onto the basement mem-
brane matrix and incubated for up to 24 h at 37°C in 95% humidified air-5% CO2. 
Formation of capillary-like structures was checked every hour. Maximum time of 
incubation was determined for each type of hMSC. Following culture on the base-
ment membrane matrix, cells were fixed and stained with antibodies specific for 
smooth muscle myosin heavy chain (smMHC; MAb hSM-V; Sigma-Aldrich, dilu-
tion 1:100) and platelet/endothelial cell adhesion molecule-1 (PECAM-1; rabbit PAb 
M20; Santa Cruz, dilution 1:200). The primary antibodies were visualized with Alexa 
568-coupled donkey anti-mouse IgG and Alexa 488-conjugated donkey anti-rabbit 
IgG (Invitrogen), respectively. All cultures were treated equally using the same anti-
body dilutions and exposure times, which were based on titration of the antibodies 
using appropriate positive and negative controls.
determination of cx43 expression
Cx43 protein levels and gene expression were detected in monocultures of hESC-
MSCs, fetal amniotic hMSCs and adult adipose hMSCs, but also in co-cultures 
of these cells with nrCMCs or nrCFBs using immunocytology and qRT-PCR, as 
described earlier. The Cx43-specific rabbit PAb (C6219; Sigma Aldrich, dilution 
1:200) was visualized with Alexa 488-conjugated donkey anti-rabbit IgG. Cx43 
expression was determined for at least 5 different isolations of each type of hMSCs 
under the different conditions (100 cells per culture and at least 3 cultures per 
isolation were analyzed). All cultures were treated equally using the same antibody 
dilutions and exposure times, which were based on titration of the antibodies using 
appropriate positive and negative controls.
Western blot analysis was used to quantify Cx43 levels in cultures of hMSCs. 
Homogenates were made from at least 5 different isolations of hMSCs per source. 
After determining the protein concentration in each sample using the BCA Pro-
tein Assay Reagent (Pierce Biotechnology, Rockford, IL, USA), equal amounts of 
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protein were size-fractionated in a 12% NuPage Tris-Acetate gel (Invitrogen) and 
transferred to a Hybond-P PVDF membrane (GE Healthcare, Waukesha, WI, USA). 
This membrane was incubated for 1 h with the PAb directed against Cx43 followed 
by incubation with horse radish peroxidase (HRP)-conjugated goat anti-rabbit sec-
ondary antibody (Santa Cruz). To check for equal protein loading, a mouse MAb 
recognizing the housekeeping protein GAPDH (Chemicon International, Temecula, 
CA, USA) was used, which was detected by an HRP-conjugated goat anti-mouse 
secondary antibody (Santa Cruz). Chemiluminescence was induced with the aid 
of the ECL Advance Western Blotting Detection Kit and caught on Hyperfilm ECL 
(both from GE Healthcare).
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54 supporting information legends
Supplemental Materials and Methods S1. A detailed description of the materials and meth-
ods can be found in this supporting information file.
Supplemental figure S1. Cellular characteristics of hMSCs. (A1-F1) Bright field images of 
cultured hMSCs displaying a spindle-shaped morphology. (A2-F2) Presence of oil red 
O-stained fat vacuoles after adipogenic differentiation. (A3-F3) Calcium depositions after 
osteogenic differentiation was visualized by alizarine red S staining. (A) hESC-MSC; (B) fetal 
amniotic hMSC; (C) fetal UC hMSC; (D) fetal BM hMSC; (E) adult BM hMSC; (F) adult adi-
pose hMSC. (G) Growth kinetics of the different types of hMSCs estimated by cumulative 
population doublings over 20 days (*P<0.001 vs fetal hMSCs and adult hMSCs, #P<0.001 vs 
adult hMSCs). (H) Mean relative telomere lengths of hESC-MSCs, all fetal hMSC types and 
both adult hMSC types (*P<0.05 vs fetal hMSCs and adult hMSCs, #P<0.05 vs adult hMSCs).
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CD24 0.30±0.7 NT NT NT NT NT
CD31 0.0±0.0 0.0±0.0 0.0±0.0 0.0±0.0 0.0±0.0 0.0±0.0
CD34 0.13±0.1 0.0±0.0 0.13±0.1 0.0±0.0 0.17±0.1 0.06±0.0
CD45 0.20±0.4 0.07±0.0 0.10±0.1 0.18±0.1 0.20±0.1 0.6±0.5
CD73 97.6±1.9 95.4±0.8 97.3±1.3 97.7±1.1 96.6±1.4 96.4±0.3
CD90 96.0±1.7 98.2±1.3 96.3±1.5 96.3±3.1 98.2±0.9 94.6±1.8
CD105 94.0±0.9 95±0.9 96.6±0.2 97.4±0.6 96.0±2.8 96.0±0.2
SSEA-4 0.0±0.0 0.0±0.0 0.0±0.0 0.0±0.0 0.0±0.0 0.0±0.0
Supplemental table S1. Analysis of surface marker expression. All hMSC types were positive 
for the established MSC surface markers CD105, CD90 and CD73. They were negative for 
the hematopoietic, endothelial and embryonic stem cell markers CD45 and CD34, CD31 and 
SSEA-4, respectively. The hESC-MSCs were also negative for CD24, a protein present on the 
surface of hESCs. Mean percentages ± standard deviations are given; n=6 for each group. 
NT is not tested.
Supplemental figure S2. Immunocytological characterization of hESC-MSCs for MSC sur-
face markers. Immunostaining of hESC-MSCs for CD90, CD105 and CD73 (A1-A3) showed 
that these cells were positive for these established MSC surface markers.
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56 Nkx2.5 GATA-4 ANP MLC2v Cx43 VEGF Islet-1 c-kit
hESC-MSC 6.15±1.2* 5.77±0.6# 2.97±0.1† 12.0±0.6† 9.13±0.9# 1.18±0.3 0.43±0.1* 0.53±0.2#
Fetal amni-
otic hMSC
7.26±0.4# ND 1.56±0.1* ND 3.94±0.5* 3.85±0.3* 0.35±0.1# 0.75±0.2
Fetal UC 
hMSC
ND 5.79±1.4# 1.04±0.1 ND 2.72±0.2# 2.32±0.1† 0.50±0.1† 0.36±0.1*
Fetal BM 
hMSC
ND ND 3.73±0.1† ND 1.97±0.3# 0.93±0.1 6.13±1.9 6.13±1.9†
Adult BM 
hMSC
ND ND 2.07±0.4# ND 1.03±0.3 1.44±0.8* ND 0.84±0.3
Adult adi-
pose hMSC
ND ND 5.18±1.5# ND 1.22±0.2 11.7±1.8* ND 5.71±1.0#
Supplemental table S2. qRT-PCR analysis to detect mRNAs associated with cardiac differ-
entiation. Indicated is the fold change in the expression of cardiac genes in hMSCs cultured 
alone or together with nrCMCs. #P<0.05 vs hMSC monoculture; *P<0.01 vs hMSC monocul-
ture; †P<0.001 vs hMSC monoculture; ND is not detected.
Ramkisoensing.indd   56 22-4-2014   11:51:39
chapter iii
forced alignment of mesenchymal stem cells 
undergoing cardiomyogenic differentiation 
affects functional integration with 
cardiomyocyte cultures
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58 abstract
Alignment of cardiomyocytes (CMCs) contributes to the anisotropic (direction-
related) tissue structure of the heart, thereby facilitating efficient electrical and 
mechanical activation of the ventricles. This study aimed to investigate the effects 
of forced alignment of stem cells during cardiomyogenic differentiation on their 
functional integration with CMC cultures.
Labeled neonatal rat (nr) mesenchymal stem cells (MSCs) were allowed to dif-
ferentiate into functional heart muscle cells in different cell-alignment patterns 
during 10 days of co-culture with nrCMCs. Development of functional cellular 
properties was assessed by measuring impulse transmission across these stem 
cells between two adjacent nrCMC fields, cultured onto micro-electrode arrays and 
previously separated by a laser-dissected channel (230±10 mm) for nrMSC trans-
plantation. Coatings in these channels were micro-abraded in a direction (1) paral-
lel, or (2) perpendicular to the channel, or (3) left unabraded, to establish different 
cell patterns.
Application of cells onto micro-abraded coatings resulted in anisotropic cell 
alignment within the channel. Application on unabraded coatings resulted in iso-
tropic (random) alignment. Upon co-culture, conduction across seeded nrMSCs 
occurred from day 1 (perpendicular and isotropic) or day 6 (parallel) onward. Con-
duction velocity (CV) across nrMSCs at day 10 was highest in the perpendicular 
(11±0.9 cm/s,n=12), intermediate in the isotropic (7.1±1 cm/s,n=11), and lowest 
in the parallel configuration (4.9±1 cm/s,n=11) (p<0.01). nrCMCs and fibroblasts 
served as positive and negative control, respectively. Also, immunocytochemical 
analysis showed alignment-dependent increases in Cx43 expression.
In conclusion, forced alignment of nrMSCs undergoing cardiomyogenic differ-
entiation affects the time course and degree of functional integration with sur-
rounding cardiac tissue.
Ramkisoensing.indd   58 22-4-2014   11:51:39
59
cardiomyogenesis and anisotropic cell alignment
introduction
The developing heart is characterized by increases in the number and size of cells 
resulting from hyperplasia and hypertrophy.1,2 During this process, the initially 
round-shaped cardiomyocytes (CMCs) become elongated through unidirectional 
growth and align in a specific direction, thereby defining a long and short cellular 
axis.3 Later in development, intercalated disc components (including gap junction 
proteins), initially distributed more or less uniformly over the surface of the cells, 
cluster at the polar ends of the cells.4,5 Consequently, the elongated terrace-shaped 
cells are coupled end-to-end to surrounding cells and organized in unit bundles. 
This anisotropic tissue architecture has implications for the electrical activation of 
the cardiac muscle. Conduction of the electrical impulse parallel to the myocardial 
fiber axis is about 3 times faster than perpendicular to the fiber axis, indicating 
anisotropic conduction.6 In the intact heart, the resulting inhomogeneity in con-
duction is circumvented by a ~120 degrees rotation of the fiber axis from epi- to 
endocardium. As a consequence the spread of activation through the ventricular 
muscle is more or less homogeneous, coordinated and fast.7,8 Any disruption of 
this architecture, for example after myocardial infarction, may cause conduction 
abnormalities, associated with diminished pump function and increased risk of 
arrhythmias.9
Recently, stem cell therapy has been introduced as a treatment option to 
improve left ventricular function after myocardial infarction.10 Ideally, to be suc-
cessful, stem cells should not only differentiate into CMCs but also engraft and 
align with the surrounding anisotropic tissue. This latter process can be referred 
to as spatial integration. As a result, these de novo CMCs will be an integral part of 
the 3-dimentional myocardial architecture, thereby contributing to cardiac impulse 
conduction. Until now it is unknown how transplanted stem cells integrate with 
the surrounding myocardial cells, and to which extent alignment of these cells may 
influence electrical conduction. In other words, spatial integration of stem cell-
derived CMCs may contribute to restoration of tissue structure and conduction or, 
in contrast, result in increased structural and electrical inhomogeneity. In theory, 
each cell type that is coupled electrically, excitable, and aligned can acquire ani-
sotropic properties as in this situation the resistance in the transverse direction 
is higher than in the longitudinal direction. In case of stem cells this is of special 
interest as they may acquire anisotropic properties during cardiomyogenic differen-
tiation after they have been transplanted into the anisotropic myocardium, thereby 
potentially improving their functional integration with the surrounding myocar-
dium. Of note, functional integration of such transplanted cells is essential for cell 
therapy to be safe and effective.11
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tion model with a growth-directing substrate,12,13 to investigate the effects of cell 
alignment on functional integration and electrical conduction across neonatal rat 
(nr) mesenchymal stem cells (MSCs) undergoing cardiomyogenic differentiation. 
The process of differentiation occurred in a cardiac syncytium of neonatal rat car-
diomyocytes (nrCMCs) thereby allowing the study of functional integration.
materials and methods
Animal experiments were approved by the Animal Experiments Committee of the 
Leiden University Medical Center and conformed to the Guide for the Care and Use 
of Laboratory Animals as stated by the US National Institutes of Health.
A detailed description of harvesting and culturing of nrCMCs, nrMSCs, and 
cardiac fibroblasts (nrCFBs), as well as the characterization of the nrMSCs can be 
found in the online Data Supplement.
assessment of functional cardiomyogenesis
Differentiation of nrMSCs was assessed by a combination of immunofluorescence 
microscopy and electrophysiological measurements in isotropic co-cultures of nrC-
MCs and eGFP-labeled nrMSCs grown on glass coverslips during the course of 10 
days. The assessment of cardiomyogenesis by immunofluorescence and intracel-
lular measurements is described in the online Data Supplement.
micro-electrode high-density mapping
Simultaneous micro-electrode high density mapping of cultured nrCMCs and nrM-
SCs was performed using micro-electrode arrays (MEA, number of titanium nitride 
electrodes: 60; inter-electrode distance: 200 mm; electrode diameter: 30 mm) and 
associated data acquisition system (sampling rate 5 kHz/channel, Multi Channel 
Systems, Reutlingen, Germany). Further descriptions can be found in the online 
Data Supplement.
induction of conduction block and anisotropic cell alignment
Activation maps of nrCMCs were generated 2 days after culture to confirm the 
presence of a synchronously beating monolayer. Conduction block was generated 
using a P.A.L.M. microlaser system (Microlaser Technologies GmbH, Bernried, 
Germany).14 Briefly, two pre-programmed linear laser dissections were made, sepa-
rated by 225 µm, crossing the entire diameter of the monolayer in the coated MEA 
culture dish. This resulted in a detached strip of monolayer between the two laser 
dissection lines, which was removed from the culture, creating a clean a-cellular 
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channel electrically separating the two nrCMC fields. Subsequently, the uncovered 
coatings in the a-cellular channels were given a micro-groove pattern by micro-
abrasion15 with a soft micro-brush (bristle diameter: 30 mm diameter) using a 
micro-manipulator (Seizz, Göttingen, Germany) and light-microscope (40x magni-
fication), either in a direction (1) parallel or (2) perpendicular to the a-cellular chan-
nel. Another group (3) consisted of MEA culture dishes with an a-cellular channel 
that was not micro-abraded.
After confirming the presence of a conduction block between the two nrCMC 
fields, either (a) 5x104 CM-Dil-labeled nrCMCs, (b) 5x104 eGFP-labeled nrMSCs or 
(c) 5x104 eGFP-labeled nrCFBs were applied in a channel-crossing pattern in each 
of the three groups. This was achieved by gently adding the cells onto the coat-
ing in-between the CMC fields, using a pipette fixed to a micro-manipulator in 
combination with a light-microscope (20x magnification). After 24 h, the culture 
medium was refreshed to remove non-attached cells, as well as 1 h before and after 
measurements. During the following 10 days the electrical conduction (impulse 
transmission) across seeded cells was assessed daily.
The two separated and asynchronously beating nrCMC fields were considered 
electrically coupled upon application of cells, if the timing of the electrograms of 
the two nrCMC fields correlated consistently with each other for 30 consecutive 
LATs recorded at both fields, while stimulating one nrCMC field.
In an additional series of experiments, a mixture of 5x104 nrCMCs and nrCFBs 
(20%:80%) was applied to the channel and subjected to electrophysiological meas-
urements 24 h after seeding and served as positive control for the results obtained 
in the nrMSC group at day 10.
statistics
Statistical analysis was performed using SPSS 11.0 for Windows (SPSS Inc., Chi-
cago, IL, USA). Data were compared with Student’s t-test or ANOVA test with 
Bonferroni correction for multiple comparisons, and expressed as mean±SD for 
a given number (n) of observations. P-values <0.05 were considered statistically 
significant.
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characterization of bone marrow-derived neonatal rat mesenchymal stem 
cells
Analysis of in vitro adipogenic and osteogenic differentiation potential
The nrMSCs (Fig 1, A1) were assessed for their multipotency by investigating their 
adipogenic and osteogenic differentiation potential. After incubation in appro-
priate differentiation media, nrMSCs readily differentiated into adipocytes and 
osteoblasts, as determined by formation of lipid vacuoles and calcium deposits, 
respectively (Fig 1, A2-3).
Analysis of surface marker and connexin expression
A very large fraction of the nrMSCs (p2) expressed the mesenchymal markers CD29 
(97.3%), and CD90 (96.2%) at their surface, while almost none of them stained 
positive for the hematopoietic marker CD34 (1.5%). CD44 (32.8%), CD45 (10.2%), 
and CD106 (10.3%) were expressed in a small to medium sized fraction of nrMSCs 
(Fig 1, B).16
After 3 days of culture, nrMSCs showed positive staining for Cx43 (220±26x103 
intensity units (iu) in 1024 pixel x 768 pixel image) and Cx45 (149±9x103 iu) inside 
the cell and at cell-cell contacts, whereas Cx40 staining was hardly detectable 
(15±7x103 iu) (Fig 2, A1-3). At day 10, positive staining for Cx43, Cx40, and Cx45 
had increased significantly (p<0.01, Fig 2, E), without a noticeable change in their 
distribution patterns (Fig 2, C1-3).
In co-cultures of nrCMCs and eGFP-labeled nrMSCs, the latter cells stained 
positive for Cx43 (291±15x103 iu) and Cx45 (204±9x103 iu) in a dense punctuated 
pattern at day 3 of culture, with Cx40 being hardly detectable (19±9x103 iu) (Fig 2, 
B1-3). At day 10 after cell seeding, only Cx43 and Cx45 staining had significantly 
increased (p<0.01) as compared to day 3 of culture, but distribution patterns did 
not changed over time. In contrast, no increase in Cx40 staining was observed in 
or between cells at day 10 of culture (Fig 2, D1-3).
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Figure 1. Characterization of neonatal rat mesenchymal stem cells (nrMSCs). A1, Brightfield 
image of cultured nrMSCs. A2, presence of Oil Red O-stained fat vacuoles after adipogenic 
differentiation. A3, calcium accumulation was visualized by Alizarine Red S staining after 
osteogenic differentiation. B, Flow cytometric analysis of nrMSCs showed abundant sur-
face expression of CD29 and CD90, but hardly any expression of the hematopoietic marker 
CD34. Furthermore, CD44, CD45 and CD106 were expressed at low or medium levels. Flow 
cytometric analyses with isotype-matched control antibodies are included to determine 
background fluorescence levels (thin black line).
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Figure 2. Immunocytochemical analysis of connexin (Cx) staining in isotropic co-cultures of 
neonatal rat mesenchymal stem cells (nrMSCs) and nrCMCs at day 3 and day 10 of culture. 
Staining for Cx43 and Cx45 increased significantly over time in nrMSCs (A1, A3, C1 and C3) 
as well as in nrMSCs adjacent to nrCMCs (B1, B3, D1 and D3). Positive staining for Cx40 
increased only in MSCs during follow-up (A2 and C2). Quantitative analysis (E) was based 
on 36 random samples taken from 12 adjacent nrMSC-nrMSC and nrCMC-nrMSC cell pairs 
on 3 different coverslips at each time point. White arrows pinpoint the presence of Cxs at 
the site of gap junctions. *p<0.01 vs. nrMSCs at day 3, **p<0.01 vs. nrMSC-nrCMC pairs 
at day 3.
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assessment of cardiomyogenic differentiation
Immunocytochemistry
At day 3 of co-culture, a fraction of the eGFP-labeled nrMSCs stained positive for 
sarcomeric α-actinin and cardiac troponin-I in a diffuse and speckled staining pat-
tern (Fig 3, A2 and A4).
However, a larger fraction of nrMSCs stained negative for both markers (Fig 3, 
A1 and A3). Cross-striation in nrMSCs was first observed at day 6, while at day 10, 
~17% of the eGFP-labeled nrMSCs showed typical cardiac cross-striated patterns 
of sarcomeric α-actinin (Fig 3, D1-3) and cardiac troponin-I (Fig 3, D4-6). Most of 
the nrMSCs displaying cross-striation were adjacent to native CMCs. Importantly, 
none of the nrMSCs having cross-striation of contractile proteins (>60 cells ana-
lyzed per sarcomeric protein type) were heterokaryomeric, making cell fusion of 
eGFP-labeled cells with nrCMCs unlikely. Total positive staining for sarcomeric 
α-actinin and cardiac troponin-I in eGFP-labeled cells increased significantly from 
34±5% and 30±6% at day 3, to 63±3% and 60±4% at day 10 (now including 17.1±3% 
and 16.3±4% of cells that show positive staining with cross-striation), respectively 
(p<0.001) (Fig 3, B). Furthermore, sarcomere length (i.e. distance between two 
Z-lines) in differentiated nrMSCs at day 10 was comparable to that in native nrC-
MCs (Fig 3, C1-2). Samples having irregularities in sarcomere structures (less than 
10% of samples) were excluded.
Electrophysiological measurements after uncoupling
Patch-clamp recordings were obtained from nrCMCs and eGFP-labeled nrMSCs 
at day 3 and day 10 of co-culture after electrical isolation with the gap junction 
uncoupler 2-aminoethoxydiphenyl borate (2-APB). Upon 2-APB treatment, the syn-
chronously beating monolayer disintegrated into asynchronously beating cells, and 
input resistance increased from 20-120 MW (n=15) to 0.9-1.2 GW (18 other cells). 
These increases in input resistances were considered to reflect electrical uncou-
pling of the patched cell from the surrounding cells, thereby reaching the approxi-
mate seal resistance.17 After electrical uncoupling at day 3, eGFP-labeled nrMSCs 
(n=9) had maximal diastolic potentials of -16±5 mV and showed no spontaneous 
action potentials (APs). In contrast, uncoupled nrCMCs (n=12) had maximal dias-
tolic potentials of -69±8 mV in the presence of spontaneous APs.
Interestingly, after 10 days of co-culture and incubation with 2-APB, a consid-
erable fraction of nrMSC-derived nrCMCs (~16%, n=9) was found to be beating 
independently from surrounding nrCMCs (as judged by timing and frequency of 
beating), while showing AP characteristics (maximal diastolic potential: -63±4 mV) 
comparable to native nrCMCs (n=10) (Fig 4, A1-2, B1-4). The remaining nrMSCs 
(n=47) were non-beating and had a maximal diastolic potential of -19±4 mV, in the 
absence of APs (Fig 4, A2).
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Figure 3. Cardiomyogenic differentiation of neonatal rat mesenchymal stem cells (nrMSCs) 
co-cultured with nrCMCs assessed by immunocytochemistry. A fraction of eGFP-labeled 
nrMSCs stained negative for (A1) sarcomeric ɑ-actinin and (A3) cardiac troponin-I at day 3 
of culture. However, other nrMSCs stained positive for (A2) sarcomeric ɑ-actinin and (A4) 
cardiac troponin-I, which percentage increased significantly over time (B). At day 10 of co-
culture, positive staining in typical cardiac cross-striated pattern was observed for both 
(D1-6) sarcomeric ɑ-actinin and cardiac troponin-I in 17.1±3% and 16.3±4% of the nrMSCs, 
respectively (B). (C1-2) Estimation of sarcomere lengths in native nrCMCs and eGFP-labeled 
cells showed no significant difference. Quantitative analysis was based on 360 cells per 
sarcomeric protein at each time point. *P<0.01, vs. percentage positive staining at day 3. 
#P<0.01, vs. percentage cross-striation at day 3.
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Figure 4. Whole-cell patch-clamp recordings from nrCMCs and eGFP-labeled neonatal rat 
mesenchymal stem cells (nrMSCs) after 10 days of co-culture and gap junction uncoupling. 
Stable and spontaneous action potentials were recorded in (A1) nrCMCs (n=10), as well 
as in (A2, left panel) differentiated eGFP-labeled cells (n=9). In contrast, undifferentiated, 
non-beating nrMSCs had resting membrane potentials of -19±4 mV, in the absence of 
action potentials (A2, right panel; n=47). Action potential characteristics were comparable 
to each other, as shown by maximum diastolic potential (MDP, B1); action potential ampli-
tude (APA, B2); action potential duration till 50% repolarization (APD50, B3) and maximal 
rate of depolarization (dV/dtMAX, B4).
cell alignment after micro-abrasion
Only confluent monolayers with a high degree of structural and functional homo-
geneity were included in this study as determined by light-microscopy and electro-
physiological mapping. Furthermore, damaged and/or detached nrCMC fields, due 
to laser dissection or micro-abrasion, were excluded from the study. As a conse-
quence only 40% of the cultures were included for further experiments.
Application of nrCMCs, nrMSCs or nrCFBs onto the uncovered fibronectin-
gelatin coating in the a-cellular channel resulted in a confluent, isotropic cell layer 
(Fig 5, A1). Micro-abrasion of the coating, either parallel or perpendicular to the 
channel, resulted in alignment of each cell type according to the direction of abra-
sion (Fig 5, B1 and C1). nrMSCs, as other applied cells, appeared elongated with an 
average length-width ratio of 4:1 and maintained their shape throughout follow-up 
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68 (Fig 5, D1-2). In contrast, cells applied onto unabraded coatings had a variable 
length-width ratio (Fig 5, D3), but never reaching 4:1 of anisotropically aligned cells.
effect of cell alignment on conduction velocity and functional 
integration
After creating an a-cellular channel (230±10 µm) in the MEA culture dish, two asyn-
chronously beating nrCMC fields were present, proving the presence of a conduc-
tion block. CV across the two isotropic nrCMC fields was 21.3±2.3 cm/s at day 1, and 
increased slightly to 22.7±2.6 cm/s at day 10.
Isotropic cell alignment
Application of nrCMCs onto unabraded coatings in the channels resulted in con-
duction between the two nrCMC fields within 1 day. CV across nrCMCs in the 
channel was 19.7±0.7 cm/s at day 1 and 20.7±1 cm/s at day 10 (n=12, NS) (Fig 5, 
A2), which was comparable to the CV values measured across neighboring nrCMC 
fields (Fig 6, A1).
Application of nrMSCs in the channel also restored conduction between both 
nrCMC fields, but CV was significantly lower: 1.7±0.7 cm/s (p<0.01). CV across 
these isotropically aligned nrMSCs increased to 7.1±1 cm/s at day 10 (n=11, p<0.01) 
(Fig 5, A2 and Fig 6, A1). Electrical conduction between the nrCMC fields was 
also restored after application of nrCFBs, however, CV across these cells was 
1.8±0.8 cm/s at day 1 and remained stable till day 10 (n=12, NS and Fig 6, A1), being 
significantly lower than the CV across nrMSCs at day 10 (p<0.01) (Fig 5, A2).
Anisotropic cell alignment: parallel versus perpendicular cell alignment
Application of nrCMCs onto coatings abraded in a direction parallel to the chan-
nel resulted, after 1 day, in electrical recoupling of the two nrCMC fields, which 
was associated with a CV of 13.5±0.9 cm/s across the nrCMC-filled channel and 
persisted during follow-up (CV: 14.1±1 cm/s, n=10, NS) (Fig 5, B2 and Fig 6, B1). 
Application of nrCMCs onto coatings abraded in a direction perpendicular to the 
channel, however, resulted in a CV of 26.0±1.1 cm/s (p<0.01) across the channel, 
which also persisted during the follow-up till day 10 (CV: 26.8±0.9 cm/s, n=11, NS) 
(Fig 5, C2 and Fig 6, C1).
In contrast, application of nrMSCs onto coatings abraded in a direction parallel 
to the channel failed to restore electrical conduction between the two nrCMC fields 
up to day 7. However, at day 7, restoration had occurred and was associated with 
a CV of 4.9±1 cm/s at day 10 (n=11, p<0.01) (Fig 5, B2 and Fig 6, B1). Application 
of nrMSCs onto perpendicularly abraded coatings restored electrical conduction 
between the two nrCMC fields from day 1 onward. CV increased from 4.3±1 cm/s 
at day 1 to 11±0.9 cm/s at day 10 (n=12, p<0.01) (Fig 5, C2 and Fig 6, C1), thereby 
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Figure 5. The effect of cell alignment on the development of conduction across the cell 
strip displaying a random, parallel or perpendicular configuration. (D1) Cells applied on 
micro-abraded coatings showed typical alignment throughout follow-up. (D2) After align-
ment, neonatal rat mesenchymal stem cells (nrMSCs) appeared elongated with oval shaped 
nuclei (average length-width ratio of 4:1, L=length, W=width), and displayed Cx43 staining 
uniformly distributed along cell-cell contacts. (D3) In contrast, application of cells onto una-
braded coatings resulted in random cell alignment, with a variable length-width ratio (but 
always lower than the 4:1), which was maintained till day 10. Two-factor mixed ANOVA test 
(Bonferroni-corrected); †p<0.01 vs. CV at day 10 in random configuration, ‡p<0.01 vs. CV 
at day 10 in parallel configuration, #p<0.01 vs. CV at day 10 in perpendicular configuration. 
One-way repeated-measures ANOVA (Bonferroni-corrected); *p<0.05.
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70  reaching the highest CV in the nrMSC group in the different configurations (iso-
tropic: 7.1±1 cm/s and parallel: 4.9±1 cm/s at day 10). This indicates that alignment 
of nrMSCs undergoing cardiomyogenic differentiation influences the degree of 
functional integration with respect to CV across adjacent cardiac tissue.
Application of nrCFBs onto the parallel abraded coatings did not result in elec-
trical conduction between the two nrCMC fields during 10 days of culture (n=10, 
p<0.0001) (Fig 5, B2 and Fig 6, B1). However, after application of nrCFBs in perpen-
dicular abraded coatings, electrical conduction was restored at day 1, associated 
with a CV across these cells of 3.5±0.8 cm/s at day 1 and 4.3±1 cm/s at day 10 (n=10, 
NS) (Fig 5, C2 and Fig 6, C1).
Interestingly, quantitative analysis of Cx43 in different cells, configurations, 
and locations at day 10 of culture showed significant differences, revealing that the 
highest Cx43 expression was found in the group of parallel alignment (Fig 6, cor-
responding panels A2, B2, and C2).
The degree of cell alignment and confluence did not change significantly over 
time, as was shown by quantification and spatial measurements using (immuno)
fluorescence microscopy (data not shown).
Conduction velocity across control cultures of cardiomyocyte/fibroblast mixtures
In order to mimic the composition of the cell population in the channel at day 
10, which consisted of nrMSCs-derived CMCs and undifferentiated nrMSCs (~18% 
and ~82%, respectively), mixtures of native nrCMCs and nrCFBs (20% and 80%) 
were applied in all three different configurations (n=8, 8 and 9). After application 
of these mixtures onto the coatings, CVs determined at day 1 were comparable to 
CVs across eGFP-labeled nrMSCs at day 10 of culture (n=11, 10 and 10) (Fig 7). This 
suggests that the increase in CV across eGFP-labeled MSCs that was observed 
depends on the functional cardiomyogenic differentiation of nrMSCs.
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Figure 6. (A1-C1) Extracellular electrograms derived from 10-day old cultures of neonatal rat 
cardiomyocytes (nrCMCs), cardiac fibroblasts (nrCFBs), or mesenchymal stem cells (nrM-
SCs) cultured in different configurations and from different locations (white background). 
In grey, electrograms of adjacent cardiomyocyte fields are shown, and referred to as outer-
CMCs. (A2-C2) Cx43 expression was quantified in all three cell types and compared to 
expression in adjacent cardiomyocyte fields (gritted bars for outer-CMCs, set to 100%). 
Cx43 expression was also quantified and compared between all three cell types in each 
configuration. *p<0.05 vs Cx43 expression of outer-CMCs, #p<0.05 vs Cx43 expression in 
corresponding cells aligned parallel to the channel.




The present study shows that alignment of transplanted neonatal rat mesenchymal 
stem cells (nrMSCs) undergoing cardiomyogenic differentiation affects the time 
course and degree of functional integration with cultured neonatal rat cardiomyo-
cyte tissue.
Functional differentiation of neonatal rat mesenchymal stem cells
In this study, a significant fraction of nrMSCs differentiated into functional car-
diomyocytes upon co-culture with nrCMCs. In additional co-culture experiments, 
differentiation percentages of nrMSCs were assessed at day 14, showing ~18% 
differentiation (compared to ~17% differentiation at day 10), which may indicate 
that maximal differentiation percentages were reached under our culture condi-
tions. Previously, Nishiyama et al. also showed the cardiomyogenic differentiation 
potential of premature MSCs upon co-culture with CMCs.18 The results of our study 
confirm these results using nrMSCs and nrCMCs. In addition, Jiang et al. demon-
strated that MSCs from young rats differentiated into cardiac-like cells after trans-
plantation in the infarcted rat myocardium, whereas MSCs from old rats did not.19
Figure 7. Positive control for cardiomyogenesis-related increase in CV across neonatal rat 
mesenchymal stem cells (nrMSCs). CVs across nrMSCs at day 10, cultured in one of the 
three configurations (n=11, 10 and 10), were compared to CVs across a mixture of 20% nrC-
MCs and 80% neonatal rat cardiac fibroblasts at day 1 (n=8, 8 and 9).
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In the present study, differentiation of nrMSCs into functional cardiomyocytes 
was also demonstrated by intracellular (patch-clamp) membrane potential record-
ings after uncoupling. One might argue that the 2-APB-induced uncoupling in the 
patch-clamp experiments may be incomplete and that 180 mmol/L 2-APB may have 
affected plasma membrane ion channels, thereby affecting excitability of the nrC-
MCs and differentiated nrMSCs. However, the observed desynchronized beating 
and high whole-cell input resistance (~1 GW) in the presence of 2-APB indicated 
preserved single-cell excitability and strong uncoupling. These findings, together 
with the presence of cardiomyocyte-like action potentials in the uncoupled differ-
entiated nrMSCs but not in uncoupled undifferentiated nrMSCs are indicative for 
functional differentiation of at least a fraction of the nrMSCs.
Alignment of stem cell-derived cardiomyocytes and electrical conduction
Several studies have shown anisotropic conduction across aligned CMCs in vitro. 
The longitudinal and transverse CVs measured across nrCMCs in this study are in 
line with the results of previous studies using the same source,13 although some 
studies have reported higher CVs.15,20 These differences in CV might have been 
caused by the presence of different numbers of cardiac fibroblasts in the CMC 
culture, or by the methods used to produce anisotropic cell cultures.13 However, 
in our study, we also applied other cells than CMCs to the micro-abraded coatings 
and these also appeared elongated with oval shaped nuclei and a certain level of 
Cx43 uniformly distributed along cell-cell contacts. Anisotropic alignment of cells 
in our model most likely created a low-resistance conduction pathway in longitudi-
nal direction, where fewer (high resistance) cell borders have to be crossed, thereby 
favoring conduction in this direction. These phenomena were not restricted to a 
specific cell type. However, after culture and cardiomyogenic differentiation of 
nrMSCs the anisotropic electrical properties further developed and functional inte-
gration with adjacent cardiomyocyte fields improved. The anisotropic ratio (per-
pendicular CV vs parallel CV) was comparable between nrCMCs and nrMSCs at 
day 10 of culture, however only CV across nrMSCs increased over time.
Distribution patterns of Cx43 did not appear to be of major influence on con-
duction, which has been confirmed by other studies.15,21 The uniform distribu-
tion of Cx43 in nrCMCs, reported in the present and other studies, is typical for 
neonatal CMCs. Importantly, cells aligned parallel to the channel, thereby having 
adjacent, beating cardiac tissue perpendicular to their cell axis, were associated 
with the highest increase in Cx43 expression levels. A previous study reporting on 
neonatal CMCs subjected to anisotropic stretch showed a higher increase in Cx43 
expression in CMCs stretched perpendicular to their cell axis than when CMCs 
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74 were stretched in a parallel direction.22 In our model, the cells in the channel seem 
to be influenced by stretch originating from the adjacent cardiomyocyte fields, 
thereby indicating that alignment per se is not only affecting functional integra-
tion but that it also has an effect on gap junction regulation. In fact, our model 
could allow the study of stretch-related protein expression levels, as alternative 
to mechanically induced pulsatile stretch, which also was shown to significantly 
increase Cx43 expression in nrCMCs.23 In addition, cardiomyogenic differentiation 
of nrMSCs may lead to increased Cx expression. Also, long-term culturing of MSCs 
itself leads to upregulation of Cx expression.24 However, the relative contributions 
of each of these phenomena to the improvement of AP transmission by increased 
gap junctional coupling warrants further study.
In the present study, nrMSCs in all three cell orientation groups showed a 
time-dependent increase in CV which correlated with differentiation of nrMSCs, 
although the maximum CV differed among the groups. Comparison of the CV val-
ues of the transplanted nrMSCs with CV values of nrCMCs at different time points 
revealed the effect of stem cell alignment on functional integration with cardiac 
tissue. This is best illustrated by the finding that non-excitable nrMSCs aligned par-
allel to the channel were unable to conduct the electrical current across the chan-
nel for up to 6 days. However, after cardiomyogenic differentiation of these cells, 
electrical conduction across the channel was established. Most likely, in this situ-
ation passive conduction across non-differentiated nrMSCs is supported by active 
propagation across nrMSC-derived CMCs, resulting in AP transmission across the 
channel and subsequent activation of the distal CMC field. Thus, the alignment of 
stem cells not only influences the degree of functional integration, as reflected by 
CV values, but also the time course of functional integration. Whether alignment 
also influenced the degree of cardiomyogenic differentiation in itself is intriguing. 
The minor differences between CVs across mixtures of native nrCMCs and nrCFBs 
and CVs across differentiated nrMSCs indicate that alignment per se is a major 
determinant of functional integration. However, the increased expression of Cx43 
in the nrMSCs aligned to the channel could suggest that alignment has some effect 
on cardiomyogenic differentiation, but this increase may also be due to the factors 
mentioned above. Future studies will be necessary to investigate the role of cell 
alignment in cardiomyogenic differentiation and subsequent effects on structural 
and electrical integration.
Possible therapeutic implications
To our knowledge, no study of stem cell transplantation has yet reported on the 
effects of cell alignment on electrical conduction, functional integration and the 
therapeutic implications. Furuta et al. have used transplanted sheets of nrCMCs 
onto the epicardial surface of the heart to improve cardiac function and showed 
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anisotropic electrical conduction across the cell sheets.25 Interestingly, these cells 
appeared to orientate themselves spontaneously in line with the fiber axis of native 
cells. However, it is unknown whether and how stem cells align after transplanta-
tion into the myocardium of the infarcted heart, and to which extent alignment of 
these cells is influencing conduction and contraction. Of note, alignment of resi-
dent ventricular CMCs has major influence on electrical and mechanical activation 
of the heart,26 but the cellular assessment in vivo is technically challenging. The 
present study introduces alignment of transplanted stem cells as a novel determi-
nant of functional integration, and although conducted ex vivo, the study may have 
important implications for future cardiac cell therapy. Presumably, cell alignment 
will become even more important in the near future, as higher engraftment rates of 
transplanted cells will be achieved using novel application techniques. For example, 
misalignment of transplanted cells with respect to the native cardiac architecture 
might result in increased electrical heterogeneity potentially leading to arrhythmias 
as well as dyssynchronous contraction leading to decreases in cardiac output.9 On 
the other hand, enforcing transplanted cells to adapt to the native tissue architec-
ture might contribute to improved therapeutic efficiency and safety. In this view, 
an important and promising role is reserved for tissue engineering, in which the 
transplanted cells can be aligned with the use of scaffolds.27,28
Study limitations
Ideally, the nrCMC fields adjacent to the channel should be made anisotropic to 
mimic cardiac tissue architecture. This was however not possible with the tech-
niques described in the study. Although the spatial resolution of the extracellular 
mapping experiments is acceptable to allow standardized measurements, the rela-
tively low spatial resolution may have resulted in an underestimation of actual CVs. 
In the present study, a growth-directing substrate was created by micro-abrasion 
and although effective and reproducible, this procedure is time-consuming and 
yields only a limited number of cultures suitable for further study. Nevertheless, 
our study provides the first evidence that alignment of stem cells undergoing cardi-
omyogenic differentiation has significant impact on functional integration of these 
cells with cardiac tissue.
conclusions
Forced alignment of nrMSCs undergoing cardiomyogenic differentiation affects the 
time course and degree of functional integration with surrounding host cardiac 
tissue. This study introduces cell alignment as an important determinant of func-
tional integration of transplanted cells, which may contribute to the  improvement 
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76 of therapeutic outcome and reduction of potential hazards. Further study is needed 
to determine the full biological, biophysical, and therapeutic relevance of cell align-
ment in functional integration of transplanted cells with host myocardium.
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78 expanded materials and methods
isolation and culture of neonatal rat cardiomyocytes and cardiac 
fibroblasts.
All animal experiments were approved by the Animal Experiments Committee of 
the Leiden University Medical Center and conformed to the Guide for the Care and 
Use of Laboratory Animals as stated by the US National Institutes of Health.
Cardiomyocytes (CMCs) were dissociated from ventricles of 2-day old male neo-
natal (nr) Wistar rats and grown in culture medium supplemented with 5% horse 
serum (HS, Invitrogen, Carlsbad, CA, USA), penicillin (100 U/mL) and streptomy-
cin (100 µg/mL; P/S; Bio-Whittaker, Verviers, Belgium), as previously described 1.
Before their use in cell pattern experiments, nrCMCs were collected in culture 
flasks and labeled with the viable fluorescent dye chloromethylbenzamido (CM-
DiI) (CellTrackerä, Molecular Probes, Eugene, OR, USA) according to the recom-
mendations of the manufacturer.
Micro-electrode array culture dishes (MEA, Multi Channel Systems, Reutlingen, 
Germany) and glass coverslips were pre-coated for 4 h with fibronectin-gelatin 
(8:2,v/v, 0.1% fibronectin and gelatin in PBS), and dried using pressurized nitrogen. 
nrCMCs were plated (1.5x106 cells) on MEAs or on glass coverslips in 6-well culture 
dishes (2x106 cells/well) and incubated in a humidified incubator at 37° C and 5% 
CO2 to obtain confluent spontaneously beating monolayer of nrCMCs.
In addition, adherent neonatal rat cardiac fibroblasts (nrCFBs) were collected, 
purified (by re-plating), enhanced green fluorescent protein (eGFP)-labeled and 
cultured in a 1:1 (V/V) mixture of Dulbecco’s modified Eagle’s medium (DMEM, 
Invitrogen) and Ham’s F10 medium (ICN Biomedicals, Irvine, CA, USA) supple-
mented with 10% fetal bovine serum (FBS, Invitrogen), penicillin (100 U/mL) and 
streptomycin (100 µg/mL). CFBs were labeled with eGFP using the vesicular sto-
matitis virus G protein-pseudotyped self-inactivating lentivirus vector CMVPRES 2 
essentially as described by van Tuyn et al 3.
Proliferation of residual nrCFBs in nrCMC cultures was inhibited by incubation 
with 100 mmol/L 5-bromo-2-deoxyuridine (BrdU, Sigma-Aldrich, Saint Louis, MO, 
USA) in culture medium during the first 24 after culture initiation.
harvesting and characterization of bone marrow-derived neonatal rat 
mesenchymal stem cells and cardiomyogenic differentiation.
Harvesting
Bone marrow was isolated from femora and tibiae of the same 2-day-old male 
Wistar rats used for nrCMC harvesting. Marrow was extruded from the bones by 
centrifugation at 13,000 rpm for 30 s (rotor diameter: 15 cm), suspended in 10 mL 
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of stem cell medium [human mesenchymal stem cell growth medium (MSCGM) 
consisting of 440 ml basal medium, 50 ml of mesenchymal growth supplements, 
15% FBS (Invitrogen), 4 mmol/L of L-glutamine, penicillin (50 U/L) and streptomy-
cin (50 mg/L), amphothericin B solution (1 mL/mL, Sigma-Aldrich) (Cambrex Bio 
Science, Walkersville, MD, USA)], and 6% heparin (400 IE/ml). This suspension 
was centrifuged again at 1000 rpm for 10 min. Next, the pellet was resuspended in 
7 ml of this medium supplemented with 5.75 µg/mL deoxyribonuclease I (DNase, 
Sigma-Aldrich). The cells were then plated in 25-cm2 culture flasks (Becton Dickin-
son, Franklin Lakes, NJ, USA) and incubated at 37° C and 5% CO2 for 2 days after 
which non-adherent cells were removed. Stem cell medium was refreshed twice a 
week until the primary cultures of nrMSCs were confluent, after which they were 
expanded by serial passage. In this study passages 2 to 4 were used. To ensure 
identification, nrMSCs were transduced with CMVPRES as described earlier in this 
section.
characterization of nrmscs
Adipogenic and osteogenic differentiation of mesenchymal stem cells
The nrMSCs were characterized by established differentiation assays4. Briefly, 5x103 
nrMSCs per well were plated in a 12-well culture plate, and exposed to adipogenic 
or osteogenic induction medium. Adipogenic differentiation medium consisted of 
a regular culture medium (DMEM supplemented with 15% FBS, 100 U/L penicillin 
and 100 µg/mL streptomycin, 1 µg/mL amphothericin B solution) supplemented 
with 5 µg/mL insulin, 1 µmol/L dexamethason, 50 µmol/L indomethacin and 0.5 
µmol/L 3-isobutyl-1-methylxanthine (IBMX) (all from Sigma-Aldrich), and was 
refreshed every 3-4 days for a period of 3 weeks. Lipid accumulation was assessed 
by Oil Red O staining of the cultures (15 mg Oil Red O/mL 60% isopropanol) and 
light microscopy. Osteogenic differentiation medium consisted of culture medium 
supplemented with 10 mmol/L b-glycerophosphate, 50 µg/mL ascorbic acid and 
10 nmol/L dexamethason (all from Sigma-Aldrich), and was refreshed every 3-4 
days for a period of 2 weeks. Afterwards, the cells were washed with phosphate-
buffered saline (PBS), and calcium deposits were visualized by staining of the cells 
for 2-5 min with 2% Alizarine Red S in 0.5% NH4OH (pH 5.5).
Flow cytometry
Analysis of surface marker expression was carried out by flow cytometry. The 
nrMSCs were detached using trypsin/EDTA (Bio-Whittaker) and resuspended in 
PBS containing 0.5% bovine serum albumine (BSA, Sigma-Aldrich), and divided 
in aliquots of 5x104 cells. Cells were then incubated for 30 min at 4°C with fluores-
cein isothiocyanate (FITC)- or phycoerythrin (PE)-conjugated antibodies against 
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80 rat CD34 (Santa Cruz Biotechnology, Santa Cruz, CA, USA), CD29, CD44, CD45, 
CD90, CD106 (Becton Dickinson). Labeled cells were washed and analyzed using 
a FACSort flow cytometer (Becton Dickinson), equipped with a 488-nm argon ion 
laser and a 635-nm red diode laser. Isotype-matched control antibodies (Becton 
Dickinson) were used to determine background fluorescence. At least 5x103 cells 
per sample were acquired and data were processed using CellQuest software (Bec-
ton Dickinson).
immunocytological analysis of gap junction content and cardiomyogenic 
differentiation potential
Isotropic co-cultures of 2x106 nrCMCs and 5x104 eGFP-labeled nrMSCs were stained 
for cardiac connexins and sarcomeric proteins on day 3 or day 10 after culture ini-
tiation. To detect sarcomeric proteins, we used mouse monoclonal antibodies 
specific for sarcomeric α-actinin (Sigma-Aldrich) or mouse anti-cardiac troponin I 
(HyTest Ltd., Turku, Finland), both at a dilution of 1:400. Rabbit polyclonal anti-
connexin 40 (Cx40), anti-Cx43 and anti-Cx45 antibodies were used to stain gap 
junctional proteins, and examined as previously described.1 In addition, anisotropic 
co-cultures were stained for Cx43 to show the effects of anisotropic cell alignment 
on Cx distribution in nrMSCs. In these cultures, cellular distribution and quantity 
of Cx43 were studied by the use of fixed Areas of Interest (AOI) which were placed 
on both longitudinal and transversal sides of the cells (n=32 for each cell type in 
each configuration). In each AOI the fluorescent spots were quantified using dedi-
cated software (Image-Pro Plus, Version 4.1.0.0, Media Cybernetics, Silver Spring, 
MD, USA), this allowed us the estimate global distribution of Cx staining. An AOI 
covering the whole cell-area was used in cultures of isotropic cell alignment. The 
primary antibodies were visualized with rabbit anti-mouse IgG or goat anti-rabbit 
IgG Alexa antibodies (Invitrogen). Unless stated otherwise, antibodies were used 
at a dilution of 1:200.
The percentage of eGFP-labeled cells showing positive staining for sarcomeric 
proteins was calculated by quantification of 6 cultures (60 cells per culture per sar-
comeric protein, at 40x magnification) at each time point, using a threshold value 
of 50 on the 0-255 intensity scale. To assess structural integrity, sarcomere lengths 
in native nrCMCs and eGFP-labeled cells were estimated from 64 standardized 
individual measurements (4 areas of 20µmx20µm per cell). The area of measure-
ment covered the cell-surface aspect of in total 8 native nrCMCs and 8  eGFP-
labeled cells that exhibited typical sarcomeric α-actinin cross-striation without any 
observable inhomogeneities. A fluorescence microscope equipped with a digital 
camera (Nikon Eclipse, Nikon Europe, Badhoevedorp, The Netherlands) and dedi-
cated software (Image-Pro Plus, Version 4.1.0.0, Media Cybernetics, Silver Spring, 
MD, USA) were used to analyze data. All co-cultures of nrCMCs and eGFP-labeled 
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nrMSCs were stained using the same solutions, and equal exposure times. Quanti-
fications were performed by an independent investigator.
electrophysiological measurements in pharmacologically uncoupled cell 
monolayers
Whole-cell patch-clamp measurements were performed in co-cultures of 5x104 
eGFP-labeled nrMSCs and 2x106 nrCMCs. To perform single-cell measurements 
from eGFP-labeled nrMSCs in a syncytium of beating nrCMCs, cells were phar-
macologically uncoupled by incubation with 180 µmol/L of 2-aminoethoxydiphenyl 
borate (2-APB) (Tocris, Ballwin, MO, USA) for 15 min. This agent largely,5 or fully6 
blocks gap junctional intercellular coupling by Cx40, Cx43, and Cx45. Whole-cell 
current-clamp recordings were performed at 25°C using a L/M-PC patch-clamp 
amplifier (3 kHz filtering) (List-Medical, Darmstadt, Germany) 3 and 10 days after 
culture initiation. Pipette solution contained (in mmol/L) 10 Na2ATP, 115 KCl, 
1 MgCl2, 5 EGTA, 10 HEPES/KOH (pH 7.4). Tip resistance was 2.0 - 2.5 MW, and 
seal resistance >1 GW. The bath solution contained (in mmol/L) 137 NaCl, 4 KCl, 
1.8 CaCl2, 1 MgCl2, 10 HEPES (pH 7.4). For data acquisition and analysis pClamp/
Clampex8 software (Axon Instruments, Molecular Devices, Sunnyvale, CA, USA) 
was used. Action potentials were analyzed and compared between nrCMCs and 
eGFP-labeled nrMSCs. We did not correct for an existing tip potential during the 
membrane potential measurements, because this tip potential is assumed to be 
relatively small (~3 mV) for our bath and pipette solutions.7 Input resistance of 
whole-cells coupled to their surrounding cells was measured in voltage-clamp by 
dividing the applied voltage steps by the stationary membrane current change.6
Micro-electrode high-density mapping
Electrograms were analyzed off-line using MC-Rack software (version 3.5.6, Multi 
Channel Systems). Electrical stimulation of cell cultures was performed via an 
external pipette electrode producing bipolar rectangular pulses (1.5x threshold, 
pulse width 10 ms), placed ~1 mm above the cell culture and >5 mm away from the 
measurement sites. Cultures were stimulated for at least 30 s, before recordings 
were started.
The maximal negative intrinsic deflection was taken as local activation time 
(LAT) and used to construct 2-dimensional color-coded activation maps (S-plus, 
version 6.2, Insightful Corporation, Seattle, WA, USA). Conduction velocities were 
calculated from averaged LATs recorded at 8 fixed measuring points, distributed 
equally over the two lines of electrodes adjacent to the channel.1,8
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84 abstract
Rationale: Gap junctional coupling is important for functional integration of trans-
planted cells with host myocardium. However, the role of gap junctions in cardio-
myogenic differentiation of transplanted cells has not been directly investigated.
Objective: To study the role of connexin43 (Cx43) in cardiomyogenic differentia-
tion of human mesenchymal stem cells (hMSCs).
Methods: Knockdown of Cx43 gene expression was established in naturally 
Cx43-rich fetal amniotic membrane hMSCs (Cx43↓ fetal AM hMSCs), while Cx43 
was overexpressed in inherently Cx43-poor adult adipose tissue hMSCs (Cx43↑ 
adult AT hMSCs). The hMSCs were exposed to cardiomyogenic stimuli by co-
incubation with neonatal rat cardiomyocytes (nrCMCs) for 10 days. Differentiation 
was assessed by immunostaining and whole-cell current-clamping. To establish 
whether the effects of Cx43 knockdown could be rescued Cx45 was overexpressed 
in Cx43↓ fetal AM hMSCs.
Results: Ten days after co-incubation not a single Cx43↓ fetal AM hMSC or 
adult AT MSC expressed α-actinin, while control fetal AM hMSCs did (2.18±0.4%, 
n=5,000). Moreover, functional cardiomyogenic differentiation, based on action 
potential recordings, occurred only in control fetal AM hMSCs. Of interest, Cx45 
overexpression in Cx43↓ fetal AM hMSCs restored their ability to undergo cardio-
myogenesis (1.57±0.4%, n=2,500) in co-culture with nrCMCs.
Conclusion: Gap junctional coupling is required for differentiation of fetal AM 
hMSCs into functional cardiomyocytes after co-incubation with nrCMCs. Hetero-
cellular gap junctional coupling thus plays an important role in the transfer of car-
diomyogenic signals from nrCMCs to fetal hMSCs but is not sufficient to induce 
cardiomyogenic differentiation in adult AT hMSCs.
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introduction
Gap junctional coupling is essential in establishing electrochemical communica-
tion between cardiomyocytes (CMCs).1 Such coupling of cytoplasmic compart-
ments is mediated by gap junctions, consisting of two hexameric assemblies of 
connexin (Cx) proteins embedded in the plasma membranes of neighboring cells 
thereby forming so-called hemichannels or connexons. Gap junctions permit the 
bidirectional passage of small molecules and ions between cells and play an impor-
tant role in the regulation of both physiological and pathophysiological processes.
During embryonic development, spreading of signals across tissues through 
gap junctions contribute to the migration and specialization of cells.2 In the devel-
oping heart, connexin40 (Cx40), connexin43 (Cx43) and/or connexin45 (Cx45) defi-
ciency results in serious cardiac malformation.3-7 Besides cardiac development, gap 
junctional communication also affects the therapeutic and hazardous potential of 
cardiac cell therapy.8-10 However, the role of gap junctional coupling in cardiomyo-
genic differentiation of stem cells remains unclear, although gap junction- mediated 
processes, such as spread of micro RNAs (miRs) and hyperpolarization, have been 
implicated in the induction of cardiomyogenesis.11,12
Mesenchymal stem cells (MSCs) are a population of mononuclear stromal 
cells that can be harvested from a wide variety of tissues, are easily expandable in 
vitro, have immunomodulatory properties, secrete paracrine factors that stimulate 
tissue regeneration and can differentiate into various types of mesodermal and 
non- mesodermal cells.13,14 In addition, these cells were shown to improve cardiac 
function upon transplantation in diseased rodent, pig and human hearts.15 How-
ever, to what extent MSCs can undergo cardiac differentiation and which factors 
are involved in this process is still unclear.16-18 Although donor age and heterocellu-
lar interactions were found to affect the cardiomyogenic differentiation potential of 
MSCs19, more research is needed into their biological properties and the modifica-
tion thereof to improve the therapeutic potential of MSC-based cardiac cell therapy.
Accordingly, in this study, we specifically investigated the role of Cx43, the major 
gap junction protein of the working myocardium, in cardiomyogenic differentiation 
of naturally Cx43-rich fetal and Cx43-poor adult human MSCs (hMSCs)19 in co- 
cultures with neonatal rat ventricular CMCs (nrCMCs). To this end, Cx43 expression 
levels in hMSCs were either downregulated by short hairpin RNA (shRNA)-medi-
ated RNA interference (RNAi) or upregulated by recombinant human Cx43 (hCx43) 
gene delivery. To control for possible off-target effects of hCx43-specific shRNAs, an 
RNAi rescue experiment based on the forced expression of human Cx45 (hCx45) in 
Cx43 knockdown cells was included. The consequences of these genetic interven-
tions on the cardiomyogenic differentiation capacity of the hMSCs were assessed 
using immunocytological and patch-clamp analyses.
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of cardiomyogenic signals from nrCMCs to fetal hMSCs. Downregulation of Cx43 
gene expression in these hMSCs prevented their cardiomyogenic differentiation in 
co-cultures with nrCMCs. Overexpression of hCx45 in the Cx43 knockdown cells, 
on the other hand, restored their ability to respond to cardiomyogenic stimuli pro-
vided by neighboring nrCMCs.
materials and methods
The role of gap junctional coupling in the transfer of cardiomyogenic signals from 
nrCMCs to hMSCs was investigated by suppressing Cx43 expression in naturally 
Cx43-rich fetal amniotic membrane (AM) hMSCs using two lentiviral vectors (LVs) 
encoding different hCx43-specific shRNAs (Cx43↓(1) fetal AM hMSCs and (Cx43↓(2) 
fetal AM hMSCs) and by LV-mediated overexpression of hCx43 in intrinsically Cx43-
poor adult adipose tissue (AT) hMSCs (Cx43↑ adult AT hMSCs). To facilitate the 
identification of genetically modified cells, the LVs also directed the synthesis of 
the green fluorescent protein (GFP) of Renilla reniformis (hrGFP). Fetal AM hMSCs 
transduced with an LV encoding an shRNA directed against the Aequorea victo-
ria enhanced green fluorescent protein (eGFP) gene and adult AT hMSCs trans-
duced with an LV coding for hrGFP alone served as control cells (control fetal AM 
hMSCs and control adult AT hMSCs, respectively). For an optimized analysis of 
the adult AT hMSCs these cells were also transduced with an LV encoding Cx43 
and a puromycin resistence gene. Control cells were transduced with an LV coding 
for the puromycin-resistence gene alone. Immunocytological analysis, quantitative 
reverse transcriptase-polymerase chain reaction (qRT-PCR) and western blot analy-
sis were applied to determine Cx43 expression levels, while dye transfer assays and 
whole-cell current-clamp recordings were used to assess the level of functional 
coupling. To induce cardiomyogenic differentiation, hMSCs were co-incubated with 
nrCMCs for 10 days. Differentiation was assessed by immunocytological staining 
and whole-cell current-clamping. LV-encoded hCx45 was overexpressed in Cx43↓(1) 
fetal AM hMSCs (Cx43↓(1)+Cx45↑ fetal AM hMSCs) to establish whether the effects 
of Cx43 knockdown could be reversed using the techniques described above. 
Cx43↓(1) fetal AM hMSCs transduced with an LV encoding eGFP were used as con-
trol cells (Cx43↓(1)+eGFP fetal AM hMSCs) in these experiments. For a detailed 
description of the materials and methods the reader is referred to the Supplement 
Material and previous papers of our research group.19-21
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results
characterization of fetal am hmscs and adult at hmscs
Both fetal AM hMSCs and adult AT hMSCs were characterized according to estab-
lished criteria. To this purpose, their cell surface marker profile and adipogenic and 
osteogenic differentiation capacity were studied. Both types of hMSCs were nega-
tive for CD31 (endothelial cell marker), CD34 and CD45 (both hematopoietic cell 
markers), whereas they were positive for CD73, CD90 and CD105 (mesenchymal 
stem cell markers) (Figure 1A-C). In vitro differentiation assays showed that the 
two types of hMSCs were able to differentiate into adipocytes (Figure 1D1-D2) and 
osteoblasts (Figure 1E1-E2) confirming their multipotency.
evaluation of cx43 expression levels
The impact of the different genetic interventions on the Cx43 expression levels in 
fetal AM hMSCs and adult AT hMSCs was investigated by three different methods. 
Immunocytological analysis showed that Cx43↑ adult AT hMSCs (Figure 2A2) con-
tained higher levels of Cx43 than control adult AT hMSCs (Figure 2A1), while the 
protein was also more abundant in control fetal AM hMSCs (Figure 2B1) than in 
Cx43↓(1) fetal AM hMSCs (Figure 2B2) or in Cx43↓(2) fetal AM hMSCs (Figure 2B3) 
(for each genetic modification n=4 isolates of each hMSC type were assessed). 
These results were validated by western blot analysis (n=4 hMSC isolates per exper-
imental group), which showed that Cx43↑ adult AT hMSCs contained 1,798±146% 
more Cx43 protein than control adult AT hMSCs (P<0.001) (Figure 2C1 and C3). 
Western blot analysis also confirmed the presence of significantly less Cx43 in 
Cx43↓(1) fetal AM hMSCs (79.4±3.0% reduction) and in Cx43↓(2) fetal AM hMSCs 
(77.4±2.6% reduction) than in control fetal AM hMSCs (P<0.001) (Figure 2C2 and 
C4). In agreement with these results, qRT-PCR revealed that Cx43↑ adult AT hMSCs 
contained 9.77±0.63-fold (P<0.001) (Figure 2D1) more Cx43 transcripts than con-
trol adult AT hMSCs while the amount of Cx43 RNA in Cx43↓(1) fetal AM hMSCs 
and in Cx43↓(2) fetal AM hMSCs was, respectively, 3.67±0.14- and 3.94±0.25-fold 
(P<0.001) lower than in control fetal AM hMSCs (Figure 2D2).
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Figure 1. Characterization of fetal AM hMSCs and adult AT hMSCs. (A-B) Flow cytometric 
analyses showed for both types of hMSCs abundant surface expression of the MSC mark-
ers, CD90, CD105 and CD73 and hardly any surface expression of the hematopoietic cell 
markers CD34 and CD45 or the endothelial cell marker CD31 (black lines). Isotype-matched 
control antibodies were included to determine background fluorescence levels (gray lines). 
Percentages are means of ≥4 measurements. (C) Only minor differences in the expression 
levels of the surface marker proteins were present between fetal AM hMSCs and adult AT 
hMSCs. ND is not detected. (D1-D2) Adipogenic differentiation was visualized by the pres-
ence of Oil Red O-stained fat vacuoles. (E1-E2) Calcium depositions after osteogenic dif-
ferentiation were visualized by Alizarin Red S staining.
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Figure 2. Analysis by immunofluorescence microscopy, western blotting and qRT-PCR of 
Cx43 expression in monocultures of genetically modified fetal AM hMSCs and adult AT 
hMSCs. (A1-A2) Immunocytological analyses revealed low Cx43 levels in control adult AT 
hMSCs, while high levels of Cx43 were detected in Cx43↑ adult AT hMSCs. (B1) High Cx43 
levels were present in control fetal AM hMSCs. (B2-B3) After knockdown of Cx43 gene 
expression, low Cx43 levels were detected in Cx43↓(1) fetal AM hMSCs and in Cx43↓(2) 
fetal AM hMSCs. Nuclei were stained with the DNA-binding fluorochrome Hoechst 33342. 
(C1-C2) Pictures of representative western blots showing that Cx43↑ adult AT hMSCs have 
large amounts of Cx43 in contrast to control adult AT hMSCs and that control fetal AM 
hMSCs contain large amounts of Cx43 in contrast to Cx43↓(1) fetal AM hMSCs and Cx43↓(2) 
fetal AM hMSCs. The GAPDH-specific immunostaining was included for normalization pur-
poses. (C3-C4) Bar graphs of the quantification by western blotting of Cx43 levels in the 
different populations of hMSCs corrected for differences in GAPDH expression. *P<0.001 
vs. Cx43↑ adult AT hMSCs or vs. Cx43↓(1) fetal AM hMSCs and Cx43↓(2) fetal AM hMSCs. 
(D1-D2) Bar graphs of the assessment by qRT-PCR of Cx43 mRNA levels in control adult AT 
hMSCs, Cx43↑ adult AT hMSCs and in control fetal AM hMSCs, Cx43↓(1) fetal AM hMSCs 
and Cx43↓(2) fetal AM hMSCs. *P<0.001 vs. control adult AT hMSCs or vs. Cx43↓(1) fetal 
AM hMSCs and Cx43↓(2) fetal AM hMSCs.
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cx43
The effects of modulating Cx43 expression levels in fetal AM hMSCs and in adult 
AT hMSCs on their functional heterocellular coupling with nrCMCs were investi-
gated by dye transfer experiments using the gap junction-permeable fluorochrome 
calcein red-orange AM (calcein). Cx43↑ adult AT hMSCs showed a significantly 
higher dye intensity than control adult AT hMSCs (67.6±4.7% vs. 8.43±1.6% of that 
in adjacent nrCMCs) (P<0.001) (Figure 3A1-A2 and C1). Furthermore, the fraction 
of hMSCs that took up calcein from neighboring nrCMCs was much higher for 
the Cx43↑ adult AT hMSCs than for the control adult AT hMSCs (71.6±7.6% vs. 
28.3±4.6% of cells) (P<0.001) (Figure 3C3). The relative dye intensity in control fetal 
AM hMSCs (63.2±3.8%) was higher than in Cx43↓(1) fetal AM hMSCs (5.94±1.4%) 
and in Cx43↓(2) fetal AM hMSCs (6.00±1.9%) (P<0.001) (Figure 3B1-B3 and C2). 
Moreover, significantly more of the control fetal AM hMSCs (75.9±9.2%) had taken 
up calcein than of the Cx43↓(1) fetal AM hMSCs (13.2±2.4%) or of the Cx43↓(2) fetal 
AM hMSCs (13.0±2.1%) (P<0.001) (Figure 3C4).
To further assess functional coupling between hMSCs and nrCMCs, maximal 
diastolic membrane potentials (MDPs) were measured in each group of hMSCs in 
the absence and presence of adjacent nrCMCs. Similar average MDPs were found 
in hMSC monocultures (n=6) (Figure 3D, black bars). However, MDPs, on aver-
age, became more negative when nrCMCs were adjoining the hMSCs, although the 
degree of hyperpolarization differed between the various groups (n=8) (Figure 3D, 
white bars). Cx43↑ adult AT hMSCs and control fetal AM hMSCs showed the most 
negative MDPs (-38±4 mV and -43±5 mV, respectively). On the other hand, control 
adult AT hMSCs, Cx43↓(1) fetal AM hMSCs and Cx43↓(2) fetal AM hMSCs, which all 
contain low levels of Cx43, showed less negative MDPs.
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Figure 3. Study of the influence of Cx43 levels in hMSCs on their functional coupling with 
nrCMCs. (A1-A2) Calcein transfer from nrCMCs to Cx43↑ adult AT hMSCs was much more 
efficient than to control adult AT hMSCs. (B1-B3) Dye transfer from nrCMCs to fetal AM 
hMSCs was strongly inhibited by shRNA-mediated downregulation of Cx43 gene expres-
sion in the hMSCs. (C1-C2) Bar graphs of the quantification of dye intensity in GFP-positive 
hMSCs. Dye intensity in the GFP-positive hMSCs was expressed as percentage of the dye 
intensity in the surrounding nrCMCs. (C3-C4) Bar graphs of the assessment of the percent-
age of GFP-positive hMSCs that had taken up calcein from neighboring nrCMCs. *P<0.001 
vs. control adult AT hMSC or vs. Cx43↓(1) fetal AM hMSCs and Cx43↓(2) fetal AM hMSCs. 
(D) Average MDPs in hMSC monocultures (indicated as MSC) as measured by whole-cell 
current-clamping were similar for the different experimental groups. However, the average 
MDP in hMSCs became more negative in the presence of adjoining nrCMCs (indicated as 
MSC-CMC), with Cx43↑ adult AT hMSCs and control fetal AM hMSCs reaching the most 
negative values.
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genetically altered cx43 levels
Human-specific immunocytological evaluation
At day 10 of co-culture with nrCMCs, 2.27±0.4% GFP/human lamin A/C-double-
positive control fetal AM hMSCs were positive for the sarcomeric protein α-actinin 
with a cross-striated staining pattern like that of the nrCMCs (Figure 4A1-A2 and 
C). However, GFP/human lamin A/C-double-positive Cx43↓(1) fetal AM hMSCs and 
Cx43↓(2) fetal AM hMSCs did not contain detectable amounts α-actinin (Figure 
4A3-A4 and C). Furthermore, neither Cx43↑ adult AT hMSCs nor control adult AT 
hMSCs stained positive for α-actinin (Figure 4B1-B3 and C). These results were 
confirmed with Cx43↑ adult AT hMSCs and control adult AT hMSCs that were trans-
duced with LVs that encoded the puromycin-resistence gene instead of GFP (Sup-
plemental figure 1A – B). Also, only in co-cultures of control fetal AM hMSCs with 
nrCMCs, some GFP-positive cells were detected to be positive for the cardiac tran-
scription factors Nkx2.5 and GATA4 (Supplemental figure 2A1 and 3A1). In the other 
hMSC groups, all GFP-positive cells were negative for these cardiac transcription 
factors (Supplemental figure 2A2-B2 and 3A2-B2).
hMSC-specific intracellular electrophysiological measurements
To assess cardiomyogenic differentiation at a functional level, the ability of GFP-
positive hMSCs to generate spontaneous action potentials was studied after 
gap junction uncoupling (Figure 5A-B). A fraction of the control fetal AM hMSCs 
showed spontaneous action potentials (n=6), with MDPs similar to those of native 
CMCs (n=9) (Figure 5B-C). In contrast, both Cx43↑ adult AT hMSCs and control 
adult AT hMSCs (n=7) showed more depolarized MDPs of -15.0±4 mV and -14.8±3 
mV, respectively. Also, Cx43↑ adult AT hMSCs stayed inexcitable (n=5). Importantly, 
knockdown of Cx43 in fetal AM hMSCs rendered these cells incapable of generating 
spontaneous action potentials after 10 days of co-culture with nrCMCs (n=9 for 
both shRNAs) and left them with an MDP comparable to those of adult AT hMSCs 
(-15 mV vs. -12 and -14 mV for Cx43↓(1) fetal AM hMSCs and for Cx43↓(2) fetal AM 
hMSCs, respectively).
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Figure 4. Immunocytological assessment of cardiomyogenic differentiation of genetically 
modified adult AT hMSCs and fetal AM hMSCs after 10 days of co-culture with nrCMCs. 
(A1) Upon co-culture with nrCMCs, a fraction of the GFP- and human lamin A/C-double-
positive control fetal AM hMSCs became positive for sarcomeric α-actinin (indicated 
as Act). (A2) Intense punctate Cx43 (indicated as Cx) immunostaining of the interfaces 
between a control fetal AM hMSC and two adjacent nrCMCs (white arrows). (A3-A4, B1-B2) 
GFP-labeled Cx43↓(1) fetal AM hMSCs, Cx43↓(2) fetal AM hMSCs, Cx43↑ adult AT hMSCs 
and control adult AT hMSCs in co-culture with nrCMCs did not stain positive for α-actinin. 
(B3) Presence of Cx43 plaques at the interfaces between Cx43↑ adult AT hMSCs and two 
bordering nrCMCs (white arrows). (C) Quantitative analysis of the cardiomyogenic differ-
entiation ability of the genetically modified hMSCs using immunopositivity for sarcomeric 
α-actinin as read-out. The graph is based on a minimum of 5,000 cells analyzed from 4 sep-
arate hMSC isolates per experimental group. ND is not detected.
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Figure 5. Electrophysiological assessment, after gap junctional uncoupling, of cardiomyo-
genic differentiation of hMSCs. (A1-A2) Bright field (A1) and fluorescence (A2) image of a 
GFP-positive hMSC with adjacent nrCMCs and patch-clamp electrode. (B) Current-clamp 
recordings in nrCMCs and in GFP-positive hMSCs from the different experimental groups. 
Action potentials were measured in nrCMCs and in some control fetal AM hMSCs, while the 
other cells displayed stable membrane potentials. (C) Average MDPs of nrCMCs and in the 
different groups of GFP-positive hMSCs. For the control fetal AM hMSCs, only the average 
MDP of cells showing action potentials is presented.
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evaluation of cx45 expression levels
To check whether the inability of Cx43↓ fetal AM hMSCs to undergo cardiomyo-
genic differentiation in co-cultures with nrCMCs was not caused by some off-target 
effect(s) of the hCx43-specific shRNAs, a rescue experiment was carried out. To 
this end, the Cx43↓(1) fetal AM hMSCs were transduced with an LV encoding hCx45 
or with a control LV directing the synthesis of eGFP. Immunocytological analysis 
of the resulting cell populations showed that Cx45 was much more abundant in 
Cx43↓(1)+Cx45↑ fetal AM hMSCs than in Cx43↓(1)+eGFP fetal AM hMSCs (Figure 
6A1-A2). Western blot analysis confirmed these results by showing 1,163±57% higher 
levels of Cx45 in Cx43↓(1)+Cx45↑ fetal AM hMSCs than in Cx43↓(1)+eGFP fetal AM 
hMSCs (n=4 for both sample types) (P<0.001) (Figure 6B1-B2). Consistently, qRT-
PCR showed that Cx45 transcript levels were 12.5±1.9 fold higher in Cx43↓(1)+Cx45↑ 
fetal AM hMSCs than in Cx43↓(1)+eGFP fetal AM hMSCs (P<0.01) (Figure 6C).
assessment of functional heterocellular gap junctional coupling via 
cx45
The extent of functional heterocellular coupling between nrCMCs and 
Cx43↓(1)+Cx45↑ fetal AM hMSCs or Cx43↓(1)+eGFP fetal AM hMSCs was deter-
mined in dye transfer assays. The dye intensity relative to that in neighboring nrC-
MCs was much higher in Cx43↓(1)+Cx45↑ fetal AM hMSCs (92.3±3.2%) than in 
Cx43↓(1)+eGFP fetal AM hMSCs (5.96±0.8%) (P<0.001) (Figure 6D1-D2 and E1). 
Also, the proportion of hMSCs that took up calcein from adjacent nrCMCs was 
~4-fold higher for the Cx43↓(1)+Cx45↑ fetal AM hMSCs than for the Cx43↓(1)+eGFP 
fetal AM hMSCs (66.7±7.6% vs. 16.0±2.3%) (P<0.001) (Figure 6E2).
To study the impact of Cx45 overexpression on the electrophysiological proper-
ties of Cx43↓ fetal AM hMSCs, whole-cell current-clamp measurements were per-
formed. Cx45 overexpression did not significantly alter the average MDP of Cx43↓(1) 
fetal AM hMSCs in monoculture (n=6) (Figure 6F). However, in co-culture with 
nrCMCs, Cx43↓(1)+Cx45↑ fetal AM hMSCs (n=6) showed more negative MDPs as 
compared to Cx43↓(1)+eGFP fetal AM hMSCs (-24.8±5 mV and -43±5 mV, respec-
tively) (Figure 6F), indicating that electrical coupling of Cx43↓ fetal AM hMSCs with 
neighboring nrCMCs was enhanced by Cx45 overexpression.
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Figure 6. Assessment of Cx45 expression and functionality. (A1-A2) Immunocytological 
analyses showed abundant Cx45 expression in monocultures of Cx43↓(1)+Cx45↑ fetal AM 
hMSCs but not of Cx43↓(1)+eGFP fetal AM hMSCs. A part of the Cx45 signal was detected 
at the interfaces between Cx43↓(1)+Cx45↑ fetal AM hMSCs. Nuclei were stained with Hoe-
chst 33342. (B1) Representative picture of a western blot confirming high-level expression 
of Cx45 in Cx43↓(1)+Cx45↑ fetal AM hMSCs and the presence of very low amounts of Cx45 
in Cx43↓(1)+eGFP fetal AM hMSCs. The GAPDH-specific immunostaining was included for 
normalization purposes. (B2) Bar graph of the assessment by western blotting of Cx45 lev-
els in Cx43↓(1)+Cx45↑ fetal AM hMSCs and in Cx43↓(1)+eGFP fetal AM hMSCs corrected 
for differences in GAPDH expression. *P<0.001 vs. Cx43↓(1)+eGFP fetal AM hMSCs. (C) 
Bar graph of the quantification by qRT-PCR of Cx45 mRNA levels in Cx43↓(1)+Cx45↑ fetal 
AM hMSCs and in Cx43↓(1)+eGFP fetal AM hMSCs. *P<0.01 vs. Cx43↓(1)+eGFP fetal AM 
hMSCs. (D1-D2) Cx43↓(1)+Cx45↑ fetal AM hMSCs much more readily take up calcein from 
adjacent nrCMCs than Cx43↓(1)+eGFP fetal AM hMSCs. (E1) Quantitative analysis of the dye 
intensity in Cx43↓(1)+Cx45↑ fetal AM hMSCs and in Cx43↓(1)+eGFP fetal AM hMSCs. Dye 
intensity in GFP-positive hMSCs was expressed as percentage of the dye intensity in the sur-
rounding nrCMCs. (E2) Bar graph of the assessment of the percentage GFP-positive hMSCs 
that had taken up calcein from neighboring nrCMCs. *P<0.001 vs. Cx43↓(1)+eGFP fetal AM 
hMSCs. (F) The average MDPs of Cx43↓(1)+Cx45↑ fetal AM hMSCs and of Cx43↓(1)+eGFP 
fetal AM hMSCs in monocultures are less negative than in co-cultures with nrCMCs. The 
effect of adjacent nrCMCs on the average MDP was bigger for fetal AM hMSCs in which 
the knockdown of Cx43 expression was compensated by Cx45 overexpression than for 
Cx43↓(1)+eGFP fetal AM hMSCs.
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Figure 7. Investigation by immunocytological and patch-clamp analysis of cardiomyogenic 
differentiation of fetal AM hMSCs in co-culture with nrCMCs after rescue of Cx43 knock-
down by Cx45 overexpression. In the presence of nrCMCs, a fraction of the GFP- and human 
lamin A/C-double-positive Cx43↓(1)+Cx45↑ fetal AM hMSCs (A1) expressed α-actinin (indi-
cated as Act) in a striated pattern typical of sarcomeric proteins, while Cx43↓(1)+eGFP fetal 
AM hMSCs (A2) did not. (A3) Punctate Cx45 immunostaining of the interface between a 
Cx43↓(1)+Cx45↑ fetal AM hMSC and an adjacent nrCMC (white arrows). (B) Quantitative 
analysis of the cardiomyogenic differentiation capacity of Cx43↓(1)+Cx45↑ fetal AM hMSCs 
and of Cx43↓(1)+eGFP fetal AM hMSCs using immunopositivity for sarcomeric α-actinin 
as read-out. The graph is based on a minimum of 5,000 cells analyzed from 4 separate 
hMSC isolates per experimental group. ND is not detected. (C1) Current-clamp record-
ings in pharmacologically uncoupled co-cultures of nrCMCs and Cx43↓(1)+eGFP fetal AM 
hMSCs or Cx43↓(1)+Cx45↑ fetal AM hMSCs. Fetal AM hMSCs that had lost the capacity to 
produce action potentials due to knockdown of Cx43 expression regained this ability fol-
lowing forced Cx45 expression but not after eGFP overexpression. (C2) Average MDPs of 
nrCMCs, Cx43↓(1)+eGFP fetal AM hMSCs and Cx43↓(1)+Cx45↑ fetal AM hMSCs. For the 
Cx43↓(1)+Cx45↑ fetal AM hMSCs, only the average MDP of cells showing action potentials 
is presented.
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after rescue of cx43 knockdown by cx45 overexpression
Human-specific immunocytological evaluation
Ten days after co-incubation with nrCMCs, Cx43↓(1)+Cx45↑ fetal AM hMSCs and 
Cx43↓(1)+eGFP fetal AM hMSCs were analyzed for α-actinin positivity. While 
Cx43↓(1)+eGFP fetal AM hMSCs did not contain detectable amounts of α-actinin, 
1.57±0.4% (n=2,500) GFP/human lamin A/C-double-positive Cx43↓(1)+Cx45↑ 
fetal AM hMSCs stained positive for this sarcomeric protein indicating that these 
human cells had differentiated into CMCs (Figure 7A1-A2 and B). Furthermore, only 
in co-cultures of Cx43↓(1)+Cx45↑ fetal AM hMSCs with nrCMCs, GFP-positive cells 
were detected that were positive for the cardiac transcription factors Nkx2.5 and 
GATA4 (Supplemental figure 4A1-B1). Cx43↓(1)+eGFP fetal AM hMSCs in co-culture 
with nrCMCs did not stain positive for these transcription factors (Supplemental 
figure 4A2-4B2).
hMSC-specific intracellular electrophysiological measurements
To further study the cardiomyogenic differentiation capacity of Cx43↓(1)+Cx45↑ 
fetal AM hMSCs, these cells were subjected to whole-cell current-clamp measure-
ments following pharmacological uncoupling. Cx43↓(1)+eGFP fetal AM hMSCs 
(n=5) showed steady membrane potentials, while some of the Cx43↓(1)+Cx45↑ fetal 
AM hMSCs (n=5) produced spontaneous action potentials with MDPs comparable 
to those of nrCMCs (n=7) (-65±4 mV and -69±5 mV, respectively) (Figure 7C1-C2). 
Thus, the loss of excitability in Cx43↓(1) fetal AM hMSCs could be overcome by 
Cx45 overexpression, at least in a subpopulation of cells.
discussion
The key findings of this study are 1) Fetal hMSCs, which intrinsically express Cx43 
at high levels, efficiently communicate with adjacent nrCMCs via gap junctions and 
can differentiate into functional heart muscle cells when co-cultured with nrCMCs. 
2) Adult hMSCs that contain low amounts of Cx43 by nature do not undergo cardio-
myogenic differentiation in co-culture with nrCMCs. 3) Overexpression of Cx43 in 
adult hMSCs does not lead to their cardiomyogenic differentiation upon co-culture 
with nrCMCs. 4) Cardiomyogenic differentiation of fetal hMSCs in co-culture with 
nrCMCs is inhibited by Cx43 knockdown, but is rescued by concurrent overexpres-
sion of Cx45.
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gap junctions and hmscs
The expression of the three major cardiac Cx (i.e. Cx40, Cx43 and Cx45) genes by 
hMSCs has previously been demonstrated.22,23 Also, the formation of functional 
gap junctions, important for integration of donor cells with the surrounding myo-
cardium after cardiac stem cell therapy, has been shown to occur.9,22,23 Recently, our 
group showed that hMSCs derived from fetal tissues contain much higher levels 
of Cx43 than those derived from adult tissues.19 In addition, evidence was provided 
that hMSCs of embryonic or fetal origin can undergo cardiomyogenesis when co-
cultured with nrCMCs while hMSCs derived from adult sources fail to do so. To 
directly investigate the role of gap junctional coupling in cardiomyogenic differen-
tiation of hMSCs, in the present study, Cx43 expression was downregulated in fetal 
AM hMSCs and upregulated in adult AT hMSCs through LV gene transfer. These 
genetic interventions resulted in a strong reduction in gap junctional communica-
tion between fetal AM hMSCs and nrCMCs and led to a substantial increase in 
the gap junctional coupling between adult AT hMSCs and nrCMCs. In addition, 
it was investigated whether the effects of Cx43 knockdown could be reversed by 
Cx45 overexpression. The reason to choose Cx45 for this purpose was that it can 
be engaged in the formation of functional homotypic as well as heterotypic gap 
junctions composed of homomeric or heteromeric connexins.24-27 In the current 
study, it was indeed established that after transduction with a Cx45-encoding LV, 
Cx43↓(1) fetal AM hMSCs express high levels of Cx45 mRNA leading to rescue of 
their efficient gap junctional communication with nrCMCs.
role of gap junctional communication in cardiomyogenic differentiation
Connexins have been reported to be involved in differentiation processes such 
as osteogenesis, neural differentiation and hematopoiesis.28-32 However, little is 
known about the role of gap junctional communication in cardiomyogenic differ-
entiation. As already stated above, our group recently found that fetal AM hMSCs 
express Cx43 at high levels in contrast to adult AT hMSCs. Interestingly, these fetal 
AM hMSCs were able to differentiate, in co-culture with nrCMCs, into functional 
CMCs while adult AT hMSCs were not.19 Other investigators using co-cultures with 
CMCs to induce cardiomyogenic differentiation in stem cells have also proposed 
that intercellular communication through gap junctions might be essential in this 
differentiation process.33,34 However, the role of gap junctional communication in 
the transfer of cardiomyogenic signals from CMCs to other cell types has not yet 
been investigated. In the current study, the role of Cx43 in cardiomyogenic differen-
tiation of hMSCs in the presence of neighboring CMCs was further elucidated. Fetal 
AM hMSCs lost their ability to differentiate into functional CMCs after knockdown 
of Cx43 gene expression. However, not only did overexpression of Cx45 restore the 
ability of these hMSCs to form functional gap junctions with nrCMCs but it also 
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incubation with nrCMCs. In contrast to these findings, adult AT hMSCs did not gain 
the ability to differentiate into functional CMCs after overexpression of Cx43. The 
inability of adult AT hMSCs to undergo cardiomyogenesis following co-culture with 
nrCMCs could have an epigenetic explanation.35-37 According to this hypothesis, 
genes important for cardiomyogenic differentiation could, in adult AT hMSCs, exist 
in a transcriptionally repressive state imposed by specific DNA methylation pat-
terns and/or chromatin signatures. Also, qualitative and/or quantitative differences 
in the repertoire of transcription factors and miRs expressed by fetal AM hMSCs 
and by adult AT hMSCs might contribute to their differential responsiveness to 
cardiomyogenic signals produced by neighboring nrCMCs.38,39
Since gap junctions enable intercellular communication, induction of cardio-
myogenesis after co-incubation with nrCMCs may be caused by exchange of signals 
between nrCMCs and fetal hMSCs. Stimulation of cardiomyogenic differentiation 
by miRs-499, as previously described, has been inferred to be a gap junction-medi-
ated process.11 Moreover, intercellular communication makes [Ca2+] oscillations 
possible, which has been shown to increase the regenerative potential of human 
cardiac progenitor cells in a mouse myocardial infarction model.40 In line with 
these findings are the observations by Muller-Borer et al. who found that in co-cul-
ture with nrCMCs rat liver stem cells obtain CMC-like properties and display [Ca2+] 
oscillations synchronous with those of adjoining CMCs. The [Ca2+] oscillations in 
the liver stem cells were dependent on gap junctional communication with neigh-
boring CMCs and their inhibition led to a decrease in the expression of CMC-spe-
cific genes by the liver stem cells.34 The recent observation that hyperpolarization 
is sufficient to induce cardiomyogenic differentiation of human CMC progenitor 
cells underlines the importance of gap junctional coupling in this process.12 In the 
current study, fetal AM hMSCs in co-culture with nrCMCs were hyperpolarized in 
contrast to those that were transduced with hCx43-specific shRNAs. More impor-
tantly, Cx43↓(1) fetal AM hMSCs were also hyperpolarized in co-culture with nrC-
MCs after overexpression of Cx45. As a matter of fact, the average MDPs of control 
fetal AM hMSCs and Cx43↓(1)+Cx45↑ fetal AM hMSCs in contact with nrCMCs 
were identical. This could explain why knockdown of Cx43 leads to an inability of 
fetal AM hMSCs to differentiate towards functional CMCs, while after subsequent 
Cx45 overexpression their cardiomyogenic differentiation potential was restored. 
So while the precise composition of the gap junctions involved in the restoration 
of the cardiomyogenic differentiation capacity in Cx43↓(1) fetal hMSCs following 
Cx45 overexpression remains elusive, the factor(s) that exert their cardiomyogenic 
effects on fetal AM hMSCs via gap junctions can pass Cx45-containing channels in 
high enough amounts to set off the cardiomyogenic differentiation of these cells.
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conclusions
The results of this study indicate that efficient gap junctional coupling with adja-
cent CMCs is essential to induce cardiomyogenic differentiation of naturally Cx43-
rich fetal hMSCs in co-culture with nrCMCs. However, adult AT hMSCs that contain 
relatively low intrinsic levels of Cx43 and do not undergo cardiomyogenesis in the 
presence of nrCMCs, cannot be endowed with cardiomyogenic differentiation abil-
ity by overexpression of Cx43.
limitation
It would have been of interest to conduct Cx43 knockdown experiments using a 
cell type with a higher propensity to differentiate into functional CMCs than fetal 
hMSCs. However, such a cell type was not available to us. Furthermore, it would 
have been clinically more relevant to co-culture different hMSC subtypes with adult 
human CMCs, but obtaining these cells in the numbers needed to conduct these 
experiments was impossible. Also, adult human CMCs cannot be maintained ex 
vivo long enough in a differentiated state to perform some of the key experiments 
described in this paper.
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104 supplemental materials and methods
isolation, culture and characterization of human mesenchymal stem 
cells (hmscs)
All investigations with human-derived tissues conformed to the Declaration of Hel-
sinki and were approved by the Medical Ethics Committee of the Leiden University 
Medical Centre (LUMC). Written informed consent was obtained from all subjects 
or, in case of the fetal material, from the parents of the fetuses.
Human fetal amniotic membranes were collected from placentas at gestational 
weeks 17-22 through legal interventions by the Department of Obstetrics. The 
membranes were washed twice with phosphate-buffered saline (PBS) and finely 
minced into 1-2 mm fragments using scissors and scalpels. Cells were dissociated 
by treatment with 0.1% collagenase type I (Worthington, Lakewood, NJ) for 3 h at 
37°C in a humidified 95% air/5% CO2 atmosphere. Thereafter, 10 mL of Dulbec-
co’s modified Eagle’s medium (DMEM) containing 10% fetal bovine serum (FBS), 
100 U/mL penicillin and 100 µg/mL streptomycin (all from Invitrogen, Breda, the 
Netherlands; hereinafter referred to as MSC medium) was added. The cell suspen-
sion was transferred to a 25-cm2 culture flask (Becton Dickinson, Franklin Lakes, 
NJ) and incubated for 3-4 days at 37°C in a humidified atmosphere of 95% air/5% 
CO2 to allow the cells to adhere. The MSC medium was replaced twice a week until 
the primary cultures had reached ±80% confluency, after which the fetal amniotic 
membrane (AM) hMSCs were amplified by serial passage using a buffered 0.05% 
trypsin-0.02% EDTA solution (TE; Lonza Vervier, Vervier, Belgium) for cell detach-
ment.
Adult adipose tissue (AT) hMSCs were derived from subcutaneous abdominal 
fat tissue (n=4 donors, mean donor age 42.5±5.4 yrs). Tissue samples were washed 
twice with PBS containing 100 U/mL penicillin and 100 µg/mL streptomycin and 
finely minced with a scissor. For tissue disruption 0.1% collagenase type I solution 
was added and the samples were incubated for 1 h at 37°C in a humidified incubator 
containing 95% air and 5% CO2. Collagenase type I activity was quenched by add-
ing MSC medium. Samples were then centrifuged at 330×g for 10 min. After cen-
trifugation the top layer of primary adipocytes was removed and the collagenase 
type I-containing solution was aspirated. The cell pellet was suspended in MSC 
medium, passed through a nylon cell strainer with a mesh pore size of 70 μm (Bec-
ton Dickinson) and the cells were once again collected by centrifugation. The latter 
procedure was repeated twice, after which the cell pellet was resuspended in 8 ml 
MSC medium. The resulting cell suspension was transferred to a 75-cm2 culture 
flask (Becton Dickinson) and the adult AT hMSCs were expanded by serial passage 
using standard methods.
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The isolated cells were characterized according to generally accepted criteria 
using flow cytometry for the detection of surface antigens and adipogenic and 
osteogenic differentiation assays to establish multipotency. Surface marker expres-
sion was examined after culturing the cells for at least 3 passages. Thereafter, the 
hMSCs were detached using TE, suspended in PBS containing 1% bovine serum 
albumin fraction V (BSA; Sigma-Aldrich Chemie, Zwijndrecht, the Netherlands) 
and divided in aliquots of 105 cells. Cells were then incubated for 30 min at 4°C 
with fluorescein isothiocyanate- or phycoerythrin-conjugated monoclonal antibod-
ies (MAbs) directed against human CD105 (Ancell, Bayport, MN), CD90, CD73, 
CD45, CD34 or CD31 (all from Becton Dickinson). Labeled cells were washed three 
times with PBS containing 1% BSA and analyzed using a BD LSR II flow cytometer 
(Becton Dickinson). Isotype-matched control MAbs (Becton Dickinson) were used 
to determine background fluorescence. At least 104 cells per sample were acquired 
and data were processed using FACSDiva software (Becton Dickinson).
Established differentiation assays were used to determine the adipogenic and 
osteogenic differentiation ability of the cells.1 Briefly, 5×103 hMSCs per well were 
plated in a 12-well culture plate (Corning Life Sciences, Amsterdam, the Nether-
lands) and exposed to adipogenic or osteogenic differentiation medium. Adipo-
genic differentiation medium consisted of MEM-plus (i.e. α-minimum essential 
medium [Invitrogen] containing 10% FBS, 100 U/mL penicillin and 100 µg/mL 
streptomycin) supplemented with insulin, dexamethason, indomethacin and 
3-isobutyl-1-methylxanthine (all from Sigma-Aldrich Chemie) to final concentra-
tions of 5 µg/mL, 1 µM, 50 µmol/L and 0.5 µmol/L, respectively, and was refreshed 
every 3-4 days for a period of 3 weeks. Lipid accumulation was assessed by Oil Red 
O (Sigma-Aldrich Chemie) staining of the cultures (15 mg of Oil Red O per mL 
of 60% 2-propanol). Osteogenic differentiation medium consisted of MEM-plus 
containing 10 mmol/L b-glycerophosphate, 50 µg/mL ascorbic acid and 10 nmol/L 
dexamethason (all from Sigma-Aldrich Chemie) and was refreshed every 3-4 days 
for a period of 3 weeks. Afterwards, the cells were washed with PBS and calcium 
deposits were visualized by staining of the cells for 5 min with 2% Alizarin Red S 
(Sigma-Aldrich Chemie) in 0.5% NH4OH (pH 5.5).
isolation and culture of neonatal rat cardiomyocytes and cardiac 
fibroblasts
All animal experiments were approved by the Animal Ethics Committee of the 
LUMC and conformed to the Guide for the Care and Use of Laboratory Animals, as 
stated by the US National Institutes of Health (permit number: 10236).2
Primary myocardial cells were dissociated from ventricles of 2-day-old male 
Wistar rats. Neonatal rat cardiomyocytes (nrCMCs) and cardiac fibroblasts 
(nrCFBs) were separated from each other by differential plating and maintained 
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106 in a 1:1 (v/v) mixture of DMEM and Ham’s F-10 medium (MP Biomedicals, Solon, 
OH) containing 5% horse serum (Invitrogen), 100 U/mL penicillin and 100 µg/mL 
streptomycin as previously described.3
Myocardial cells were plated on fibronectin (Sigma-Aldrich Chemie)-coated cov-
erslips (15 mm Ø) at a density of 2×105 cells per well in 12-well plates and incubated 
at 37°C in a humidified incubator containing 95% air and 5% CO2. Proliferation 
of residual nrCFBs in nrCMC cultures was inhibited by incubating the cells with 
10 mg/mL mitomycin-C (Sigma-Aldrich Chemie) in PBS for 1 h.4
Production of lentiviral vectors
Two self-inactivating (SIN) lentiviral vector (LV) shuttle plasmids encoding 
short hairpin (sh) RNAs targeting the human connexin 43 (hCx43) gene (i.e. 
TRCN0000059773 and TRCN0000059775) were selected from the Mission 
Library (Sigma-Aldrich Chemie). The shRNAs encoded by these constructs effi-
ciently inhibit hCx43 expression in hMSCs as assessed by western blotting and 
contain sense strands that differ at 3 positions from the codinq sequence of the rat 
Cx43 gene. As negative control, a SIN-LV shuttle plasmid directing the synthesis 
of an enhanced green fluorescent protein (eGFP) gene-specific shRNA (SHC005; 
Sigma-Aldrich Chemie) was used. To allow for the easy assessment of transduc-
tion efficiencies, the puromycin N-acetyl transferase-coding sequence in each of 
these constructs was replaced by that of version I of the green fluorescent pro-
tein of Renilla reniformis (hrGFPI) as previously described.5 The resulting SIN-LV 
shuttle plasmids were designated pLV.shRNA-hCx43.1.hPGK1.hrGFPI, pLV.shRNA-
hCx43.2.hPGK1.hrGFPI and pLV.shRNA-eGFP.hPGK1.hrGFPI, respectively.
Overexpression of hCx43 or hCx45 in hMSCs was accomplished using bicis-
tronic SIN-LVs. The shuttle plasmids for generating these SIN-LVs were made as 
follows. First, pIRES.hrGFPII (Stratagene/Agilent Technologies, Santa Clara, CA) 
was digested with HincII and XbaI and the 2.1-kb fragment containing the human 
cytomegalovirus immediate-early gene promoter, the internal ribosome entry site 
of encephalomyocarditis virus and the hrGFP version II open reading frame was 
combined with the 6.1-kb SmaI×XbaI fragment of pLV.MCS.WHVPRE (GenBank 
accession number: JN622008) to create pLV.hCMV-IE.IRES.hrGFPII.WHVPRE. 
Next, the hCx43- and hCx45-coding sequences were released from Mammalian 
Gene Collection clones IRATp970C0822D and IRAMp995E152Q (Source BioSci-
ence, LifeSciences, Nottingham, United Kingdom) by restriction enzyme digestion 
using EcoRI (hCx45) or CfrI and MunI (hCx43). After treatment with the Klenow 
fragment of DNA polymerase I, the resulting hCx43- and hCx45-coding fragments 
of 1.3 and 1.2 kb, respectively, were combined with the 8.3-kb Eco32I fragment of 
pLV.hCMV.IRES.hrGFPII.WHVPRE using T4 DNA ligase to create pLV.hCMV-IE.
hCx43.IRES.hrGFPII.WHVPRE and pLV.hCMV-IE.hCx45.IRES.hrGFPII.WHVPRE. 
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As negative control the original SIN-LV shuttle plasmid pLV.hCMV-IE.IRES.hrGFPII.
WHVPRE was used. All restriction and DNA modifying enzymes were obtained 
from Fermentas (St. Leon-Rot, Germany).
Ligation mixtures were introduced in chemocompetent GeneHogs cells (Invit-
rogen) and large stocks of the correct plasmids were prepared with the aid of the 
JETSTAR 2.0. Plasmid Maxiprep Kit (Genomed, Löhne, Germany).
Vesicular stomatitis virus G-protein-pseudotyped SIN human immunodefi-
ciency virus type I vectors were produced in 175-cm2 culture flasks (Greiner Bio-
One, Alphen a/d Rijn, the Netherlands) seeded with 105 293T cells per cm2 in 
DMEM supplemented with 10% FBS and 0.01 mmol/L cholesterol. The next day, 
the producer cells in each flask were transfected with a total of 35 μg of DNA at a 
2:1:1 molar ratio of 1) one of the SIN-LV shuttle plasmids, 2) psPAX2 (Addgene, 
Cambridge, MA) and 3) pLP/VSVG (Invitrogen) using 3 µg of polyethyleneimine 
(Polysciences Europe, Eppelheim, Germany) per µg of DNA as transfection agent. 
Sixteen hours later, the transfection medium in each flask was replaced by 15 ml of 
DMEM containing 5% FBS, 10 mmol/L HEPES-NaOH (pH 7.4) and 0.01 mmol/L 
cholesterol. At 64 h post-transfection, the culture fluid was collected and freed of 
cellular debris by centrifugation at room temperature for 10 min at 825×g and fil-
tration through a 0.45-µm pore-size cellulose acetate filter (Pall Corporation, East 
Hills, NY). To concentrate the SIN-LV particles, 5 ml of 20% (w/v) sucrose in PBS 
was carefully layered under 30 ml of the cleared culture medium, which was then 
centrifuged for 2 h at 15,000 rounds per min and 10°C in an SW28 rotor (Beckman 
Coulter, Fullerton, CA). Next, the supernatant was discarded and the pellet contain-
ing the SIN-LV particles was suspended in 500 µl of PBS-1% BSA by gentle rocking 
overnight at 4°C.
The gene transfer activity of the SIN-LV stocks was determined by end-point 
titration on HeLa indicator cells using flow cytometric analysis of hrGFPI or hrGF-
PII expression as read-out. The titers of the SIN-LV preparations are thus expressed 
in HeLa cell-transducing units (HTUs) per ml.
Overexpression of hCx43 was also established by a SIN-LV shuttle plasmid pLV.
hCMV-IE.hCx43.IRES.PurR.hHBVPRE. This SIN-LV shuttle plasmid was constructed 
using a PCR-based cloning procedure. The hCx43-coding sequence was ampli-
fied by high-fidelity PCR from pLV.hCMV-IE.hCx43.IRES.hrGFPII.WHVPRE in 30 
cycles using the primers 5’ atacgcgttaacatgggtgactggagc 3’ and 5’ cgtgtacagttaact-
tagatctccaggtcatcagg 3’ (Eurofins MWG Operon, Ebersberg, Germany), Bioline’s 
VELOCITY DNA polymerase (GC biotech, Alphen aan den Rijn, the Netherlands) 
and the standard reaction conditions, including an annealing temperature of 55°C, 
recommended by the supplier. The 1175-bp PCR product was purified using Sure-
Clean (Bioline), incubated with the restriction enzymes MluI and Bsp1407I (both 
from Fermentas) and the 1.2-kb digestion product was extracted from  agarose gel 
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108 using JetSorb Gel Extraction Kit (GENOMED). Finally, the hCx43-coding DNA frag-
ment was combined with the 8.2-kb MluI× Bsp1407I fragment of pLV.CMV.IRES.
PURO6 to generate pLV.hCMV-IE.hCx43.IRES.PurR.hHBVPRE. This SIN-LV shuttle 
plasmid was subsequently used for the production of SIN-LV vector particles as 
described above.
transduction of hmscs
hMSCs were seeded at a density of 2×104 cells per well in 6-well plates (Corning) 
and incubated overnight in a humidified 95% air/5% CO2 atmosphere. Next, the 
culture fluid was replaced by 1 ml per well of fresh MSC medium supplemented 
with 10 μg/ml diethylaminoethyl-dextran sulfate (GE Healthcare, Leiderdorp, the 
Netherlands) and 20 HTUs per cell of SIN-LV. After an incubation period of 4 h 
at 37°C in a humidified atmosphere of 5% CO2 in air, the cells were washed with 
PBS, cultured in MSC medium and passaged ≥2 times before being used in any of 
the co-culture experiments. AT hMSCs were transduced with LV.hCMV-IE.hCx43.
IRES.hrGFPII.WHVPRE or pLV.hCMV-IE.hCx43.IRES.PurR.hHBVPRE to overexpress 
Cx43 (Cx43↑ adult AT hMSCs), while cells exposed to LV.hCMV-IE.IRES.hrGFPII.
WHVPRE or pLV.CMV.IRES.PURO served as control (control adult AT hMSCs). 
Adult AT hMSCs transduced with LVs encoding for the puromycin-resistence gene, 
were cultured in MSC medium supplemented with 5 ug/mL puromycin (Sigma-
Aldrich) for at least three weeks before any of the following experiments were con-
ducted. To suppress hCx43 gene expression, fetal AM hMSCs were transduced with 
LV.shRNA-hCx43.1.hPGK1.hrGFPI (Cx43↓[1] fetal AM hMSCs) or with LV.shRNA-
hCx43.2.hPGK1.hrGFPI (Cx43↓[2] fetal AM hMSCs). Fetal AM hMSCs used as con-
trol cells (control fetal AM hMSCs) were incubated with LV.shRNA-eGFP.hPGK1.
hrGFPI. Cx43↓(1) fetal AM hMSCs were transduced with LV.hCMV-IE.hCx45.
IRES.hrGFPII.WHVPRE to overexpress Cx45 (Cx43↓(1)+Cx45↑ fetal AM hMSCs) in 
these cells. Cx43↓(1) fetal AM hMSCs transduced with the eGFP-encoding SIN-LV 
LV.hCMV-IE.IRES.eGFP.HBVPRE (previously designated LV-CMV-IRES-eGFP7) were 
used as control cells (Cx43↓(1)+eGFP fetal AM hMSCs).
analysis of cx43 and cx45 expression
The distribution of Cx43 and Cx45 was studied by immunocytological stainings as 
described previously.8 In short, cells were fixed on ice with 4% paraformaldehyde 
in PBS for 30 min, washed with PBS, permeabilized with 0.1% Triton X-100 in PBS 
for 5 min at 4°C and rinsed again with PBS. To decrease non-specific binding of the 
primary antibodies the cells were incubated with 1% donkey serum (Sigma Aldrich 
Chemie) in PBS for 30 min. Thereafter, cells were incubated overnight at 4°C with 
Cx43-specific rabbit polyclonal antibodies (PAbs; C6219; Sigma Aldrich Chemie) 
or with Cx45-specific goat PAbs (C-19; Santa Cruz Biotechnology, Santa Cruz, CA) 
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diluted 1:200 and 1:100, respectively, in PBS containing 0.1% donkey serum. Bind-
ing of these primary antibodies to their target antigen was visualized using Alexa 
568-conjugated donkey anti-rabbit IgG or anti-goat IgG (both from Invitrogen) at 
dilutions of 1:200. Nuclei were stained by incubating the cells for 10 min at room 
temperature with 10 µg/mL Hoechst 33342 (Invitrogen) in PBS. Cells that went 
through the entire staining procedure but were not exposed to primary antibodies 
served as negative controls. A fluorescence microscope equipped with a digital 
color camera (Nikon Eclipse 80i; Nikon Europe, Badhoevedorp, the Netherlands) 
and dedicated software (NIS Elements, Nikon) were used to analyze the data.
Quantification of Cx43 and Cx45 protein levels was done by western blot analy-
sis. Lysates were made from ³4 different isolates of hMSCs per experimental group. 
After determining the protein concentration in each sample using the BCA Pro-
tein Assay Reagent (Thermo Fisher Scientific, Etten-Leur, the Netherlands), equal 
amounts of protein per slot was size-fractionated in a 12% NuPage Bis-Tris gel 
(Invitrogen) and transferred to a Hybond-P polyvinylidene difluoride membrane 
(GE Healthcare) using a wet blotting system. This membrane was blocked for 1 h 
at room temperature with 2% blocking buffer (ECL Advance blocking agent; GE 
Healthcare) in Tris-buffered saline wit Tween-20 (TBST) solution composed of 
10 mmol/L Tris-HCl (pH7.6), 0.05% Tween-20 and 150 mmol/L NaCl. Thereafter, 
the membrane was incubated for 1 h at room temperature with the PAbs directed 
against Cx43 or Cx45 diluted 1:15,000 and 1:2,000 in blocking buffer, respectively. 
After multiple washing steps in TBST, the membrane was incubated with horserad-
ish peroxidase (HRP)-conjugated goat anti-rabbit or donkey anti-goat secondary 
antibodies (both from Santa Cruz Biotechnology) diluted 1:15,000. For normali-
zation purposes, a mouse MAb recognizing the housekeeping protein glyceralde-
hyde-3-phosphate dehydrogenase (GAPDH; Chemicon International, Temecula, 
CA; clone 6C5) was used, which was detected by HRP-conjugated goat anti-mouse 
secondary antibodies (Santa Cruz Biotechnology; 1:15,000). Chemiluminescence 
was induced with the aid of the ECL Advance Western Blotting Detection Kit and 
was captured on Hyperfilm ECL (both from GE Healthcare). The intensity of the 
Cx43-, Cx45- and GAPDH-specific signals was quantified using Image J software 
(version 1.43; National Institutes of Health, Bethesda, MD). For each sample, the 
ratios between the GAPDH signal intensity and that of the Cx43 or Cx45 protein 
were taken as measure of the absolute amounts of both these gap junction proteins 
in the different hMSC cultures. The Cx43 or Cx45 levels in the experimental sam-
ples were expressed as percentage of those of the corresponding control samples, 
which were set to 100%.
hCx43 and hCx45 transcript levels were determined by quantitative reverse tran-
scription-polymerase chain reaction (qRT-PCR). To this purpose, total cellular RNA 
was extracted from ³4 samples for each group of hMSCs using the RNeasy Mini 
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110 Kit (QIAGEN Benelux, Venlo, the Netherlands). cDNA was synthesized in 20-μl 
volumes using 2 µg of RNA, 0.25 μg of random hexanucleotides, 25 nmol of dNTPs 
and 500 U of Superscript III RNase H− reverse transcriptase (all from Invitrogen). 
The resultant cDNA was amplified by PCR using the primer pairs QT00012684 and 
QT00239659 (both from QIAGEN), which are specific for the hCx43 (official name: 
human gap junction protein, alpha 1 [GJA1]) and hCx45 (official name: human gap 
junction protein, gamma 1 [GJC1]) gene, respectively. The annealing temperature for 
these primer combinations was 55°C. The expression of the genes of interest was 
normalized to that of the housekeeping gene GAPDH using primer set QT01192646 
(QIAGEN) also at an annealing temperature of 55°C. The resultant cDNA was PCR 
amplified using the QuantiTect SYBR Green PCR kit (QIAGEN) following the rec-
ommendations of the supplier. Agarose gel electrophoresis and melting curve anal-
ysis were carried out to verify that each primer pair yielded a single PCR product of 
the expected size. PCR amplifications carried out with human right atrium-specific 
cDNA or without cDNA served as positive and negative controls, respectively. Data 
were analyzed using the ΔCt method.9
assessment of functional heterocellular gap junctional
Dye transfer
Dye transfer assays were used to directly determine functional heterocellular cou-
pling between nrCMCs and the GFP-positive hMSCs. Four days after cell isolation, 
nrCMC cultures with a density of 2×105 cells per 3.8-cm2 well were loaded with dye 
by incubation for 15 min with 4 mmol/L calcein red-orange AM (calcein; Invitro-
gen) in Hank’s balanced salt solution (Invitrogen). Thereafter, the cells were rinsed 
three times with PBS and were kept in the incubator in nrCMC culture medium 
supplemented with 2.5 mmol/L probenecid (Invitrogen) for ³30 min before 2×104 
GFP-positive hMSCs were added. Fluorescent images (³30 per group) were cap-
tured after 10 h and evaluated in a blinded manner. In all experimental groups, 
GFP-positive hMSCs surrounded by the same number of nrCMCs were analyzed. 
ImageJ software was used to determine the intensity of the calcein-associated flu-
orescence in several randomly-chosen, equally-sized subcellular regions for both 
the GFP-positive hMSCs and the adjoining nrCMCs. To correct for possible vari-
ations in calcein loading efficiency, the dye intensity in the GFP-positive hMSCs 
was expressed as a percentage of that in the surrounding nrCMCs. The percentage 
of calcein-positive cells among the GFP-labeled hMSCs was also determined by 
counting these cells in ³60 fields of view per group.
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Intracellular measurements
Whole-cell patch-clamp measurements were performed in co-cultures of 2×106 
nrCMCs and 5×104 GFP-positive hMSCs. Typically, 4-6 nrCMCs were adjacent to 
a single hMSC. Four days after culture initiation, current-clamp recordings were 
performed at 25°C using an L/M-PC patch-clamp amplifier (List-Medical, Darm-
stadt, Germany; 3 kHz filtering).8 Tip and seal resistance were 2.0-2.5 MW and 
>1 GW, respectively. The pipette solution contained (in mmol/L) 10 Na2ATP, 115 
KCl, 1 MgCl2, 5 EGTA and 10 HEPES/KOH (pH 7.4) and the bath solution consisted 
of (in mmol/L) 137 NaCl, 4 KCl, 1.8 CaCl2, 1 MgCl2 and 10 HEPES (pH 7.4) in water. 
pClamp/Clampex8 software (Axon Instruments, Molecular Devices, Sunnyvale, 
CA) was used for data acquisition and analysis. All patch-clamp measurements 
were conducted in a blinded manner.
assessment of cardiomyogenic differentiation
To investigate their cardiomyogenic differentiation ability, 2×104 hMSCs from each 
experimental group were co-incubated for 10 days with 2×105 nrCMCs. The GFP-
positive hMSCs were added to the nrCMC cultures 2 days after isolation of the 
nrCMCs.
Human-specific immunocytological analysis of cardiomyogenic differentiation 
potential
Immunocytological stainings were conducted as previously described.3 On day 10 
after culture initiation, the co-cultures of nrCMCs and GFP-positive hMSCs were 
fixed and stained with a mouse MAb recognizing the sarcomeric protein α-actinin 
(clone EA53; Sigma-Aldrich Chemie; dilution 1:400) and with the Cx43-specific PAb 
described above or in case of nrCMC co-cultures with Cx43↓(1)+Cx45↑ fetal AM 
hMSCs with a Cx45-specific PAb (clone H-85; Santa Cruz Biotechnology, dilution 
1:200). The primary antibodies were visualized using Alexa 568-coupled donkey 
anti-mouse IgG and Alexa 532-linked goat anti-rabbit IgG secondary antibodies 
at dilutions of 1:200. Besides through their green fluorescence, the hMSCs in the 
co-cultures were identified by labeling with a human lamin A/C-specific murine 
MAb (clone 636; Vector Laboratories, Burlingame, CA; dilution 1:200). Lamin A/C 
staining was visualized with Qdot 655-streptavidin conjugates (Invitrogen; dilu-
tion 1:200) after incubation of the cells with biotinylated goat anti-mouse IgG2b 
secondary antibodies (Santa Cruz Biotechnology; dilution 1:200). Nuclei were 
stained using a 10 µg/mL solution of Hoechst 33342 in PBS. Co-cultures of nrC-
MCs with adult AT hMSCs transduced with LVs encoding for the puromycin-resist-
ence gene instead of GFP were stained with primary Abs recognizing α-actinin, 
Cx43 and human- specific lamin A/C. The Cx43 PAb was visualized using an Alexa 
488- coupled donkey anti-rabbit IgG, while α-actinin and human-specific lamin A/C 
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112 were visualized as described above. The percentage of GFP/lamin A/C-double-
positive cells expressing α-actinin was determined by the microscopic analysis, at 
40× magnification, of 25 cultures (200 cells per culture) of a total of 4 hMSC iso-
lates per experimental group. Furthermore, the co-cultures were also stained with 
a goat PAb recognizing the cardiac transcription factor GATA4 (clone C-20; Santa 
Cruz Biotechnology, dilution 1:100) or with an Nkx2.5-specific rabbit PAb (clone 
H-114; Santa Cruz Biotechnology, dilution 1:200). These primary antibodies were 
visualized using Alexa 568-coupled donkey anti-goat or anti-rabbit IgG secondary 
antibodies (dilutions of 1:200). A fluorescence microscope equipped with a digital 
color camera (Nikon Eclipse 80i, Nikon Europe, Badhoevedorp, the Netherlands) 
and dedicated software (NIS Elements, Nikon) were used to analyze the data. All 
co-cultures were treated equally using the same antibody dilutions and exposure 
times.
Electrophysiological measurements in co-cultures of hMSCs and nrCMCs after 
pharmacological uncoupling
Cells were plated, cultured and studied under the same conditions as described 
above. Whole-cell current-clamp recordings were performed 10 days after culture 
initiation. Prior to the start of the measurements, the cells were treated for 15 min 
with 180 μmol/L of the pharmacological gap junctional uncoupler 2-aminoethoxy-
diphenyl borate (Tocris, Ballwin, MO) as previously described.8 All measurements 
were conducted in a blinded manner.
statistics
Experimental results were expressed as mean±standard deviation for a given num-
ber (n) of observations. Data was analyzed by Student’s t-test for direct compari-
sons. Analysis of variance followed by appropriate post-hoc analysis was performed 
for multiple comparisons. Statistical analysis was carried out using SPSS 16.0 for 
Windows (SPSS, Chicago, IL). Differences were considered statistically significant 
at P<0.05.
Ramkisoensing.indd   112 22-4-2014   11:51:54
113
gap junctions and cardiac differentiation
references
1.  Pittenger MF, Mackay AM, Beck SC et al. Multilineage potential of adult human mesenchymal 
stem cells. Science 1999;284:143-147.
2.  National Institutes of Health. Guide for the Care and Use of Laboratory Animals. 1-1-2002.
3.  Pijnappels DA, Schalij MJ, van Tuyn J et al. Progressive increase in conduction velocity across 
human mesenchymal stem cells is mediated by enhanced electrical coupling. Cardiovasc Res 
2006;72:282-291.
4.  Askar SF, Ramkisoensing AA, Schalij MJ et al. Antiproliferative treatment of myofibroblasts 
prevents arrhythmias in vitro by limiting myofibroblast-induced depolarization. Cardiovasc Res 
2011;90:295-304.
5.  Swildens J, de Vries AA, Li Z et al. Integrin stimulation favors uptake of macromolecules by 
cardiomyocytes in vitro. Cell Physiol Biochem 2010;26:999-1010.
6.  Uil TG, de VJ, Vellinga J et al. A lentiviral vector-based adenovirus fiber-pseudotyping approach 
for expedited functional assessment of candidate retargeted fibers. J Gene Med 2009;11:990-
1004.
7.  van Tuyn J, Pijnappels DA, de Vries AA et al. Fibroblasts from human postmyocardial infarction 
scars acquire properties of cardiomyocytes after transduction with a recombinant myocardin 
gene. FASEB J 2007;21:3369-3379.
8.  Pijnappels DA, Schalij MJ, Ramkisoensing AA et al. Forced alignment of mesenchymal stem 
cells undergoing cardiomyogenic differentiation affects functional integration with cardiomyo-
cyte cultures. Circ Res 2008;103:167-176.
9.  Schefe JH, Lehmann KE, Buschmann IR et al. Quantitative real-time RT-PCR data analysis: 
current concepts and the novel “gene expression’s CT difference” formula. J Mol Med (Berl) 
2006;84:901-910.
supplemental figures
Supplemental Figure 1. Immunocytological assessment of cardiomyogenic differentiation of 
genetically modified adult AT hMSCs after 10 days of co-culture with nrCMCs. (A-B) Upon 
co-culture with nrCMCs, Cx43↑ adult AT hMSCs nor control adult AT hMSCs stained posi-
tive for α-actinin. Cx43 (indicated as Cx) plaques at the interfaces between Cx43↑ adult AT 
hMSCs and an adjacent nrCMC are present.
Ramkisoensing.indd   113 22-4-2014   11:51:55
114
chapter iv
Supplemental figure 2. Immunocytological assessment of cardiomyogenic differentiation 
of genetically modified adult AT hMSCs and fetal AM hMSCs after 10 days of co-culture 
with nrCMCs. (A1) Upon co-culture with nrCMCs, a fraction of the GFP-positive control 
fetal AM hMSCs became positive for the cardiac transcription factor Nkx2.5. (A2-A3, B1-B2) 
GFP-labeled Cx43↓(1) fetal AM hMSCs, Cx43↓(2) fetal AM hMSCs, Cx43↑ adult AT hMSCs 
and control adult AT hMSCs in co-culture with nrCMCs did not stain positive for Nkx2.5.
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Supplemental figure 3. Immunocytological assessment of cardiomyogenic differentiation of 
genetically modified adult AT hMSCs and fetal AM hMSCs after 10 days of co-culture with 
nrCMCs. (A1) Upon co-culture with nrCMCs, a fraction of the GFP-positive control fetal AM 
hMSCs became positive for the cardiac transcription factor GATA4. (A2-A3, B1-B2) GFP-
labeled Cx43↓ (1) fetal AM hMSCs, Cx43↓(2) fetal AM hMSCs, Cx43↑ adult AT hMSCs and 
control adult AT hMSCs in co-culture with nrCMCs did not stain positive for GATA4.
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Supplemental figure 4. Investigation by immunocytology of cardiomyogenic differentiation 
of fetal AM hMSCs in co-culture with nrCMCs after rescue of Cx43 knockdown by Cx45 
overexpression. In the presence of nrCMCs, a fraction of the GFP-positive Cx43↓(1)+Cx45↑ 
fetal AM hMSCs (A1 and B1) expressed Nkx2.5 and GATA4, while Cx43↓(1)+eGFP fetal AM 
hMSCs (A2 and B2) did not. 
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118 abstract
Aims: Cardiac fibrosis is associated with increased incidence of cardiac arrhythmias, 
but the underlying proarrhythmic mechanisms remain incompletely understood 
and antiarrhythmic therapies are still suboptimal. This study tests the hypothesis 
that myofibroblast (MFB) proliferation leads to tachyarrhythmias by altering the 
excitability of cardiomyocytes (CMCs), and that inhibition of MFB proliferation 
would thus lower the incidence of such arrhythmias.
Methods&Results: Endogenous MFBs in neonatal rat CMC cultures proliferated 
freely, or under control of different dosages of antiproliferative agents (mitomycin-
C and paclitaxel). At day 4 and 9, arrhythmogeneity of these cultures was studied by 
optical and multi-electrode mapping. Cultures were also studied for protein expres-
sion and electrophysiological properties.
MFB proliferation slowed conduction from 15.3±3.5 cm/s (day 4) to 8.8±0.3 cm/s 
(day 9) (n=75,p<0.01), while MFB numbers increased to 37.4±1.7% and 62.0±2%. 
At day 9, 81.3% of these cultures showed sustained spontaneous reentrant arrhyth-
mias. However, only 2.6% of mitomycin-C treated cultures (n=76,p<0.0001) 
showed tachyarrhythmias, and ectopic activity was decreased. Arrhythmia inci-
dence was drug-dose dependent and strongly related to MFB proliferation. Pacli-
taxel-treatment yielded similar results. CMCs were functionally coupled to MFBs, 
and more depolarized in cultures with ongoing MFB proliferation, in which only 
L-type Ca2+ channel-blockade terminated 100% of reentrant arrhythmias, in con-
trast to Na+-blockade (36%,n=12).
Conclusion: Proliferation of MFBs in myocardial cultures gives rise to sponta-
neous, sustained reentrant tachyarrhythmias. Antiproliferative treatment of such 
cultures prevents the occurrence of arrhythmias by limiting MFB-induced depolari-
zation, conduction slowing and ectopic activity. This study could provide a ration-
ale for a new treatment option for cardiac arrhythmias.
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introduction
Cardiac arrhythmias remain a leading cause of mortality in the Western world, 
despite a variety of treatment options.1 Particularly, implantable cardioverter defi-
brillators have shown to be effective in improving survival of patients at risk. How-
ever, the underlying arrhythmogenic substrate is left untreated and therefore the 
occurrence of arrhythmias is not prevented.2 Catheter ablation therapy may serve as 
an alternative and potentially curative treatment modality. However, its long-term 
benefits and effects on survival are yet unknown.3 Furthermore, anti-arrhythmic 
drug therapy appears to have no significant effect on the survival in larger groups of 
patients suffering from cardiac arrhythmias and is associated with significant and 
potentially lethal side effects.4 The limited therapeutic efficacy and adverse effects 
associated with these therapies is partly explained by our insufficient understand-
ing of the tissue substrate and proarrhythmic mechanisms that are responsible for 
the occurrence of lethal ventricular tachyarrhythmias.
Taken together, current treatment of cardiac arrhythmias, including means to 
prevent arrhythmias, is still suboptimal. It is therefore essential to better compre-
hend the underlying proarrhythmic tissue substrate and to provide new rationales 
for the development of more effective treatment options aimed at preventing 
arrhythmias from occurring.
Cardiac fibrosis, for example as a result of ischemic heart disease and aging, 
deteriorates the well organized nature of the working myocardium due to a dra-
matic increase in fibroblastic cells, called myofibroblasts (MFBs).5,6 This may 
increase electrical heterogeneity and the risk for lethal arrhythmias.7,8 However, 
the functional role of MFBs in cardiac arrhythmias is still incompletely under-
stood, especially the impact of their proliferative capacity on myocardial tissue. We 
hypothesized that MFB proliferation is a key factor in the incidence of spontaneous 
arrhythmias by altering the excitability of cardiomyocytes (CMCs), resulting in slow 
conduction and increased ectopic activity, and that inhibition of MFB prolifera-
tion may lower, or even prevent, the incidence of cardiac arrhythmias. To test this 
hypothesis, we studied the role of MFB proliferation in the occurrence of spontane-
ous reentrant arrhythmias in cardiac cultures using several antiproliferative agents, 
with cytochemical and extra- and intracellular electrophysiological techniques.
methods
All animal experiments were approved by the Animal Experiments Committee of 
the Leiden University Medical Center and conform to the Guide for the Care and 
Use of Laboratory Animals as stated by the US National Institutes of Health.
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120 cell isolation, cell culture and antiproliferative treatment
Neonatal rat ventricular CMCs were isolated and cultured as described previously.9 
Cells were plated on fibronectin-coated, round coverslips (15 mm) at a density of 
4-8x105 cells/well in 24-well plates. Endogenous MFBs, present in these cultures, 
were allowed to proliferate freely, or under control of antiproliferative agents (mito-
mycin-C (0.05-10 µg/ml) and paclitaxel (0.085 mg/ml), which were added at day 1 
of culture and incubated for 2h, resulting in partial or full inhibition of MFB prolif-
eration. In addition, defined ratios of MFBs and CMCs (10/90%, 25/75%, 50/50%) 
were mixed and co-cultured in 24-well plates and treated with mitomycin-C as 
described above, to maintain initial ratio and cell density.
immunocytological analyses
Cultures were fixed in 1% paraformaldehyde, permeabilized with 0.1% Triton X-100 
and stained with 1:50-1:200 diluted primary antibodies (see Online Supplement for 
details on antibodies). Corresponding Alexa fluor-conjugated secondary (Invitro-
gen, Carlsbad, CA, USA) antibodies were used at a dilution of 1:400. Subsequently, 
nuclei were counterstained with Hoechst 33342. Cultures were photographed and 
quantified with dedicated software (Image-Pro Plus, version 4.1.0.0, Media Cyber-
netics, Silver Spring, MD, USA).
western blot analyses
Homogenates were made from either 3 different purified CMC cultures, 50/50% 
CMC/MFB co-cultures or purified MFB cultures. Next, proteins were separated by 
SDS-page and transferred to Hybond PVDF membranes. Blots were blocked in 
5% bovine serum albumin in TBS-T. Primary and corresponding HRP-conjugated 
secondary antibodies were incubated for 1 h, after which chemiluminescence was 
induced by ECL advance detection reagents.
proliferation assays
Proliferation assays consisted of quantification of Ki67 expression as judged by Ki67 
staining. Furthermore, MFB numbers in cardiac cultures were quantified at day 1, 4 
and 9, based on collagen-I staining.
apoptosis assay
Possible pro-apoptotic effects of the antiproliferative treatments were investigated 
by active caspase 3 staining, using aforementioned protocol.
optical and multi-electrode mapping
At day 4 and 9, cardiac cultures were loaded with 16 µmol/L di-4-ANEPPS, given 
fresh DMEM/Ham’s F12 (37ºC) and immediately mapped using the Ultima-L 
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 optical mapping setup (SciMedia, Costa Mesa, CA, USA). Throughout mapping 
experiments, cultures were kept at 37ºC. Optical signal recordings were analyzed 
using Brain Vision Analyze 0909 (Brainvision Inc, Tokyo, Japan) in order to assess 
conduction velocity (CV). Spontaneous ectopic activity was assessed in all groups 
for 24 s after unipolar electrical stimulation, so that if present, reentrant arrhyth-
mias were eliminated, which allowed for ectopic or other spontaneous activity to 
resume.
For multi-electrode array (MEA) mapping, cells were cultured in glow-discharged, 
fibronectin-coated MEA culture dishes (Multi Channel Systems, Reutlingen, Ger-
many) and measurements were performed in the associated data acquisition sys-
tem, typically within 10 seconds after optical mapping. Electrograms were analyzed 
off-line using MC-Rack software (version 3.5.6, Multi Channel Systems).
whole-cell patch clamp and dye transfer
Measurements were performed in co-cultures of CMCs and MFBs treated with or 
without mitomycin-C at day 9 of culture, or co-cultures of CMCs and eGFP-labeled 
MFBs. After identification of CMCs by phase contrast or fluorescence microscopy, 
maximal diastolic potentials in CMCs were recorded in current-clamp. For data 
acquisition and analysis, pClamp/Clampex8 software (Axon Instruments, Molecu-
lar Devices, Sunnyvale, CA, USA) was used.
To further study functional cell-cell coupling, co-cultures of calcein AM-loaded 
CMCs (green) and Katushka-expressing MFBs (red) were investigated for gap junc-
tion-mediated calcein transfer into MFBs by fluorescence microscopy.
pharmacological interventions
The role of ion channel blockade in the maintenance of reentrant arrhythmias was 
investigated using the selective Nav1.5 blocker Tetrodotoxin (TTX, 5-10 mmol/L; 
TTX, Sigma-Aldrich) or verapamil (100 mmol/L; Centrafarm, Etten-Leur, the Neth-
erlands) as Cav1.2 blocker. These blockers were added to the mapping medium, 
after which the cultures were studied by optical mapping.
statistical analyses
Statistical analyses were performed using SPSS11.0 for Windows (SPSS Inc., Chi-
cago, IL, USA). Differences were considered statistically significant if p<0.05.
A more detailed description of the Materials and Methods can be found in the 
Online Supplement.
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characterization of cardiac cell cultures
Cultures from neonatal rat ventricles (25 isolations) were studied for expression of 
cell type-specific and gap junction proteins at day 9 of culture. All cultured fibro-
blasts had the MFB phenotype as judged by α-smooth muscle actin (α-SMA) and 
vimentin expression (Figure 1). Connexin43 (Cx43) was present between adjacent 
CMCs, MFBs and at heterocellular junctions (Figure 1A).Dye transfer experiments 
demonstrated functional gap junctional MFB-CMC coupling (supplemental Fig-
ure 1). Western blot analyses revealed an inverse linear relationship between MFB 
percentage and Cx43 levels. In contrast, α-SMA levels showed a positive linear rela-
tionship with MFB numbers (Figure 1B-C). Of all α-SMA positive MFBs, 98.5±1.6% 
also expressed cytoplasmic collagen-I, centered around the nucleus (R2=0.9921) 
(Figure 1D, G). CMCs did not express collagen-I, but stained positive for α-actinin 
(Figure 1E). Of the vimentin-positive MFBs, 98.4±1.3% also co-expressed collagen-I 
(R2=0.9960) (Figure 1F, H). Immunocytochemical staining for collagen-I as MFB 
marker and cardiac α-actinin as CMC-specific marker therefore allowed us to quan-
tify endogenous MFBs in a reliable and standardized manner.
uninhibited mfb proliferation and spontaneous reentrant arrhythmias
MFB percentage in primary cardiac cultures was 15.6±3.2% at day 1 and progres-
sively increased to 37.4±1.7% at day 4 (p<0.0001) (Figure 2A). At day 2, a spontane-
ously beating confluent monolayer had formed. At day 4, 24.2% of these cultures 
showed sustained, spontaneous reentrant tachyarrhythmias (n=33) (Figure 2F), 
with an average cycle-length of 267±22 ms and conduction velocity (CV) of 15.3±3.5 
cm/s. Sustained reentry was defined as repetitive circular activation lasting ≥30 s. 
MFB proliferation resulted in an MFB percentage of 62.2±2.0% at day 9 (p<0.0001 
vs day 1 and 4) (Figure 2B), and a decrease in CV to 8.8±0.3 cm/s (p<0.0001) 
(Figure 2C). At day 9, 81.3% of all spontaneously active cultures showed reentrant 
activity (n=75) (Figure 2D). The cycle-lengths of these arrhythmias had increased to 
365±57 ms (p<0.001 vs day 4) (Figure 2E).
inhibition of mfb-proliferation preserves high cv, decreases ectopic 
activity and prevents reentrant arrhythmias
Assessment of proliferative activity of MFBs was performed by Ki67 staining (Fig-
ure 3A). Quantification showed a significant decrease in proliferating MFBs follow-
ing mitomycin-C treatment (Figure 3B). In such cultures, MFB quantities remained 
constant throughout follow-up (Figure 3C), with no significant increase in apopto-
sis compared to control (Figure 3D and Supplemental Figure 2).
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Figure 1. Characterization of cardiac cell cultures at day 9. (A) Immunocytochemical double-
staining for Cx43, α-SMA (MFB) or α-actinin (CMC). White arrows mark intercellular expres-
sion. (B) Western blot of primary CMC cultures, 50%/50% co-cultures of MFBs/CMCs, and 
purified MFB cultures. (C) Quantification of Western blots normalized for β-tubulin shows 
opposing trends of Cx43 and α-SMA expression related to MFB quantity. *:p<0.05 vs CMC; 
**:p<0.05 vs CMC and 50%/50%. (D) a-SMA and collagen-I double-staining in MFBs. 
(E)  Collagen-I and α-actinin double-staining showing highly specificity for MFBs and 
CMCs, respectively. (F) Collagen-I and vimentin double-staining in MFBs. (G) Relationship 
between co-expression of a-SMA and collagen-I in MFBs, and (H) co-expression of vimen-
tin and collagen-I in MFBs. FOV=Field of View.
Under mapping conditions, ≥60% of both treated and untreated cultures 
were spontaneously active at day 4 and 9. At day 4, CV of mitomycin-C treated 
cultures was 23±1.9 cm/s, which was significantly higher than in control cultures 
(~15 cm/s, p<0.0001) (Figure 4E). Furthermore, no arrhythmias were observed 
(n=17) in mitomycin-C treated cultures (Figure 4C, H). At day 9, CV in mitomycin-C 
treated cultures remained unaltered. Interestingly, at day 9, only 2.6% of sponta-
neously active mitomycin-C treated cultures showed sustained reentrant tachy ar-
rhythmias (n=76), which is a dramatic decrease compared to proliferating control 
cultures (~81% arrhythmias (n=75) at day 9, Figure 4B, F-G). For further  evaluation 
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of arrhythmogeneity, the incidence of ectopic activity was studied in treated and 
untreated cultures. Ectopic activity, e.g. multiple simultaneous or alternating pace-
maker sites in one culture, was observed less frequently in mitomycin-treated cul-
tures than in untreated cultures at day 4 (25% (n=24) versus 43% (n=23)) and day 
9 (8% (n=37) versus 71% (n=35), respectively (Figure 4A, D).
Analyses of extracellular electrograms from MEA mapping experiments showed 
distinct differences between control cultures (n=12) and mitomycin-C treated 
cultures (n=11) (Figure 4I-J). Peak-to-peak electrogram amplitude was higher in 
mitomycin-C treated cultures (702±304 mV vs 96±23 mV, p<0.0001) (Figure 4K). 
Figure 2. Proliferation of MFBs in cardiac cultures causes conduction abnormalities. 
(A) Immunocytochemical staining for α-actinin (CMC;red) and collagen-I (MFB;green) in 
cardiac cultures at day 1, 4, and 9. (B) Quantification of collagen-I positive MFBs at day 1, 
4 and 9. Quantities are expressed as a percentage of total number of nuclei. *:p<0.0001 vs 
day 1. **:p<0.0001 vs day 1 and 4. (C) Progressive increase in MFBs is associated with a 
lower CV. *:p<0.0001 vs day 4, and (D) is also associated with an increase in the occurrence 
of spontaneous reentrant tachyarrhythmias and (E) an increase in cycle-length of the reen-
trant circuits between day 4 and 9. *:p<0.0001 vs day 4. (F) Time-lapse (spacing: 40ms) of 
a typical high-pass-filtered, spatially averaged optical signal of reentrant activation. Colours 
represent signal intensities related to changes in membrane potential.
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Figure 3. Mitomycin-C is a potent inhibitor of MFB proliferation (A) Typical examples of Ki67 
staining in MFBs, indicating proliferation at baseline (day 1) and 3 days later for control and 
mitomycin-C treated cultures. Insets show magnified nucleus positive for Ki67  staining. 
(B) Effect of mitomycin-C treatment on Ki67 positive staining in MFBs. *:p<0.001 vs base-
line and control. (C) MFB quantification in mitomycin-C treated cardiac cultures shows 
a stable MFB quantity throughout time (p=ns). (D) Quantification of active caspase-3 
 staining shows no significant differences in apoptosis between mitomycin-C treated and 
control cultures, although small but significant increases were found over time (*:p<0.05).
Spontaneous electrical activation frequency was lowered by mitomycin-C treat-
ment compared to control (0.28±0.22HZ vs 3.22±0.22Hz, p<0.0001) (Figure 4L).
dose-dependent effects of mitomycin-c treatment on preservation of 
electrophysiological parameters
As mitomycin-C treatment had such a profound impact on conduction properties 
of myocardial cultures, dose-dependency was studied next. Dosages administrated 
at day 1 of culture were 10, 5, 2.5, 0.5 and 0.05 mg/ml. At day 9, cultures were stud-
ied and subsequently stained for collagen-I (Figure 5A). Mitomycin-C decreased 
the amount of MFBs in a dose-dependent manner (Figure 5B). Furthermore, mito-
mycin-C had a strong dose-dependent effect on cell density (p<0.001). In addition, 
cardiomyocyte count, calculated by subtracting collagen-I positive cells from total 
cell count, did not change significantly (Figure 5C).
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Figure 4. Effects of mitomycin-C treatment on ectopic activity, CV and reentrant tachyar-
rhythmias in cardiac cultures. (A) Activation map of ectopic activity in an untreated culture 
at day 4 (4 ms isochrone spacing). Red asterisks mark ectopic foci. (B) Activation map 
of a reentrant tachyarrhythmia in an untreated cardiac culture (spacing: 4ms). (C) Typi-
cal activation map of uniform conduction across a mitomycin-C treated culture (spacing: 
4ms). (D) Quantification of incidence of ectopic activity at day 4 and 9 reveals a substantial 
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These dose-dependent changes in MFB quantities and cell density were related 
to significant electrophysiological changes in the cultures. At day 9, CV was 7.3±2.4 
cm/s at 0.05 µg/ml mitomycin-C and significantly rose with increasing dosages 
(Figure 5D). MFB percentages at various mitomycin-C dosages directly correlated 
with CV (R2=0.94) (Figure 5E). Furthermore, the incidence of sustained reentrant 
arrhythmias showed a negative mitomycin-C dose-dependent relationship, with no 
occurrence of arrhythmias at 10 mg/ml (n=25) and 5 mg/ml (n=20), 10% at 2.5 mg/
ml (n=31), 29% at 0.5 mg/ml (n=17), 92% at 0.05 mg/ml (n=13), and 93% for control 
(n=27) (Figure 5F).
cmc-mfb co-cultures at predetermined cell density and mfb-dependent 
conduction abnormalities
Cell density is an important determinant of conduction patterns, as this directly 
influences cell-to-cell contacts essential for action potential propagation. To fur-
ther study the quantitative effects of MFBs on conduction and arrhythmias, fixed 
ratios of MFBs and CMCs were plated out, while inhibiting proliferation with 
10 mg/ml mitomycin-C. As a result, average cell density between the co-culture 
groups did not differ significantly at day 9. MFB quantities were 15.7±2.0% (0% 
added MFBs), 26.8±2.5% (10% added), 38.0±3 (25% added) and 59.0±1.6% (50% 
added) at day 9. CV did not differ significantly between 0% (n=18) and 10% (n=20) 
added MFBs (23.1±2.2 cm/s vs 22.1±1.8 cm/s, p=0.51) at day 9. However, 25% and 
50% added MFBs slowed conduction to 14.2±3.5 cm/s and 10.9±2.4 cm/s, respec-
tively (p<0.05 vs all) (Supplemental Figure 3A). Furthermore, no arrhythmias were 
found in cultures containing 0% and 10% added MFBs, but at 25% and 50% added 
MFBs, occurrence was 27.8% (n=36) and 35.7% (n=28), respectively (Supplemental 
Figure 3C).
Unfortunately, cultures with added MFB percentages higher than 50% devel-
oped structural inhomogeneities from day 6 onwards and could therefore not be 
reduction by mitomycin-C treatment. (E) CV measured by optical mapping. *:p<0.001 vs 
mitomycin-C day 4-9 and control day 9. **:p<0.001 vs day 4-9 mitomycin-C. (F) Spon-
taneous reentry occurrence in mitomycin-C treated and control cultures at day 4 and 9. 
(G) Typical example of a non-high-pass-filtered, spatially filtered optical signal of repetitive 
activation in a non-treated, fibrotic culture showing reentrant tachyarrhythmias. (H) Typical 
example of a non-high-pass-filtered, spatially filtered optical signal of uniform conduction 
across a mito mycin-C treated culture. (I) Local extracellular multi-electrode array recording 
of a reentrant tachyarrhythmia. (J) Multi-electrode array recording of a mitomycin-C treated 
culture. (K) Quantification of electrical signal amplitude from multi-electrode array record-
ings at day 9 (p<0.0001 vs control). (L) Beating frequency of cultures measured by such 
arrays at day 9. *: p<0.0001 vs control.
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Figure 5. Dose-dependent effect of mitomycin-C treatment on arrhythmias at day 9 of 
culture. (A) Immunocytochemical double-staining for α-actinin (CMC;red) and collagen-I 
(MFB;green) in cardiac cultures treated with different dosages of mitomycin-C. (B) Dose-
dependent effect of mitomycin-C on MFB quantities in cardiac cultures as determined by 
collagen-I staining. *:p<0.001 vs all including control (0 µg/ml). (C) Quantification of col-
lagen-I staining shows a dose-dependent effect of mitomycin-C on total cell count without 
affecting CMC count. CMC count was calculated by subtract the number of MFBs from 
the total number of nuclei. *:p<0.01 vs all including control. (D) Dose-dependent effect of 
mitomycin-C on CV (*:p<0.05 vs all). (E) Plot of average MFB percentage found for differ-
ent dosages against CV found in these groups shows a negative linear association between 
MFB percentage and CV. FOV: Field of View. (F) Dose-dependent effect of mitomycin-C on 
reentry occurrence.
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studied at day 9. Nevertheless, linear regression analysis revealed a strong inverse 
relationship between plated MFB percentages and CV at day 4 (Supplemental Fig-
ure 3B).
A potentially secondary preventive effect of mitomycin-C on the occurrence of 
spontaneous arrhythmias was studied in 50%/50% CMC/MFB co-cultures either 
treated with mitomycin-C or allowed to proliferate freely. At day 4, CV in mito-
mycin-C treated cultures was 10.9±3.3 cm/s with 60.2±3.8% MFBs. In contrast, 
in control cultures with an equally high initial number of MFBs, CV decreased to 
4.9±1.1 cm/s, while MFB percentages increased to 78.8±4.7% (p<0.0001 vs treated 
cultures) (Supplemental Figure 3D). Furthermore, arrhythmia occurrence was 3.1-
fold higher in the non-treated cultures (26% (n=17) vs 82% (n=23)) (Supplemental 
Figure 3E).
characteristics of reentrant tachyarrhythmias
In untreated, arrhythmic cultures, cycle-length of the reentrant circuits was strongly 
related to CV (R2=0.83, Figure 6A). Reentry was typically associated with a decrease 
in CV of 5.0±1.2 cm/s as compared to non-reentrant conduction in cultures from 
the same experimental group. Furthermore, administration of tetrodotoxin (TTX) 
to 12 untreated, arrhythmic cultures at concentrations of 5 mM and 20 mM at day 9 
of culture, resulted in a significantly lower CV (Figure 6B, D-E), but had only a mild 
to moderate effect on terminating reentrant arrhythmias (Figure 6C). Next, 100 
mM verapamil was administered to block L-type Ca2+-channels, which terminated 
100% of the remaining arrhythmias (Figure 6C). Internal PBS control did not affect 
arrhythmia persistence. Additionally, 12 untreated, arrhythmic cultures were imme-
diately treated with verapamil without prior TTX administration, which also ter-
minated all arrhythmias. In mitomycin-C treated cultures, 20 µM TTX completely 
blocked propagation for ≥30 seconds, after which propagation resumed at a sig-
nificantly lower CV of 11.5±2.0 cm/s (n=10, previously 24.2±2.0 cm/s, p<0.0001).
To further study the role of MFB proliferation in arrhythmogeneity, CMCs were 
investigated for their electrophysiological properties by patch-clamp experiments 
in active cultures treated with or without mitomycin-C. Cultures had comparable 
beating frequencies (0.5-1 Hz). After 9 days of ongoing MFB proliferation, the maxi-
mal negative diastolic potential of CMCs was significantly reduced
(-44±9mV, n=11) as compared to those of CMCs in mitomycin-C treated cul-
tures (-68±7mV, n=12, p<0.001) (Figure 6F).
In co-cultures of eGFP-labeled MFBs with CMCs, at equal density and ratio as 
day 9 of free proliferation, diastolic membrane potentials of CMCs (-48±6mV, n=8) 
were comparable to those derived at day 9 of free proliferation. This is in agreement 
with the low CV and increased ectopic activity found in such cultures and their 
tolerance to TTX treatment.
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prevention of arrhythmias by paclitaxel, another antiproliferative agent
Cultures were treated with 0.085 mg/ml paclitaxel and studied identically to mito-
mycin-C treated cultures. In paclitaxel-treated MFB cultures, less Ki67 positive 
cells were found (Supplemental Figure 4B-C) and apoptosis was not significantly 
increased compared to vehicle-control (0.9% DMSO) treated cultures (Supplemen-
tal Figure 4D, 5). Interestingly, vehicle treatment alone also inhibited proliferation. 
Spontaneous activity under optical mapping conditions was >60% for both treated 
and untreated groups. CV at day 4 was 17.3±1.6 (vs 11.1±3.6 cm/s in control), with-
out reentry (n=27) in the paclitaxel-treated group, whereas 61.5% (n=11) of controls 
showed reentry (Supplemental Figure 4E-F). At day 9, paclitaxel-treated cultures 
contained 33.3±2.9% MFBs (Supplemental Figure 4A), and CV was 15.0±1.5 cm/s 
(p<0.01 vs day 4 and control), while arrhythmias were observed in 5% of spontane-
ously active cultures (n=23). In control cultures at day 9, CV was 6.5±1.4 cm/s, with 
a reentry incidence of 93% (n=15) (Supplemental Figure 4E-F).
Figure 6. Characteristics of reentrant tachyarrhythmias at day 9. (A) Linear association 
between cycle-length and CV (R2=0.83, n=35). (B) TTX significantly decreased CV in a dose 
dependent manner (*:p<0.05 vs baseline, **:p<0.0001 vs 0 and 5 µM). (C) Persistence of 
reentrant circuits after administration of TTX and/or verapamil. (D) Activation map of a 
reentrant tachyarrhythmia in an untreated cardiac culture (spacing: 4ms). (E) Activation 
map of the same reentrant tachyarrhythmia shown in panel E after 5 min of incubation 
with 20 µM TTX. Of note is the increased number of isochronal lines (4 ms), indicating 
conduction slowing. (F) Maximal diastolic potential measured in CMCs from control and 
mitomycin-C treated cultures at day 9.
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discussion
Key findings of this study are (1) proliferation of myofibroblasts in myocardial cul-
tures results in a highly pro-arrhythmogenic substrate, in which CMCs are depolar-
ized, conduction is slow and mainly Ca2+-driven, and ectopic activity is increased, 
thereby giving rise to spontaneous, sustained reentrant tachyarrhythmias, and 
(2) antiproliferative treatment of these cultures prevents or substantially reduces 
the occurrence of arrhythmias by limiting myofibroblasts-induced depolarization 
and preserving uniform, rapid, Na+-driven impulse propagation in CMCs, with 
less ectopic activity, but without noticeable adverse effects on electrophysiological 
properties and without increased apoptosis in the treated cultures.
myofibroblasts and cardiac arrhythmogeneity
In vitro studies indicate that MFBs could play a role in modulating electrophysi-
ological properties in remodeled hearts, and thereby contribute to arrhythmo-
genesis. Rook et al. showed that cardiac fibroblasts and CMCs are able to form 
functional heterocellular gap junctions.10 Gaudesius et al.,11 and previous studies 
by our group,12,13 demonstrate that fibroblasts coupled to CMCs are able to slowly 
conduct electrical impulses through electrotonic interaction. Paracrine activity of 
cardiac fibroblasts may also contribute to a reduction in CV.14 Besides their effects 
on CV, MFBs may also induce ectopic activity in cardiac cultures as demonstrated 
by Miragoli et al.15 Recently, a study by Zlochiver et al. showed that MFBs are able to 
contribute to rhythm disturbances in cardiac cultures,16 which was further investi-
gated in a number of in silico studies.17,18 Novel in the present study is the finding that 
ongoing proliferation of endogenous MFBs in neonatal rat CMC cultures results in 
the creation of a highly arrhythmogenic substrate, and that antiproliferative treat-
ment of cardiac cultures prevents spontaneous reentrant tachyarrhythmias.
reentrant tachyarrhythmias in cardiac cultures with ongoing mfb 
proliferation
In previous studies, functional reentry was induced by rapid electrical pacing of 
the cultures.16,19,20 In the present study the focus was on the ability of myocardial 
cultures to spontaneously generate such reentrant arrhythmias. MFBs are known 
to contribute to both automaticity and slow conduction,11,15,21 therefore reentry may 
occur in the absence of externally applied electrical impulses. We confirmed this 
by showing that ~81% of all cultures with ongoing MFB proliferation and without 
apparent anatomical obstacles, showed spontaneous, sustained reentrant tachyar-
rhythmias at day 9 of culture.
By allowing MFBs to proliferate freely in CMC cultures, CMCs became increas-
ingly depolarized due to increasing MFB-CMC interactions. The present study 
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132 shows that this eventually leads towards a depolarized resting membrane potential 
at which voltage-gated fast Na+-channels are largely inactivated and propagation 
becomes mainly dependent on activation of Ca2+-channels. It is known that Ca2+-
driven propagation contributes to slow conduction.7 In line with this observation, 
all arrhythmias in the present study were terminated when L-type Ca2+-channels 
were blocked. In contrast, most arrhythmias sustained after Na+-channel blockade, 
indicating that electrical propagation in such conditions appears to be mainly Ca2+-
driven. Recently, Chang et al. showed similar results in another in vitro model of 
reentry, using non-fibroblastic cells.20 Moreover, as these CMCs become depolar-
ized by increasing numbers of MFB, they could become active as local pacemaker 
site through depolarized-induced automaticity,22 and thereby add to the proar-
rhythmogenic nature of fibrotic cultures. The present study shows that around 50% 
of all fibrotic cultures, which did not show reentrant arrhythmias at the time of 
mapping, showed multiple simultaneous or alternating pacemaker sites.
Ongoing MFB proliferation also had an effect on the cycle-length of the tach-
yarrhythmias. At day 4, average cycle-length was 267±22 ms at a CV of 15.3±3.5 
cm/s, whereas at day 9, the cycle-length increased to 365±57 ms at a CV of only 
8.8±3 cm/s. These data may explain how different degrees of fibrosis during various 
stages of cardiac remodeling could both determine the vulnerability to arrhythmias 
and the rate of atrial or ventricular arrhythmias. Therefore, future in vivo studies are 
required to better understand the role of MFBs in the arrhythmic heart.
antiproliferative treatment of endogenous myofibroblasts
In the present study, two different antiproliferative agents were used to study the 
role of MFB proliferation in arrhythmogeneity. One of these agents is mitomycin-
C, a potent DNA-crosslinking agent. After proliferation inhibition by mitomycin-
C, CV remained stable from day 4 to day 9, and spontaneous reentry occurrence 
decreased from 81.3% to 2.6%. Concerning the underlying mechanisms, in cul-
tures treated with mitomycin-C the resting membrane potential of CMCs remained 
more negative. Therefore propagation remained fast and mainly Na+-driven, as was 
shown by addition of TTX to these cultures, in contrast to cultures with ongoing 
MFB proliferation. In addition, less ectopic activity was observed in cultures treated 
with mitomycin-C, which most likely resulted from limited MFB-induced depolari-
zation and a subsequent reduction of the occurrence of depolarization-induced 
automaticity. As a consequence of fast propagation and less ectopic activity the 
occurrence of reentrant arrhythmias is expected to decrease, which was confirmed 
in the present study.
By inhibition of MFB proliferation, not only MFB-induced depolarization of 
CMCs is minimized, but also disruption of low-resistant gap junctional coupling 
between CMCs by infiltrating MFBs may be prevented, thereby preserving rapid 
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propagation. Calculations on cell densities indicated that antiproliferative treat-
ment does coincide with a lower total cell density while maintaining the same num-
ber of CMCs as the non-treated cultures. In addition, any negative, paracrine effect 
of MFBs on CV in cardiac cultures will be stabilized after inhibition of proliferation, 
as such an effect is expected to be cell number-dependent.
To exclude a mitomycin-C specific effect and to establish that proliferation is 
the key factor in this study, another antiproliferative agent was studied. Paclitaxel, 
a member of the taxanes drug category, interferes with breakdown of microtubules 
during cell division. Park et al. used the antiproliferative potential of paclitaxel 
to inhibit coronary restenosis and neointimal hyperplasia in the myocardium.23 
We show that paclitaxel is also suited as agent to reduce the incidence of reen-
trant tachyarrhythmias in myocardial cultures. Control experiments for paclitaxel 
included incubation with DMSO (0.9%). DMSO is known to have several effects 
on cells,24 and therefore may explain the high incidence of reentry at day 4 in these 
cultures.The lower CV found in paclitaxel-treated cultures may also be explained 
by its mechanism of action.25 Nevertheless, no reentry was observed in paclitaxel-
treated cultures with DMSO as vehicle. Importantly, both agents did not result in 
increased apoptosis, which is in agreement with earlier studies.26,27
in vivo translation
The present study provides new insights in the way cardiac fibrosis may result 
in arrhythmias, and how this may provide a rationale for a preventive strategy, 
which currently does not exist. In the clinical setting, myocardial fibrosis increases 
arrhythmia vulnerability in diseased and aged hearts, and finds its basis in prolif-
eration of MFBs and matrix deposition by these cells. Although functional MFB-
CMC coupling remains to be proven in vivo, the key role of MFBs in cardiac fibrosis 
suggests a high significance for in vivo arrhythmogeneity of these cells. Measures 
to control MFB proliferation may therefore counteract different pro-arrhythmic 
aspects at once. Naturally, in vivo studies are necessary to determine whether pro-
gressive fibrosis (e.g. in post myocardial infarction or aging) and its pro-arrhythmic 
consequences can be limited by reducing MFB proliferation. Considering the role 
of cell proliferation in different physiological processes in the heart,5,28,29 and pos-
sible cardiotoxic effects of antiproliferative agents,30 careful consideration of the 
time-frame, location and strength of intervention seems of importance. Still, the 
strong in vitro evidence from this study suggests that approaches to limit MFB pro-
liferation in hearts vulnerable to fibrosis-related conduction disturbances may have 
profound effects on arrhythmia vulnerability.
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134 study limitations
The use of adult human CMCs and MFBs may have been more clinically relevant, 
but these CMCs cannot be kept in culture for longer periods and the proliferation 
rate of such MFBs in vitro does not allow a study like this within a reasonable time-
frame. Furthermore, cardiac MFBs are also involved in secretion of extracellular 
matrix components, which could contribute to deleterious effects on conduction 
in fibrotic cardiac tissue. These aspects were not studied in detail and need more 
dedicated studies in the future. However, it may be expected that with inhibition of 
MFB proliferation, the secretion of such components is indirectly lowered.
conclusions
Proliferation of MFBs in myocardial cultures gives rise to spontaneous, sustained 
reentrant tachyarrhythmias. However, antiproliferative treatment of such cultures 
prevents the occurrence of arrhythmias significantly by preserving a physiological 
membrane potential and rapid, Na+-driven propagation in CMCs. Hence,our study 
indicates that MFB proliferation may be a novel target for future anti-arrhythmic 
strategies.
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online supplement
methods
All animal experiments were approved by the Animal Experiments Committee of 
the Leiden University Medical Center and conform to the Guide for the Care and 
Use of Laboratory Animals as stated by the US National Institutes of Health.
cell isolation and culture
Primary neonatal rat cardiomyocytes (CMCs) and cardiac fibroblasts were isolated 
and cultured as described previously1,2. Immediately following isolation, cell sus-
pensions were spinned down, resuspended and filtered through a 20 mm cell-
strainer to remove cell-aggregates. Subsequently, cells were counted and plated 
out on fibronectin-coated round coverslips (15 mm) at a cell density of 4-8x105 
cells/well in 24-well plates (Corning Life Sciences, Amsterdam, the Netherlands), 
depending on the experiment.
For co-culture experiments with fixed myofibroblast (MFB) quantities (0%, 
10%, 25%, 50%, 75%, and 90%), primary CMCs, and MFBs obtained from an ear-
lier isolation (passage 3-4), were counted and mixed in specific, pre-determined 
ratios before plating. Co-cultures were treated with mitomycin-C (Sigma-Aldrich, 
St. Louis, MO, USA) to maintain original CMC-fibroblast ratios. All cultures were 
refreshed daily and cultured in a humidified incubator at 37ºC and 5% CO2.
antiproliferative treatment
Antiproliferative treatment of cultures was performed at day 1 of culture. The choice 
of different types of antiproliferative agents was based on their specific mecha-
nisms of action, thereby allowing a more accurate study of the role of proliferation 
in arrhythmogeneity, rather than an agent-specific effect.
Different dosages of the antiproliferative agent of interest (mitomycin-C dis-
solved in PBS; ranging from 10 µg/ml to 0.05 µg/ml or paclitaxel dissolved in 
DMSO; 0.085 mg/ml, both from Sigma-Aldrich) were diluted in growth medium 
(Ham’s-F10 supplemented with 10% fetal bovine serum (FBS, Invitrogen, Carls-
bad, CA, USA), 10% horse serum (HS, Invitrogen), and penicillin (100 U/ml) and 
streptomycin (100 mg/ml, P/S; Bio-Whittaker, Carlsbad, CA, USA)) and incubated 
for 2 hours. Cultures were then rinsed twice in PBS and once in a 1:1 mixture of 
Dulbecco’s modified Eagle’s medium (DMEM, Invitrogen) and Ham’s F10 medium 
(ICN Biomedicals, Irvine, CA, USA) supplemented with 5% HS and P/S, before 
being kept on this medium throughout the experiment. Non-treated controls were 
rinsed identically.
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Immunocytochemical analyses
Following mapping experiments, cultures were stained for proteins of interest, 
or cultures were stained parallel to mapping experiments, as described in earlier 
studies1. Cultures were stained for α-smooth muscle actin (α-SMA) and vimentin 
expression to study fibroblasts phenotype (Sigma-Aldrich), collagen-I expression 
to quantify myofibroblast (MFB) numbers (Abcam, Cambridge, MA, USA), Ki67 
expression to identify actively proliferating cells (Abcam) and α-actinin as cardio-
myocyte-specific marker (Sigma-Aldrich). Furthermore, cultures were also stained 
for connexin 43 (Cx43) (Sigma-Aldrich) to study gap junction formation between 
CMCs and MFBs. Alexa donkey-anti-mouse IgG 568 and Alexa donkey-anti-rabbit 
IgG 488 secondary (Invitrogen) antibodies were used at a dilution of 1:400. For 
all staining, nuclei were counterstained using Hoechst 3342 (Invitrogen). A fluo-
rescent microscope equipped with a digital camera (Nikon Eclipse, Nikon Europe, 
Badhoevedorp, the Netherlands) and dedicated software (Image-Pro Plus, version 
4.1.0.0, Media Cybernetics, Silver Spring, MD, USA) was used to analyze the cul-
tures. All proteins of interest were studied in at least 6 different cultures from a 
specific group, from which at least 20 representative images were taken at different 
magnifications (10, 40, 100x). All cultures were stained using the same solutions 
and captured using equal exposure times for the protein of interest.
Western-blot analyses
Cx43 expression was studied in a MFB-density dependent manner and corre-
lated with α-SMA expression. Homogenates were made from 3 different purified 
CMC cultures, 50%/50% CMC/MFB co-cultures and purified MFB cultures, size-
fractionated on NuPage 12% Tris-Acetate NuPage gels (Invitrogen) and trans-
ferred to Hybond PVDF membranes (GE Healthcare, Waukesha, WI, USA). These 
membranes were incubated with antibodies against Cx43 or α-SMA (both from 
Sigma-Aldrich) for 1 h followed by incubation with corresponding HRP-conjugated 
secondary antibodies (Santa Cruz Biotechnologies,Santa Cruz, CA, USA). β-tubulin 
(Millipore, Billerica, MA, USA) expression was determined to check for equal pro-
tein loading. Chemiluminescence was induced by ECL advance detection reagents 
(GE Healthcare) and caught on Hyperfilm ECL (GE Healthcare), after which the 
intensity of Cx43 and α-SMA bands were quantified by Scion Image analysis soft-
ware (Scion Corporation, Frederick, MD, USA).
Proliferation assays
To assess the effect of antiproliferative treatments on MFB proliferation, MFB 
cultures were seeded at 5x104 cells/well in a 24-wells plate and stained for Ki67 
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(Abcam). Ki67 is a cellular marker for cell proliferation, and was quantified for 
positive staining in MFBs, before and 3 days after treatment. Quantification was 
performed on 6 cultures from which 8 images were taken per culture at 40x mag-
nification. These cultures were kept on DMEM/Ham’s F10 + 5% HS and refreshed 
daily. Furthermore, collagen-I staining was performed after optical mapping experi-
ments on at least 6 cardiac cultures to determine the number of MFBs in cultures 
treated with different antiproliferative agents and dosages (mitomycin-C 10 µg/ml, 
5 µg/ml, 2.5 µg/ml, 0.5 µg/ml, 0.05 µg/ml) at day 1, 4 and 9. Quantification of total 
nuclei count, and cells expressing collagen-I was performed on at least 6 images 
and averaged per culture per timepoint per dosage.
Apoptosis assay
Antiproliferative treatment may lead to increased apoptosis. Therefore, we investi-
gated the expression of active caspase-3 (Abcam), an established marker for apop-
tosis, in cultures treated with antiproliferative agents and appropriate controls. 
These cardiac cultures were seeded at 4x105 cells/well in a 24-wells format. The 
same protocol was used as described earlier for immunocytochemical staining. 
Total nuclei number and cells expressing active caspase-3 were quantified within 
the same image and averaged for 6 images per culture for 6 different cultures at 
40x magnification.
optical and multi-electrode mapping
To investigate action potential propagation patterns on a whole-culture scale, 
cultures (8x105 cells/well in a 24-wells format), treated with or without antiprolif-
erative agents, were optically mapped with the voltage-sensitive dye di-4-ANEPPS 
(Invitrogen), on day 4 and 9. For reasons of standardization and reproducibility, 
only spontaneously active cultures with high degrees of structural and functional 
homogeneity (determined by light-microscopy and electrophysiological mapping) 
were included for further analyses. As a result, 95 out of every 100 cultures (wells) 
were included. On days of mapping experiments, cells were incubated with culture 
medium (DMEM/Ham’s F10 + 5% horse serum) containing 16 µmol/L di-4-AN-
EPPS for 15±5 minutes. Following incubation, cells were refreshed with DMEM/
Ham’s F12 (37ºC) and immediately mapped. Mapping experiments in a 24-well 
plate typically did not exceed 30 min. Excitation light (λex=525±25nm) was delivered 
by a halogen arc-lamp (MHAB-150W, Moritex Corporation, San Jose, CA, USA). 
Fluorescent emission light (λem>590 nm) was passed through a camera lens (1x 
Plan-Apo, WD=15 mm; Leica, Wetzlar, Germany) and focused onto a 100 by 100 
pixels (100 mm2) CMOS camera (Ultima-L, SciMedia, Costa Mesa, CA, USA) by a 
1.6x converging lens, resulting in a total field of view of 256 mm2 and a spatial reso-
lution of 160 µm/pixel. During measurements, cultures were kept at 37ºC.  Electrical 
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pass filtered and analyzed using Brain Vision Analyze 0909 (Brainvision Inc, Tokyo, 
Japan). The same culture was never exposed for longer than 40 s to minimize 
phototoxic effects. Importantly, mapping of the same culture at both day 4 and 9 
appeared to be well tolerated as no structural inhomogeneities were observed and 
CV did not change significantly over time in mitomyocin-C treated cultures.
Each pixels’ signal was averaged in a fixed grid of 3x3 pixels. Activation time 
points were determined at dF/dtmax, which corresponds to the timepoint of maxi-
mum upstroke velocity. Conduction velocity (CV) in cultures with a uniform activa-
tion pattern was calculated between two 3 by 3 pixel grids, typically spaced 2-8 mm 
apart, and perpendicular to the activation wavefront. For cultures showing reen-
trant conduction wavefronts, CV was determined similarly at half the maximal dis-
tance from the core perpendicular to the wavefront over a length of 2-4 mm. Per 
culture, CV was determined in 6-fold and averaged for further comparisons. Reen-
trant cycle length was calculated from 3 separate cycles per culture and averaged. 
As this study focuses on reentry occurrence and prevention of such arrhythmias, 
all CV values for reentry and non reentry cultures were pooled within each different 
group, as this inclusion makes CV a valuable parameter in determining therapeutic 
effects in vitro.
For multi-electrode array (MEA) mapping, cells were cultured in glow-dis-
charged, fibronectin-coated MEA culture dishes (Multi Channel Systems, Reutlin-
gen, Germany) and measurements were performed as described previously (2), 
typically within 10 seconds after optical mapping.
assessment of ectopic activity
Spontaneous ectopic activity was defined as multiple simultaneous or alternating 
pacemaker sites. In our cultures, 53% of fibrotic cultures (n=47) versus 23% (n=44) 
in mitomycin-C treated cultures showed ectopic activity spontaneously at day 4. 
However, at day 9 a high percentage of non-treated cultures showed spontaneous 
reentry, which continuously excites the cardiac tissue and thereby greatly decreases 
the possibility of ectopic activity. Therefore, to be able to quantify ectopic activity 
at day 9, reentry needed to be eliminated in a non-pharmacological manner. For 
this purpose, we used a custom-made epoxy-coated platinum electrode and per-
formed unipolar stimulation with 6 V for 4 seconds using an electrical stimulus 
module with corresponding software (Multichannel Systems), which successfully 
eliminated re-entry in >90% of the cultures. This allowed for spontaneous ectopic 
activity to resume, which was detected by mapping of the cultures for 24 seconds 
directly after applying the stimulus. This allowed for quantification of ectopic activ-
ity at day 9. To provide a balanced comparative view, these experiments were per-
formed identically at day 4 and 9 in mitomycin-C treated and control cultures.
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whole-cell patch-clamp
Whole-cell patch-clamp measurements were performed in co-cultures of CMCs and 
MFBs treated with or without mitomycin-C at day 9 of culture. In addition, MFBs 
were labeled with eGFP using lenti-viral vectors (LV.CMV.eGFP.HBVPRE; MOI 10), 
refreshed daily and passaged twice before these cells were co-cultured with CMCs 
at equal density and ratio at day 9 of free MFB proliferation. After identification of 
CMCs by phase contrast or fluorescence microscopy, maximal diastolic potentials 
in CMCs were recorded in current-clamp. Whole-cell recordings were performed at 
25°C using a L/M-PC patch-clamp amplifier (3kHz filtering) (List-Medical, Darm-
stadt, Germany). The pipette solution contained (in mmol/L) 10 Na2ATP, 115 KCl, 
1 MgCl2, 5 EGTA, 10 HEPES/KOH (pH 7.4). Tip and seal resistance were 2.0-2.5 
MW and >1 GW, respectively. The bath solution contained (in mmol/L) 137 NaCl, 
4 KCl, 1.8 CaCl2, 1 MgCl2, and 10 HEPES (pH 7.4). For data acquisition and analysis, 
pClamp/Clampex8 software (Axon Instruments, Molecular Devices, Sunnyvale, 
CA, USA) was used.
dye transfer
To establish functional coupling between MFBs and CMCs, MFBs were labeled 
with a lenti-viral vector encoding kathuska (MOI 20). MFBs were kept in culture for 
2 weeks and were at least passaged twice before usage in experiments. CMC cul-
tures with a density of 1.0x105 cells/well were treated with 10 µg/ml mitomycin-C to 
prevent endogenous MFB overgrowth. At day 4, these cultures (n=12) were loaded 
for 30 minutes with calcein-AM (Invitrogen) diluted in HBSS (Gibco), which once 
internalized is converted to the green fluorescent dye calcein. Cells were rinsed 
twice with PBS and kept on culture medium containing 2.5 mmol/L probenecid 
(Invitrogen) to block extracellular leakage. Kathuska labeled MFBs were subse-
quently plated out in a 1:1 ratio with the calcein-loaded CMCs. Brightfield and fluo-
rescent images (at least 10 per culture) were captured after 24 hours.
pharmacological interventions
To study the role of Nav1.5 and Cav1.2 channels in the maintenance of reentrant 
arrhythmias in cultures with high numbers of MFBs, increasing doses of Tetrodo-
toxin (TTX) (5 and 20 mmol/L; Sigma-Aldrich) were added to the cultures followed 
by administration of verapamil (100 mmol/L; Centrafarm, Etten-leur, the Nether-
lands) during optical mapping experiments. As internal control, PBS was adminis-
tered to the mapping medium prior to pharmacological interventions.
To study the role of Cav1.2 blockade exclusively, arrhythmic cultures were imme-
diately treated with verapamil without prior TTX administration. Both 20 mM TTX 
and 100 mM verapamil are expected to fully block the targeted ion channels in neo-
natal rat CMCs3,4. The electrophysiological effects of these drugs were evaluated by 
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142 optical mapping, directly, 1 min and 5 min after administration. In identical fashion, 
TTX was administered to mitomyocin-C treated cultures at day 9, showing uniform, 
rapid activation, and evaluated for persistence of electrical activation.
statistical analysis
Statistical analyses were performed using SPSS11.0 for Windows (SPSS Inc., Chi-
cago, IL, USA). Data were compared with one-way or two-factor mixed ANOVA test 
with Bonferroni post-hoc correction if appropriate, and expressed as mean±SD. 
Linear correlation analysis was performed by calculating Pearson’s correlation coef-
ficient. Comparison between two groups was performed using the student-t test. 
Differences were considered statistically significant if p<0.05.
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supplemental figures
Supplemental figure 1. Dye transfer experiments of CMCs loaded with calcein (green) and 
MFBs labeled with Kathushka (red). MFBs in direct contact with calcein-loaded CMCs (top) 
were positive for the gap-junctional permeable green fluorescent dye calcein. In contrast, 
MFBs that remained separate (bottom) from CMCs were negative for this dye. These results 
indicate that CMCs and MFBs are functionally coupled.
Supplemental figure 2. Mitomycin-C does not increase apoptosis in myocardial cultures. 
Representative images of immunocytochemical staining for caspase-3 in mitomycin-C 
treated cultures and control cultures at day 4 and 9. Nuclei were counterstained with Hoe-
chst and caspase-3 positive nuclei were quantified and expressed as a percentage of total 
cell count, which was not significantly affected by mitomycin-C treatment. Total cell count 
was defined as the total number of viable nuclei added to the amount of caspase-3 positive 
cells.
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Supplemental figure 3. MFB-CMC co-cultures at predetermined cell density and the effects 
on conduction abnormalities. (A) CV slows according to plated MFB percentage, except for 
10% MFBs. *:p<0.05 vs all. (B) CV at day 4 shows a strong linear association with added 
MFB percentage. Dotted line represents regression line. (C) Occurrence of spontaneous 
arrhythmias at day 9 is MFB quantity-dependent and rises with increasing added MFB per-
centages. (D) Mitomycin-C administration to 50%/50% MFB-CMC co-cultures results in a 
higher CV at day 4 compared to control. *:p<0.0001 vs control. (E) Uninhibited proliferation 
of MFBs in a 50%/50% CMC/MFB co-culture results in a 3.1-fold increase in reentry occur-
rence (n=23) compared to mitomycin-C treated cultures (n=17) of initially identical cellular 
composition.
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Supplemental figure 4. Paclitaxel exhibits anti-arrhythmic effects through MFB prolife-
ration inhibition at day 4 and 9 of culture. (A) Immunocytochemical staining for collagen-
I (MFB, green) and α-actinin (CMC, red) at day 9 in a paclitaxel-treated cardiac culture. 
(B) Ki67  staining shows a substantial reduction in positive cells by paclitaxel administration. 
(C) Quantification of Ki67-positive MFBs before and after paclitaxel treatment. *:p<0.05 vs 
baseline, **:p<0.05 vs baseline and control. (D) Quantification of apoptotic cells by active 
caspase-3 staining shows no significant increase in apoptosis by 10 μmol/L paclitaxel. 
(E) Paclitaxel-treated cultures maintain a higher CV compared to control cultures. *:p<0.05 
vs paclitaxel at day 4. **:p<0.05 vs paclitaxel at day 4 and control at day 9. ***:p<0.05 vs 
control at day 4 and paclitaxel at day 9. (F) Paclitaxel treatment dramatically decreased 
reentry occurrence compared to control at both day 4 and 9 of culture.
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Supplemental figure 5. Paclitaxel does not increase apoptosis in myocardial cultures. Rep-
resentative images of active caspase-3 immunocytochemical staining in paclitaxel-treated 
cultures and control cultures at day 4 and 9. Nuclei were counterstained with Hoechst and 
active caspase-3 positive nuclei were quantified and expressed as a percentage of total cell 
count, which was not significantly affected by paclitaxel treatment. Total cell count was 
defined as the total number of viable nuclei added to the amount of caspase-3 positive cells.
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Cardiomyogenic differentiation of stem cells can be accomplished by coculture 
with cardiomyocytes (CMCs). To facilitate their identification, stem cells are often 
labeled through viral transduction with a fluorescent protein. A second marker to 
distinguish stem cell-derived CMCs from native CMCs is rarely used. This study 
aimed to investigate the occurrence of secondary transduction of unlabeled neo-
natal rat (nr) CMCs after coculture with human cells that had been transduced 
0, 7 or 14 days earlier with a vesicular stomatitis virus (VSV) G protein-pseudo-
typed lentiviral vector (LV) encoding enhanced green fluorescent protein (GFP). 
To reduce secondary LV transfer, GFP-labeled cells were incubated with non-heat-
inactivated human serum (NHI) or with VSV-neutralizing rabbit serum (αVSV). 
Heat-inactivated human serum (HI) and normal rabbit serum were used as con-
trols. Immunostaining showed substantial GFP gene transfer to nrCMCs in cocul-
tures started at the day of transduction indicated by the presence of GFP-positive/
human lamin A/C-negative nrCMCs. The extent of secondary transduction was 
significantly reduced in cocultures initiated 7 days after GFP transduction, while it 
was completely abolished when human cells were added to nrCMCs 14 days post-
transduction. Both NHI and αVSV significantly reduced the occurrence of second-
ary transduction compared to their controls. However, under all circumstances, 
GFP-labeled human cells had to be passaged for 14 days prior to coculture initiation 
to prevent any horizontal GFP gene transfer to the nrCMCs. This study emphasizes 
that differentiation experiments involving the use of viral vector-marked donor cells 
should be interpreted with caution and describes measures to reduce/prevent sec-
ondary transduction.
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introduction
Whether somatic stem cells (SSCs) can undergo cardiomyogenic differentiation 
without genetic intervention is a topic of much debate.1,2 At least part of the con-
fusion may relate to application of different criteria and methods to identify SSC-
derived cardiomyocytes (CMCs) and to the use of SSCs from different sources and 
differently aged donors.2-4 Intramyocardial transplantation and coculture with CMCs 
are commonly used to investigate cardiomyogenic differentiation potential of SSCs. 
However, these studies often do not include the use of species-, strain- or gender-
specific markers to unambiguously demonstrate derivation of a CMC from a stem 
cell. Instead, stem cells are transduced with a viral vector encoding a fluorescent 
protein and the appearance of cells coexpressing the fluorescent protein and one or 
more CMC markers is taken as proof for their cardiomyogenic differentiation.5-11 An 
often neglected pitfall of these studies is secondary transduction of CMCs by viral 
vector-marked stem cells. Pan et al. previously showed that hematopoietic target 
cell-associated vesicular stomatitis virus (VSV) G protein-pseudotyped lentiviral 
vector (LV) particles can transduce neighboring cells.12 In this study, secondary 
transduction of neonatal rat (nr) CMCs by adult human cells that had previously 
been transduced with an enhanced green fluorescent protein (GFP)-encoding LV 
was studied. Also, options to abolish secondary transduction were investigated 
including incubation of LV-GFP-treated cells with VSV-specific antiserum or with 
normal human serum, which contains natural antibodies that can neutralize VSV 
in a complement-dependent manner.13
materials and methods
Human tissues were obtained with donors’ written informed consent and with 
approval of the Medical Ethics Committee of Leiden University Medical Center 
(LUMC). The study conformed to the principles of the Declaration of Helsinki. Ani-
mal experiments were approved by LUMC’s Animal Experiments Committee and 
conformed to the Guide for Care and Use of Laboratory Animals (10236).14
Adult bone marrow (BM)- or adipose tissue (AT)-derived human mesenchymal 
stem cells (hMSCs) and human skin fibroblasts (hSFs) were transduced with GFP 
(multiplicity of infection 18 HeLa cell-transducing units/cell) using the VSV G pro-
tein-pseudotyped human immunodeficiency virus type 1 vector CMVPRES (here-
inafter referred to as LV-GFP).15,16 This specific vector dose resulted in transduction 
efficiencies of nearly 100% without causing overt cytotoxicity. The aforementioned 
cell types and nrCMCs were isolated and cultured as previously described.17-19 
nrCMC cultures typically contained ± 10% cardiac fibroblasts and were mitomycin 
C-treated to prevent proliferation of the latter cell type.19 For a schematic  overview 
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Figure 1. Schematic overview of the experimental setup. After incubation with LV-GFP for 
4 hours, hMSCs or hSFs were washed three times with phosphate-buffered saline, detached 
using buffered 0.05% trypsin-0.02% EDTA solution and either immediately cocultured with 
nrCMCs (1:10 ratio) or subjected to an additional culture period of 7 or 14 days with 1 or 
2 passages, respectively, prior to use in coculture. Medium was refreshed weekly. To reduce 
secondary transduction, GFP-labeled cells were incubated in NHI or αVSV for 1 h before 
start of coculture with nrCMCs. Controls were cells incubated with HI and normal rabbit 
serum, respectively. Neutralization experiments were conducted with freshly transduced 
human cells, but also with GFP-labeled cells that had been kept in monoculture for 7 or 
14 days. After 9 days of coculture, cells were subjected to immunostaining. Abbreviations: 
LV-GFP, self-inactivating, vesicular stomatitis virus G-protein pseudotyped lentiviral vector 
coding for GFP; hMSCs, human mesenchymal stem cells; hSFs, human skin fibroblasts; 
nrCMCs, neonatal rat cardiomyocytes; GFP, enhanced green fluorescent protein; αVSV, 
vesicular stomatitis virus-neutralizing rabbit serum; NHI, non-heat-inactivated human 
serum; HI, heat-inactivated human serum.
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of the experimental setup see Figure 1. After 9 days of coculture, cells were sub-
jected to immunostaining as previously described.17 Primary antibodies specific 
for human lamin A/C (clone 636, VP-L550, Vector laboratories, Burlingame, CA) 
α-actinin (clone EA53, A7811) and connexin43 (C6219) (both from Sigma-Aldrich, 
Zwijndrecht, Netherlands) were used. These were visualized with Alexa Fluor-
conjugated secondary antibodies, while nuclei were stained using Hoechst 33342 
(all from Invitrogen, Breda, Netherlands). Image J software (Institutes of Health, 
Bethesda, MD) was used to determine the number of GFP-positive/human lamin 
A/C-negative nrCMCs in randomly chosen regions (³3,000 cells analyzed/condi-
tion). Human-specific quantitative RT-PCR analyses were used to detect possible 
cardiomyogenic differentiation of the human cells after 9 days of coculture with 
nrCMCs.17
Experimental results were expressed as mean±standard deviation for a given 
number (n) of observations. Data was analyzed by Student’s t-test for direct com-
parisons. Analysis of variance followed by appropriate post-hoc analysis was per-
formed for multiple comparisons. Statistical analysis was performed using SPSS 
16.0 for Windows (SPSS, Chicago, IL). Differences were considered statistically 
significant at p<.05.
results
Cocultures initiated with freshly transduced adult BM hMSCs, AT hMSCs or hSFs 
contained 51.2±2.1%, 40.6±3.8% and 8.9±0.6% of GFP-labeled nrCMCs, respec-
tively (Figure 2A&D). GFP gene transfer to nrCMCs was strongly reduced in cocul-
tures started with human cells 7 days post-transduction (BM hMSCs: 11.1±0.55%, 
AT hMSCs: 2.60±0.2%, hSFs: 2.10±0.1%; p<.01) (Figure 2B&D) and completely 
abolished using human cells that had been transduced 14 days earlier (Figure 
2C&D). In none of the cocultures, expression of human ACTN2, TNNT2, NPPA, 
MYL2, MYL7, GATA4 or NKX2-5 was observed by quantitative RT-PCR confirming 
previous findings that hSFs and adult hMSCs do not undergo cardiomyogenesis 
when coincubated with nrCMCs (Figure 2E).17
Secondary transduction was inhibited by treatment of GFP-labeled adult BM 
hMSCs with non-heat-inactivated human serum (NHI) or VSV-neutralizing rabbit 
serum (αVSV) prior to coculture initiation. Compared to controls (heat-inactivated 
human serum and normal rabbit serum, respectively), incubation of the hMSCs 
with NHI or αVSV significantly reduced GFP gene transfer to nrCMCs in cocultures 
started at the day of transduction (p<.01) (Figures 3&4, A1, B1, C) or 7 days later 
(p<.01) (Figures 3&4, A2, B2, C), while hMSCs that had been transduced 14 days 
before coculture initiation did not give rise to any secondary transduction of nrC-
MCs (Figures 3&4, A3, B3, C).
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Figure 2. Secondary transduction of nrCMCs after coculture for 9 days with GFP-labeled 
human cells. (A): Typical fluorescence images of GFP- and human lamin A/C (lamin)-dou-
ble-positive adult BM hMSCs and of cardiac α-actinin (α-Act)-positive nrCMCs in cocultures 
initiated at the day of transduction of the human cells with LV-GFP. A considerable number 
of GFP-positive/human lamin A/C-negative nrCMCs is present after 9 days of coincubation 
indicating secondary transduction of nrCMCs. Cocultures were also stained for connexin43 
(Cx43). Nuclei were stained with the DNA-binding fluorochrome Hoechst 33342. (B): In 
cocultures that were started 7 days after human cell transduction, adult BM hMSCs showed 
significant less horizontal GFP gene transfer to nrCMCs than those initiated with freshly 
transduced adult BM hMSCs. (C): Secondary transductions were not observed in mixed 
cultures of nrCMCs and LV-GFP-transduced adult BM hMSCs that had been passaged twice 
during a 14-day time period before coculture initiation. (D): Quantitative analysis of sec-
ondary transduction of nrCMCs in coculture with LV-GFP-transduced adult BM hMSCs, 
AT hMSCs or hSFs. The graph is based on a minimum of 3,000 cells analyzed per experi-
mental group and time point. *, p <.01. (E): Human-specific qRT-PCR showed that none 
of the three human cell types expressed the cardiomyocyte marker genes ACTN2, TNNT2, 
NPPA, MYL2, MYL7, GATA4 or NKX2-5 after 9 days of coculture with nrCMCs. Human right 
atrium (hRA) samples were used as a positive control. Abbreviations: nrCMCs, neonatal 
rat cardiomyocytes; GFP, enhanced green fluorescent protein; BM, bone marrow; hMSCs, 
human mesenchymal stem cells; LV-GFP, self-inactivating, vesicular stomatitis virus G-pro-
tein pseudotyped lentiviral vector coding for GFP; AT, adipose tissue; hSFs, human skin 
fibroblasts; qRT-PCR, quantitative reverse transcription-polymerase chain reaction; ND, not 
detected.
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Figure 3. Secondary transduction of nrCMCs is reduced by incubating LV-GFP-transduced 
adult BM hMSCs with NHI prior to coincubation with nrCMCs. (A1, B1): Typical fluorescence 
images of 9-day-old cocultures of GFP- and human lamin A/C (lamin)-double-positive cells 
with cardiac α-actinin (α-Act)-positive nrCMCs initiated at the day of transduction of the 
human cells with LV-GFP and following their treatment with NHI or HI. Incubation with NHI 
before coculture initiation leads to a significant reduction of horizontal GFP gene transfer to 
nrCMCs compared to incubation with HI as shown by a lower percentage of GFP-positive/
human lamin A/C-negative nrCMCs (A2, B2): Treatment prior to coculture initiation of adult 
BM hMSCs that had been transduced 7 days earlier with LV-GFP with NHI resulted in less 
secondary transduction of nrCMCs than incubation with HI. Also, in cocultures started 
7 days after exposure of adult BM hMSCs to LV-GFP the occurrence of secondary transduc-
tion was significantly reduced compared to those containing freshly transduced adult BM 
hMSCs. (A3, B3): Horizontal GFP gene transfer to nrCMCs was completely abolished in 
cocultures initiated 14 days after human cell transduction for both the NHI- and HI-treated 
adult BM hMSCs. Nuclei were stained with the DNA-binding fluorochrome Hoechst 33342. 
(C): Quantitative analysis of horizontal GFP gene transfer to nrCMCs in coculture with LV-
GFP-labeled adult hMSCs that had been treated with NHI or HI before coculture initiation. 
The graph is based on a minimum of 3,000 cells analyzed per experimental group and 
time point. *, p <.01. Abbreviations: nrCMCs, neonatal rat cardiomyocytes; LV-GFP, self-
inactivating, vesicular stomatitis virus G-protein pseudotyped lentivirus vector coding for 
enhanced green fluorescent protein; BM, bone marrow; hMSCs, human mesenchymal stem 
cells; GFP, enhanced green fluorescent protein; NHI, non-heat-inactivated human serum; 
HI, heat-inactivated human serum.
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Figure 4. Secondary transduction of nrCMCs is reduced by incubating LV-GFP-transduced 
adult BM hMSCs with αVSV prior to coincubation with nrCMCs. (A1, B1): Representative 
micrographs of 9-day-old cocultures of GFP- and human lamin A/C (lamin)-double-positive 
cells with cardiac α-actinin (α-Act)-positive nrCMCs initiated at the day of transduction of the 
human cells with LV-GFP and following their treatment with αVSV or normal rabbit serum 
(control). Incubation with αVSV before coculture initiation leads to a significant reduction 
of secondary transduction of nrCMCs compared to incubation with normal rabbit serum as 
shown by a lower percentage of GFP-positive/human lamin A/C-negative nrCMCs (A2, B2): 
Treatment prior to coculture initiation of adult BM hMSCs that had been transduced 7 days 
earlier with LV-GFP with αVSV resulted in less secondary transductions of nrCMCs than 
incubation with control serum. Also, in cocultures started 7 days after exposure of adult 
BM hMSCs to LV-GFP the occurrence of secondary transduction was significantly reduced 
compared to those containing freshly transduced adult BM hMSCs. (A3, B3): Horizontal 
GFP gene transfer to nrCMCs was completely abolished in cocultures initiated 14 days after 
human cell transduction for both the αVSV- and rabbit serum-treated adult BM hMSCs. 
Nuclei were stained with the DNA-binding fluorochrome Hoechst 33342. (C):  Quantita-
tive analysis of secondary transduction of nrCMCs in coculture with GFP-labeled adult BM 
hMSCs that had been treated with αVSV before coculture initiation. The graph is based 
on a minimum of 3,000 cells analyzed per experimental group and time point. *, p <.01. 
Abbreviations: nrCMCs, neonatal rat cardiomyocytes; LV-GFP, self-inactivating, vesicular 
stomatitis virus G-protein pseudotyped lentivirus vector coding for enhanced green fluores-
cent protein; BM, bone marrow; hMSCs, human mesenchymal stem cells; αVSV, vesicular 
stomatitis virus-neutralizing rabbit serum; GFP, enhanced green fluorescent protein.
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discussion and conclusions
The key findings of this study are 1) hMSCs, and to a lesser extent, hSFs labeled 
with GFP by lentiviral gene transfer serve as a reservoir of functional LV particles 
causing secondary transductions of cocultured nrCMCs. 2) Passaging of the LV-
GFP-transduced cells and frequent refreshment of culture medium prior to cocul-
ture initiation reduce and ultimately abolish GFP gene transfer to nrCMCs over 
time. 3) Incubation of the LV-GFP-transduced hMSCs with NHI or αVSV before 
coculture with nrCMCs greatly decreases GFP gene transfer to nrCMCs but does 
not shorten the time needed to completely eliminate secondary transduction. The 
strong inhibitory effect of NHI and αVSV on the frequency of GFP-labeled nrCMCs 
indicates that pseudo-transduction or vesicle uptake are not major contributors to 
the occurrence of GFP-positive nrCMCs in our coculture system.20 Furthermore, 
the absence in the cocultures of human lamin A/C-positive cells expressing CMC 
markers excludes heterocellular fusion as cause for the appearance of GFP-labeled 
nrCMCs. Our results are in line with those of Pan et al., who showed secondary 
transduction resulting from release of VSV G protein-pseudotyped LV particles by 
murine whole BM cells but did not investigate the effects of repeated passaging or 
treatment with αVSV or NHI of LV-transduced cells on horizontal gene transfer.12
cardiomyogenic differentiation versus secondary transduction
The ability of SSCs to undergo cardiomyogenesis remains a controversial topic. 
Coincubation with CMCs and intramyocardial transplantation are frequently used 
to investigate cardiomyogenic differentiation of SSCs.5-11 In these experiments, the 
SSCs are often labeled with GFP using viral vectors before coincubation with nrC-
MCs and their cardiomyogenic differentiation is inferred from the occurrence of 
GFP-positive cells expressing CMC markers. In our laboratory, an antibody detect-
ing human lamin A/C has been used as a second identifier besides GFP positivity to 
distinguish human cells from cocultured nrCMCs.17,18 Also, quantitative RT-PCR with 
human-specific primer pairs can be used to assess cardiomyogenesis in human 
cells cocultured with nrCMCs.17,18 Using this approach, human cardiomyocyte-spe-
cific gene expression was not observed even not under conditions that gave rise 
to high percentages of GFP- and α-actinin-double positive cells. Our finding that 
coincubation of LV-GFP-treated human cells with untransduced nrCMCs leads to 
considerable secondary transduction of the latter cells highlights the importance 
of using an endogenous marker to assess stem cell differentiation in the presence 
of the differentiated cell type(s) to be generated. This is particularly relevant when 
the combination of viral vector and target cell does not allow elimination of reidual 
gene transfer activity by repeated cell passaging/prolonged cell culture as is the 
case when using episomal viral vectors (e.g. adenoviral vectors) or post-mitotic 
target cells.
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Background: After intramyocardial injection, mesenchymal stem cells (MSCs) may 
engraft and influence host myocardium. However, engraftment rate and pattern 
of distribution are difficult to control in vivo, hampering assessment of potential 
adverse effects. In this study, the role of MSCs engraftment patterns on arrhyth-
micity in controllable in vitro models is investigated.
Methods&Results: Co-cultures of 4×105 neonatal rat cardiomyocytes (nrCMCs) 
and 7% or 28% adult human (h) MSCs in diffuse or clustered distribution patterns 
were prepared. Electrophysiological effects were studied by optical mapping and 
patch-clamping. In diffuse co-cultures, hMSCs dose-dependently decreased nrCMC 
excitability, slowed conduction and prolonged APD90. Triggered activity (14% vs. 
0% in controls) and increased inducibility of reentry (53% vs. 6% in controls) were 
observed in 28% hMSC co-cultures. MSC clusters increased APD90, slowed conduc-
tion locally, and increased reentry inducibility (23%), without increasing triggered 
activity. Pharmacological heterocellular electrical uncoupling increased excitability 
and conduction velocity to 133% in 28% hMSC co-cultures, but did not alter APD90. 
Transwell experiments showed that hMSCs dose-dependently increased APD90, 
APD dispersion, inducibility of reentry and affected specific ion channel protein 
levels, while excitability was unaltered. Incubation with hMSC-derived exosomes 
did not increase APD in nrCMC cultures.
Conclusions: Adult hMSCs affect arrhythmicity of nrCMC cultures by heterocel-
lular coupling leading to depolarization-induced conduction slowing and by direct 
release of paracrine factors that negatively affect repolarization rate. The extent 
of these detrimental effects depends on the number and distribution pattern of 
hMSCs. These results suggest that caution should be urged against potential 
adverse effects of myocardial hMSC engraftment.
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introduction
Over the past decade, stem cell therapy has been subject of studies aiming to 
improve function of damaged hearts. Particularly mesenchymal stem cells (MSCs) 
have been of interest in these efforts.1,2 In spite of the fact that only low percent-
ages of injected MSCs survive and integrate in damaged myocardium, therapeutic 
effects have been found in pre-clinical studies.3,4 Moreover, genetically modified 
MSCs have also been investigated as vehicles of biological functions such as bio-
logical pacemakers.5 Also, intramyocardial transplantation of bone marrow-derived 
cells, including human (h) MSCs, into diseased human myocardium has been 
shown to improve cardiac function.6 These positive effects on cardiac function are 
believed to be mainly mediated by paracrine factors released from the transplanted 
cells.7 Therefore, increasing engraftment rate to improve the therapeutic effects of 
transplanted cells seems a logical step and is indeed the focus of current stem cell 
research.8,9 However, the risk of adverse effects with higher engraftment rates in 
largely uncontrolled engraftment patterns is unknown. The number of transplanted 
cells that actually engrafts and their distribution patterns are difficult to regulate. 
Only few studies have focused on these aspects. Fukushima et al. showed that 
engraftment patterns of transplanted bone marrow cells may depend on adminis-
tration route, i.e. direct intramyocardial injection resulted in a more clustered distri-
bution than intracoronary infusion.10 Such clustering may lead to formation of local 
conduction blocks, potentially facilitating reentrant tachyarrhythmias. Additionally, 
in vitro studies by Chang et al. have indicated that administration of hMSCs to myo-
cardial cell cultures may indeed increase pro-arrhythmic risk.11 However, besides 
indirect implications that electrotonic coupling of MSCs with host cardiomyocytes 
may be responsible for their pro-arrhythmic effects, the mechanisms underlying 
MSC-dependent arrhythmogeneity remain unknown. Also, insights concerning dif-
ferences between pro-arrhythmic effects of distinct engraftment profiles of MSCs 
are still limited. As a result, further investigation of potentially pro-arrhythmic 
actions of hMSCs is required. Such studies are especially important to improve 
therapeutic efficacy and to contain the hazardous potential of MSC therapy in the 
heart. Therefore, this study aimed to investigate the effects of engraftment char-
acteristics of MSCs (i.e. different numbers and distribution patterns) on arrhyth-
micity using controllable in vitro models. We found that hMSCs can indeed be 
pro-arrhythmic depending on their number and distribution pattern and that direct 
contact between neonatal rat ventricular cardiomyocytes (nrCMCs) and hMSCs as 
well as paracrine effects of hMSCs on nrCMCs are important contributors to the 
pro-arrhythmic effects of hMSCs. The results of this study suggest that caution is 
warranted against potential pro-arrhythmic effects of MSC transplantation in car-
diac tissue. The acquired knowledge about the mechanisms by which hMSCs can 
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162 cause arrhythmias may help to develop strategies how to increase the safety and 
efficacy of intramyocardial hMSC administration.
materials and methods
A more detailed description of the materials and methods can be found in the Sup-
plemental Material, which also includes methods of immunocytological stainings, 
western blot, dye-transfer and patch-clamp experiments.
isolation, culture and characterization of hmscs
Human tissue samples were collected after having obtained written informed 
consent of the donors and with the approval of the medical ethics committee of 
Leiden University Medical Center (LUMC). The procedures used in this investiga-
tion conformed to the Declaration of Helsinki. Human MSCs were purified from 
leftover bone marrow samples derived from adult ischemic heart disease patients 
(n=4 donors). hMSCs were characterized by immunophenotyping and by their 
adipogenic and osteogenic differentiation potential as described in the online 
supplement.
isolation and culture of nrcmcs
All animal experiments were approved by LUMC’s animal experiments committee 
and conform to the Guide for the Care and Use of Laboratory Animals, as stated by 
the US National Institutes of Health (10236).12 Briefly, hearts were rapidly excised 
from isoflurane-anesthetized animals, the ventricles were minced into pieces and 
dissociated by treatment with collagenase type I (450 units/mL; Worthington Bio-
chemical, Lakewood, NJ). The myocardial cells were pre-plated to minimize contam-
ination of the nrCMC cultures with non-cardiomyocytes. Purified myocardial cells 
were plated on fibronectin (Sigma-Aldrich Chemie, Zwijndrecht, the Netherlands)-
coated coverslips in 24-wells plates (Corning Life Sciences, Amsterdam, the Neth-
erlands) at a density of 1-4×105 cells/well depending on the experiment. All cultures 
were treated with 10 µg/mL mitomycin-C (Sigma-Aldrich Chemie) to halt prolifera-
tion of endogenous fibroblasts.
co-culture of nrcmcs and clustered or diffusely spread hmscs
To investigate the effects on arrhythmicity of myocardial engraftment of hMSCs in 
different patterns and doses, co-cultures of nrCMCs and hMSCs were prepared. 
To mimic a diffuse engraftment pattern, 4.0×105 nrCMCs were mixed with 2.8×104 
(7%) or 1.12×105 (28%) hMSCs and added onto coverslips in wells of a 24-well 
cell culture plate. To mimic a clustered engraftment pattern, rings with an outer 
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 diameter of 15 mm and a central inner diameter of 3 or 6 mm were lasered in Para-
film M (Bemis Company, Neenah, WI, USA) and attached to the coverslips. Next, 
hMSCs were applied in these circles (3 mm: 2.8×104 cells or 6 mm: 1.12×105 cells). 
After attachment, the Parafilm was removed and the attached hMSCs were overlaid 
with 4.0×105 nrCMCs.
Optical mapping
Electrophysiological parameters were determined by optical mapping as described 
previously.13 Cultures were loaded with di-4-ANEPPS (Invitrogen, Breda, the Neth-
erlands) for 10 min at 37oC. Cultures were then given fresh DMEM/F12 (Invitrogen) 
and optically mapped using the Micam Ultima-L optical mapping system (Scime-
dia USA, Costa Mesa, CA).
analysis of the influence of paracrine factors on electrophysiological 
parameters of nrcmc cultures
Mitomycin-C-treated adult hMSCs were seeded in 24-well plate transwell inserts 
(Corning Life Sciences). To mimic as much as possible the conditions of the non-
transwell experiments, the inserts contained 2.8×104 or 1.12×105 hMSCs and were 
placed above 4.0×105 mitomycin-C-treated nrCMCs seeded on fibronectin-coated 
coverslips. Control cultures consisted of nrCMC cultures with no, empty or nrCMC 
(1.12×105 cells)-filled transwell inserts. In addition, exosomes were derived from 
hMSCs14,15 and incubated with nrCMCs cultures for 9 days.
statistics
Experimental data was analyzed by the Mann-Whitney-U test for direct com-
parisons, or the Wilcoxon signed-rank test for paired observations. For multiple 
comparisons, the Kruskal-Wallis test with Dunn’ s post-hoc correction was used. 
Experimental results were expressed as mean±standard deviation (SD) for a given 
number (n) of observations. Statistical analysis was performed using SPSS 16.0 for 
Windows (SPSS, Chicago, IL). Differences were considered statistically significant 
at P<0.05.
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Figure 1. Conduction slowing and decreased excitability in myocardial cell cultures contain-
ing diffusely spread hMSCs. (A) Fluorescent microscopy images of myocardial cell cultures 
containing 0%, 7% or 28% hMSCs stained for human-specific lamin A/C (green). (B) Acti-
vation maps of myocardial cell cultures with 0%, 7% or 28% added hMSCs. Isochrones: 
6 ms. (C) Typical action potential upstroke traces recorded with current-clamp in nrCMCs 
in a control culture or in culture with 28% hMSCs. (D) Quantification of maximum depo-
larization rate (dV/dtmax). *P<0.05 vs. 0% hMSCs. (E) Quantification of MDP recorded in 
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results
diffusely spread hmscs dose-dependently decrease conduction velocity 
(cv) and excitability in myocardial cell cultures
Adult hMSCs used in this study fulfilled established identity criteria, as shown in the 
Online Supplement (Supplemental Figure 1). The pro-arrhythmic effects of hMSCs 
were first investigated in co-cultures of hMSCs and nrCMCs in which the hMSCs 
were evenly distributed throughout the monolayer (Figure 1A). Addition of 7% or 
28% hMSCs to nrCMCs dose-dependently slowed conduction from 21.6±1.8 cm/s 
(0% hMSCs, n=15) to 17.1±3.1 (7% hMSCs, n=20) and 12.6±3.2 cm/s (28% hMSCs, 
n=64, P<0.05 between experimental groups, Figure 1B). Current-clamping of paral-
lel cultures revealed a decrease in upstroke velocity in 28% hMSC-containing myo-
cardial cell cultures (10±2 [n=5] vs. 94±10 V/s [n=7] in control cultures, P<0.05, 
Figure 1C-D). Moreover, maximal diastolic potentials (MDPs) were less negative for 
nrCMCs in co-culture with 28% hMSCs (-44±5 [n=5] vs. -72±5 mV [n=7] in control 
cultures, P<0.05, Figure 1E-F). To study the effects of diffusely spread hMSCs on 
excitability of nrCMC cultures, CV after administration of the voltage-gated sodium 
channel blocker tetrodotoxin (TTX) in increments of 5 µmol/L to 20 µmol/L was 
measured. In co-cultures containing 0% or 7% hMSCs, a TTX concentration-
dependent decrease in CV was observed for the entire dose range (Figure 1G). 
However, in cultures with 28% added hMSCs, the conduction-slowing effect of 
TTX was saturated between 15 and 20 µmol/L (P>0.05). Moreover, the magnitude 
of the drop in CV by increasing TTX doses declined with increasing hMSC num-
bers, indicating diminished availability of Nav1.5 and thereby confirming the ability 
of hMSCs to decrease excitability.
nrCMCs. *P<0.05 vs. 0% hMSCs. (F) Typical voltage traces from nrCMCs in myocardial cell 
cultures containing 0% or 28% hMSCs. (G) Quantification of the effect of stepwise increas-
ing TTX dose. *P<0.05 vs. 0 µmol/L TTX, **P<0.05 vs. 5 µmol/L TTX, #P<0.05 vs. 10 µmol/L 
TTX, ##P<0.05 vs. 15 µmol/L TTX.
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neighboring nrcmcs
The mechanisms through which hMSCs negatively affect the excitability of nrC-
MCs were studied by investigating co-cultures for the expression of N-cadherin, 
α smooth muscle actinin (αSMA) and connexin-43 (Cx43). Adult hMSCs co-cul-
tured with nrCMCs (n=3,000 hMSCs analyzed) stained negative for αSMA (Sup-
plemental Figure 2A). Also, no N-cadherin was present at hMSC-nrCMC junctions 
(Supplemental Figure 2B). Cx43 was detected at interfaces between hMSCs and 
nrCMCs (Figure 2A1), but in lower quantities (20.2±2.2%, P<0.0001) than at 
nrCMC-nrCMC junctions (Figure 2A2). Functional electrical heterocellular coupling 
between hMSCs and nrCMCs was investigated by dye-transfer experiments. The 
enhanced green fluorescent protein (GFP)-labeled hMSCs showed a significantly 
lower dye intensity (18.7±3.0%, P<0.001) than adjacent, calcein-loaded nrCMCs 
(Figure 2B1-B2). Also, although a large fraction of GFP-positive cells had taken up 
the dye (84.5±4.5%), not all hMSCs were positive for calcein. The lower Cx43 levels 
at hMSC-nrCMC borders than at nrCMC-nrCMC interfaces were utilized to inves-
tigate the effect of heterocellular uncoupling by a low dose of the gap-junctional 
uncoupler 2-aminoethoxydiphenylborate (2-APB) on conduction in hMSC-nrCMC 
co-cultures. After administration of 2 µmol/L 2-APB, CV in 19 co-cultures of nrC-
MCs and 28% hMSCs rose to 133±16% of the values measured before 2-APB addi-
tion (Figure 2C-D), whereas vehicle-treated (0.01% DMSO, n=5) cultures showed 
no significant change (i.e. CV post 0.01% DMSO was 104±8% of CV before 0.01% 
DMSO). 2-APB increased action potential upstroke velocity from 10±3 to 29±7 V/s 
(n=4, P<0.05). Furthermore, negativity of MDP of nrCMCs increased by 33% to 
-59±4 mV (P<0.05 vs. without 2-APB) while action potential duration until 90% 
repolarization (APD90) remained unaltered by the 2-APB treatment of the co-cul-
tures (Figure 2E). Importantly, treatment with 2 µmol/L 2-APB did not significantly 
affect any of these parameters in myocardial cell cultures lacking hMSCs (data not 
shown).
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Figure 2. Diffusively spread hMSCs slow conduction through electrotonic coupling. (A1) 
Immunocytological analyses reveals lower Cx43 (green) levels at heterocellular interfaces 
between human lamin A/C-positive hMSCs (red) and α-actinin-positive nrCMCs (red/
orange) than at homocellular junctions between nrCMCs. (A2) Quantification of junctional 
Cx43 levels at hMSC-nrCMC and at nrCMC-nrCMC interfaces. *P<0.001 vs. nrCMCs. (B1) 
Dye transfer from nrCMCs to GFP-positive hMSCs. (B2) Quantification of dye intensity in 
GFP-positive hMSCs. *P<0.001 vs. nrCMCs. (C) Activation maps before and after 2-APB 
administration to a myocardial cell culture containing 28% diffusely spread hMSCs. (D) 
2-APB treatment increases CV in myocardial cell cultures with hMSCs. *P<0.05 vs. pre-
2-APB. (E) Partial uncoupling by 2-APB does not affect repolarization in myocardial cell 
cultures containing evenly spread hMSCs.
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Figure 3. Slowing and dispersion of repolarization in myocardial cell cultures containing 
diffusely spread hMSCs. (A) Optical traces of myocardial cell cultures containing 0%, 7% or 
28% hMSCs show (B) prolongation of repolarization in an hMSC dose-dependent manner. 
*P<0.05 vs. 0 and 28% hMSCs, **P<0.05 vs. 0% and 7% hMSCs. (C) APD90 maps of myo-
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diffusely spread hmscs decrease repolarization reserve and increase 
arrhythmicity in myocardial cell cultures
APD90 was 314±61 and 379±60 ms in myocardial cell cultures containing 7% (n=24) 
and 28% hMSCs (n=86), respectively, compared to 221±43 ms in control cultures 
(n=16) (Figure 3A-B). This corresponds to an hMSC dose-dependent prolongation 
of repolarization time of 142% and 171%, respectively (P<0.05 between all groups). 
These findings were confirmed with patch-clamp experiments (APD60 of 186±10 
ms for nrCMCs in control cultures and of 300±21 ms in cultures with 28% added 
hMSCs [n=5, P<0.05]). Optical mapping showed that addition of hMSCs to myocar-
dial cell cultures caused an increase in spatial heterogeneity of repolarization (Fig-
ure 3C). In control cultures, the maximal spatial difference between APD90 values 
within the same culture was 65±21 ms (n=18). In cultures with 7% or 28% added 
hMSCs, APD90 dispersion was 103±29 (n=13) and 181±59 ms (n=17), respectively 
(P<0.05, Figure 3D).
Pro-arrhythmic consequences of these findings were revealed by 1 Hz stimula-
tion, which evoked triggered activity in 14% of cultures with 28% added hMSCs 
(n=66, Figure 3E). Cultures containing 7% hMSCs showed a lower incidence of 
triggered activity (2.6%, n=39) and triggered activity was absent in control cul-
tures (n=39, Figure 3F). Next, inducibility of reentrant arrhythmias was investi-
gated by applying a burst stimulation protocol (Figure 3G). Reentry was induced 
in 6% (n=16), 20% (n=10) and 53% (n=15) of cultures containing 0%, 7% and 28% 
hMSCs, respectively (Figure 3H).
After confirming reproducibility of triggered activity in the same culture, the 
ATP-sensitive K+-channel opener P1075 was administered, which abolished all epi-
sodes of triggered activity (n=6, Figure 4A, B). As P1075 strongly shortened APD90 
(Figure 4C) and reduced APD dispersion (Figure 4D) without affecting CV (Fig-
ure 4E), reduced repolarization reserve and steeper spatial APD gradients caused 
by hMSCs seem to be crucial for inducing triggered activity.
Clustered hMSCs provide a substrate for reentry in myocardial cell cultures.
Optical mapping of myocardial cell cultures containing a central cluster of hMSCs 
revealed local slowing of conduction to 4.7±1.6 and 5.4±1.3 cm/s in hMSC  clusters 
cardial cell cultures reveal (D) an hMSC dose-dependent increase in dispersion of repolari-
zation throughout the entire culture. *P<0.05 vs. 0 and 28% hMSCs, **P<0.05 vs. 0% and 
7% hMSCs. (E) Optical trace of triggered activity in a myocardial cell culture containing 28% 
hMSCs. (F) Incidence of triggered activity positively correlates with the number of hMSCs 
in myocardial cell cultures. (G) Activation map of 2 consecutive reentrant activations during 
a reentrant tachyarrhythmia in a myocardial cell culture containing 28% hMSCs. (H) Induc-
ibility of reentry increases with the number of hMSCs in myocardial cell cultures.
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Figure 4. Increasing repolarization reserve lowers the incidence of triggered activity in 
nrCMC cultures containing diffusely spread hMSCs. (A) Optical traces of a myocardial cell 
culture with 28% hMSCs before and after P1075 administration, and corresponding (B) inci-
dences of triggered activity. (C) Quantification of APD90, (D) APD90 dispersion and (E) CV 
before and after P1075 treatment in myocardial cell cultures with 28% hMSCs. *P<0.05 vs. 
28% hMSCs.
with a diameter of 3 mm (n=21) and of 6 mm (n=20), respectively (P=NS), whereas 
CV outside these clusters remained as high as in control cultures (22.2±1.7 and 
22.4±1.8 vs. 22.4±2.3 cm/s, P=NS, Figure 5A-C). APD90 was prolonged inside 
the 3-mm hMSC clusters (333±30 vs. 254±58 ms outside, P<0.05) and inside the 
6-mm hMSC clusters (343±48ms vs 310±40 ms outside, P<0.05, Figure 5D-G). 
Due to these local effects, APD90 dispersion was also increased in cultures with a 
3- or 6 mm cluster of hMSCs (Figure 5D). Interestingly, APD90 in the ring of nrC-
MCs around 6-mm hMSC clusters was significantly prolonged (310±40 ms) com-
pared to that in control cultures (245±61 ms) or in the ring of nrCMCs around 
Ramkisoensing.indd   170 22-4-2014   11:52:24
171
mesenchymal stem cells and arrhythmias
Figure 5. Myocardial cell cultures containing clustered hMSCs are substrates for reentry. 
(A) Typical activation map of a myocardial cell culture containing 28% hMSCs in a cen-
trally located cluster with a diameter of 6 mm (black dotted line). (B) Pseudo-voltage map 
sequence projected over a picture of the same culture containing a 6-mm hMSC cluster 
shows (C) local conduction slowing inside the cluster. *P<0.05 vs. outer ring. (D) APD90 
map of a culture with a 3-mm cluster of hMSCs. (E) Micrograph of a myocardial cell culture 
with a 3-mm hMSC cluster and (F) traces of action potentials inside (blue) and outside (red) 
of the hMSC cluster. (G) APD90 in myocardial cell cultures containing different-sized hMSC 
clusters. *P<0.05 vs. outer ring, **P<0.05 vs. control and outer, 3-mm ring. (H) Activation 
map and (I) pseudo-voltage map sequence of a reentrant tachyarrhythmia anchored at a 
6-mm hMSC cluster (demarcated by black dotted and white line, respectively). (J) The inci-
dence of induced reentry in myocardial cell cultures increases with the size of the centrally 
located hMSC cluster.
3-mm hMSC  clusters (254±58 ms, P<0.05 vs. all, Figure 5F-G). No triggered activity 
was observed in any of these cultures. However, burst stimulation induced reen-
try in 6% of the control cultures (n=16) and in 14% (n=22) and 23% (n=30) of the 
cultures with 3- and 6-mm central clusters of hMSCs, respectively (Figure 5H-J). 
Induced reentrant arrhythmias anchored to the hMSC clusters.
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not affect conduction
To study a possible paracrine contribution16 to hMSC-induced APD prolongation, 
transwell experiments were conducted. Transwells with inserts containing 0%, 7% 
or 28% hMSCs had almost identical CVs of 21.9±0.9, 22.3±1.3 and 22.9±0.7 cm/s 
(P=NS). Additionally, the conduction-slowing effect of TTX was very similar for 
transwell cultures containing different numbers of hMSCs (P>0.05, Figure 6A). 
However, APD90 was dose-dependently affected by hMSCs, as APD90 was 227±35 
ms for controls (n=38) as compared to 300±91 and 362±88 ms for transwells 
with inserts containing 7% hMSCs (n=46) and 28% hMSCs (n=45), respectively 
(P<0.05, Figure 6B). Dispersion of repolarization showed a similar positive relation 
with hMSC numbers, with APD90 dispersion values of 78±23, 105±50 and 148±72 
ms for transwells whose inserts contained 0%, 7% and 28% hMSCs (Figure 6C). 
None of the transwell cultures displayed triggered activity. However, inducibility 
of reentry was slightly increased from 14% (n=29) in controls to 16% (n=44) and 
24% (n=38) for transwells with 7% and 28% of hMSCs, respectively (Figure 6D). 
Patch-clamp experiments also showed a prolonged APD in nrCMCs exposed to the 
secretome of 28% hMSCs (335±6 ms, n=4) compared to unexposed CMCs (193±7 
ms, n=4, P<0.05, Figure 7A-B). However, dV/dtmax (104±7 V/s vs. 107±9 V/s in con-
trols, P=0.72, Figure 7C) and resting membrane potential (-68±4 mV vs. -67±3 
mV in controls, P=0.72) were unaffected by the hMSC secretome. Western blot 
analysis of ion channel protein levels in nrCMCs exposed to the hMSC secretome 
of 28% hMSCs revealed lower levels of Cav1.2 (0.43±0.01 vs. 0.22±0.04 arbitrary 
units, P<0.05) and Kv4.3 (0.26±0.04 vs. 0.22±0.04 arbitrary units, P<0.05), while 
the Kir2.1 level was not significantly altered (0.30±0.03 vs. 0.27±0.05, P>0.05, 
Figure 7D).
To investigate whether exosomes (i.e. microvesicles secreted by mammalian 
cells containing instructive molecules including cytokines, mRNAs and miRNAs) 
were responsible for these effects, exosomes from the hMSC secretome (represent-
ing 28% hMSCs) were added to pure nrCMC cultures and refreshed every 2 days 
(Figure 8A). At day 9, optical mapping did not reveal any changes in APD90 (Figure 
8B) or CV (Figure 8C) by adding hMSC-derived exosomes to nrCMC cultures, sug-
gesting that the effect of the hMSC secretome on APD prolongation is primarily 
mediated by directly secreted factors, rather than by secreted microvesicle-associ-
ated factors.
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Figure 6. Paracrine mechanisms are responsible for hMSC-dependent prolongation of 
repolarization in myocardial cell cultures. (A) Dose-dependent effects of Nav1.5 blockade 
by TTX do not differ between control cultures and myocardial cell cultures exposed to 
the secretomes of different numbers of hMSCs. *P<0.05 vs. 0 µmol/L TTX, **P<0.05 vs. 
5 µmol/L TTX, #P<0.05 vs. 10 µmol/L TTX, ##P<0.05 vs. 15 µmol/L TTX. (B) Quantification 
of APD90. *P<0.05 vs. 0% and 28% hMSCs, **P<0.05 vs. 0% and 7%. (C) Quantification of 
dispersion of repolarization. *P<0.05 vs. 0%. (D) Incidences of induced reentry in myocar-
dial cell cultures exposed to transwells containing 0%, 7% or 28% of added hMSCs.
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Figure 7. The hMSC secretome also affects nrCMCs at the cellular level. (A) Typical voltage 
traces of action potentials recorded in current-clamp experiments on nrCMCs subjected to 
the hMSC secretome and on control nrCMCs show (B) prolonged APD but (C) normal dV/
dtmax.*P<0.05 vs. 0% hMSCs in transwells. (D) Quantification of western blot analyses of 
Cav1.2, Kv4.3 and Kir2.1 levels. Values are corrected for glyceraldehyde 3-phosphate dehy-
drogenase (GAPDH) levels. *P<0.05 versus transwell + 0% hMSCs. TW: transwell.
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Figure 8. Human MSC-derived exosomes do not appear to exert pro-arrhythmic effects on 
nrCMCs. (A) Schematic overview of experiments investigating the pro-arrhythmic effects 
of hMSC-derived exosomes. (B) Adding exosomes to nrCMC cultures does not affect CV or 
(C) APD90 under optical mapping conditions.
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This study has shown that (i) adult bone marrow-derived hMSCs contribute to APD 
dispersion, triggered activity and reentrant tachyarrhythmias in neonatal rat myo-
cardial cell cultures; (ii) the pro-arrhythmic effects of hMSCs are mediated by two 
separate mechanisms, i.e. functional coupling of hMSCs with adjacent nrCMCs 
resulting in partial nrCMC depolarization and conduction slowing, and paracrine 
signaling of hMSCs to neighboring nrCMCs that slows nrCMC repolarization; and 
(iii) the number and distribution pattern of the MSCs in the myocardial cell cultures 
determine the type and severity of the arrhythmias.
effect of hmsc transplantation on cardiac electrophysiology
Whether and how cardiac cell therapy may increase the risk of ventricular arrhyth-
mias remain topics of debate.17-20 Gap-junctional coupling between transplanted 
cells and host cardiomyocytes appears to be essential for functional electrical 
integration, thereby preventing an increase in electrical heterogeneity, leading to 
arrhythmias.21 Other studies have emphasized the role of cell alignment in elec-
trical integration of transplanted cells in recipient myocardium and the potential 
pro-arrhythmic consequences of malalignment.22 The number and distribution of 
donor cells in the host myocardium may also affect their arrhythmogenic poten-
tial.11 However, very little is known about cell therapy-associated pro-arrhythmic 
mechanisms.
The current study demonstrates that both evenly spread and clustered hMSCs 
can exert pro-arrhythmic effects in myocardial cell cultures in a dose-dependent 
manner. However, the types of evoked arrhythmias depended on hMSC distribution 
pattern. By applying the hMSCs in a diffuse pattern, interactions with surrounding 
nrCMCs are maximized leading to increases in triggered activity and induced reen-
try incidence, while in myocardial cell cultures containing central clusters of hMSCs 
only the propensity towards reentry was increased. Triggered activity in diffuse co-
cultures was associated with decreased repolarization reserve as APD shortening 
by opening of ATP-sensitive K+-channels abolished such episodes, which together 
with pseudo-electrogram morphology, points to early afterdepolarizations as likely 
cause of triggered activity. As the P1075-treated cultures did not show any triggered 
activity, the concomitant APD shortening by P1075 did not lead to increased reentry 
incidence.23
The mechanism of early afterdepolarizations is considered to be reactivation of 
L-type calcium channels that linger within the window current due to a decreased 
repolarizing force.23 As this mechanism is based on a highly complex and delicate 
balance between depolarizing and repolarizing forces that depends on activation 
and (de-)inactivation mechanics of ion channels, the absence of triggered activ-
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ity in myocardial cell cultures containing clustered hMSCs can be explained by 
hMSC density-dependent skewing of action potential dynamics beyond the win-
dow current. The notion of density-dependent pro-arrhythmic effects of hMSCs 
is supported by findings of differences in CV and APD inside the 6-mm hMSC 
clusters in comparison to equal amounts of more diffusely integrated hMSCs. As 
hMSC clusters formed local zones of conduction delay and refractoriness, the clus-
ter size-dependent increase in inducibility of reentry is most likely attributable to 
the increased possibility of spiral wave anchoring with increasing obstacle sizes.24 
Higher inducibility of reentry in cultures with diffusely spread hMSCs than in those 
containing clustered hMSCs indicates stronger pro-arrhythmic effects of wide-
spread than of locally concentrated hMSC-nrCMC interactions.
role of heterocellular coupling in conduction slowing by hmscs
Conduction slowing is widely recognized as a pro-arrhythmic feature that increases 
the probability of wave front collision, partial conduction block and spiral wave 
formation.23 In an earlier study, Chang et al. revealed that hMSCs slow conduction 
in myocardial cell cultures, presumably by electrotonic heterocellular interactions.11 
Two other studies showed the ability of hMSCs to overcome local conduction blocks 
by functional coupling to nrCMCs and passively and slowly conducting action 
potentials.25,26 In the present study, we confirmed slowed conduction by hMSCs in 
myocardial cell cultures without anatomical conduction block. Importantly, hMSCs 
were shown to reduce nrCMC excitability as dV/dtmax and TTX sensitivity were 
decreased. Treatment of diffuse co-cultures with low doses of the gap-junctional 
uncoupler 2-ABP indicated that heterocellular coupling was the dominant mecha-
nism responsible for the conduction-slowing effect of hMSCs. Although 2-APB, as 
most pharmacological agents, has other known effects, 27,28 these effects occur at 
higher dosages and cannot account for the increase in CV observed in Figure 2D. 
Partial heterocellular uncoupling increased CV in co-cultures and nrCMCs showed 
a more negative MDP and a higher action potential upstroke velocity, which are 
all indicative of partially restored excitability.29 Heterocellular mechanical coupling 
was also investigated in the current study. Myofibroblasts were recently shown to 
exert pro-arrhythmic effects by providing a non-compliant mechanical resistance 
through their rigid cytoskeleton, which contains large amounts of αSMA and may 
thereby activate stretch-activated ion channels in nrCMCs.30,31 However, the adult 
hMSCs used in this study did not express αSMA or N-cadherin in co-cultures with 
nrCMCs, which makes it unlikely that mechanical coupling plays a major role in 
hMSC-associated conduction slowing and arrhythmicity.
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hmscs
In cardiac arrhythmogenesis, prolonged repolarization times and dispersion of 
repolarization are considered crucial pro-arrhythmic factors for triggered activity 
and reentrant tachyarrhythmias.23 Interestingly, while experiments with commer-
cially obtained hMSCs reported no effect of these cells on repolarization or the 
incidence of triggered activity,11 the present study provides evidence that clinically 
used hMSCs from ischemic heart disease patients in co-culture with nrCMCs can 
prolong repolarization time, increase repolarization dispersion and promote trig-
gered activity, which is likely to be caused by spatial repolarization gradient steep-
ening.23 The mechanism of decreased repolarization reserve was elusive at first. In 
contrast to the effects of heterocellular uncoupling between nrCMCs and myofi-
broblasts,32 decreasing heterocellular coupling between hMSCs and nrCMCs did 
not affect APD. However, it is becoming increasingly evident that the hMSC is a cell 
type with high paracrine activity that secretes a wide variety of directly secreted and 
exosome/microvesicle-associated factors associated with reverse remodeling and 
anti-inflammatory and pro-angiogenic activity.33-35 These findings combined with 
the APD prolongation at the periphery of co-cultures containing clustered hMSCs, 
where there is no physical contact between hMSCs and nrCMCs raised the pos-
sibility that paracrine rather than electrotonic mechanisms are responsible for the 
decreased repolarization reserve. Indeed, experiments with hMSCs in transwell 
inserts to allow passage of the hMSC secretome without physical contact between 
hMSCs and nrCMCs, revealed hMSC dose-dependent increases in APD, dispersion 
of repolarization and inducibility of reentry in the nrCMCs seeded on the bottom 
of the transwell. As hMSC-derived exosomes did not significantly affect nrCMC 
APD, it is likely that APD prolongation in our model was based on directly secreted 
paracrine factors. Loss of biological activity of exosomes is unlikely, since they were 
purified using established procedures.14,15 The current study has not provided any 
indication of pro-arrhythmic effects of exosomes purified from hMSC cultures. As 
exosomes may have a significant contribution to the therapeutic effects caused by 
the paracrine activity of MSCs, they might therefore represent a safer alternative to 
cell therapy for improving heart function.16,36
Paracrine activity of hMSCs has been associated with beneficial effects in in vivo 
models of cardiac remodeling.33 A common feature of these models was the low 
engraftment rate of the hMSCs. As suggested in this study, higher hMSC engraft-
ment rates might lead to increased production of paracrine factors tipping the bal-
ance from beneficial to adverse effects. Interestingly, paracrine signaling did not 
alter conduction or excitability, as the sensitivity of CV to Nav1.5 blockade by TTX 
remained the same between myocardial cell cultures exposed to the secretome of 
0%, 7% or 28% hMSCs. It did, however, change the ion channel levels as revealed 
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by western blot analyses. In particular, Cav1.2 and Kv4.3 levels were significantly low-
ered by exposure to the hMSC secretome. While decreased Cav1.2 expression would 
theoretically shorten APD, lowered Kv4.3 expression prolongs APD by decreasing 
Ito.
37 Since APD prolongation was found both in optical mapping and patch-clamp 
experiments, the effect of lowered Kv4.3 expression appeared to be dominant in 
our cultures. The Kir2.1 level was not significantly altered in nrCMCs cultured below 
hMSC-containing transwell inserts, which is consistent with findings of intact excit-
ability of nrCMCs exposed to the hMSC secretome. Although functional effects of 
altered ion channel expression are likely, more research is needed to be certain, 
since paracrine factors may also modulate the activity of proteins involved in car-
diac impulse propagation by direct binding to these proteins or by inducing their 
post-translational modification. For example, a recent study by Desantiago showed 
that MSCs are able to increase ICaL through the PI3K/Akt pathway.
38 Pinpointing the 
paracrine factors that are responsible for the pro-arrhythmic effects observed in 
our study and unraveling their mechanisms of action are subjects of future studies. 
The findings of the current study may raise cautionary concerns regarding the use 
of genetically-modified MSCs as biological pacemakers. 5 Such an approach relies 
on the premise that MSCs are electrically inert, other than their ability to couple 
to surrounding cells and achieve automaticity by electrotonic interactions. If MSCs 
modulate electrical behavior via secreted factors, using MSCs as pacemakers may 
have unintended APD prolonging effects and may increase the pro-arrhythmic risk.
Study Limitations
Due to ethical and technical limitations, cardiomyocytes of human adults could 
not be not investigated in this study. As an alternative, nrCMCs were used as these 
cells are available in large amounts and can be maintained in culture as contrac-
tile monolayers for the time period needed for mechanistic studies on stem cell 
engraftment. However, their ion channel expression profile and distribution of gap 
junctions differs from those of human adult CMCs. Therefore, the comparability 
of neonatal rat CMCs to adult and clinical situations may be limited. Nevertheless, 
2-dimensional in vitro models of rat myocardial tissue have shown to be relevant 
for studying cardiac electrophysiology, by mimicking key electrophysiological pro-
cesses in the intact heart.39
As the current model utilized healthy nrCMCs, the implications of current find-
ings for disease models for stem cell therapy need to be investigated in future 
studies. To assess the consequences of this study for hMSC transplantation in the 
heart, our findings should be considered in the context of 3-dimensional, aniso-
tropic myocardium.
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In myocardial cell cultures, adult hMSCs slow conduction, prolong repolariza-
tion, increase spatial dispersion of repolarization and cause triggered activity and 
reentrant arrhythmias by different mechanisms. Electrotonic coupling of hMSCs 
to nrCMCs reduces excitability and thereby CV, while the paracrine factors that 
are directly secreted by hMSCs slows nrCMC repolarization. Thus, caution is war-
ranted against potential pro-arrhythmic effects of MSC transplantation in cardiac 
tissue. The observation that the pro-arrhythmic activity of hMSCs in co-cultures 
with nrCMCs is strongly influenced by their number and distribution suggests that 
by controlling MSC engraftment rate and patterns the critical balance between 
therapeutic potential and hazardous risk of MSC therapy for cardiac diseases may 
be tipped in the right direction.
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isolation, culture and characterization of human mesenchymal stem 
cells (hmscs)
Human tissue samples were collected after having obtained written informed con-
sent of the donors and with the approval of the medical ethics committee of Lei-
den University Medical Center (LUMC), where all investigations were performed. 
Investigations with human tissues conformed to the Declaration of Helsinki. Adult 
hMSCs were purified from leftover bone marrow (BM) samples derived from 
ischemic heart disease patients (n=4 donors). Briefly, the mononuclear cell frac-
tion of the BM was isolated by Ficoll density gradient centrifugation, transferred 
to a 75-cm2 cell culture flask (Becton Dickinson, Franklin Lakes, NJ) in standard 
hMSC culture medium (i.e. Dulbecco’s modified Eagle’s medium [DMEM; Invitro-
gen, Breda, the Netherlands] containing 10% fetal bovine serum [FBS; Invitrogen 
and incubated at 37ºC in humidified 95% air/5%CO2. Twenty-four h after seeding, 
the non-adherent cells were removed and the remaining hMSCs were expanded by 
serial passage using standard methods.1 The hMSCs were characterized accord-
ing to generally accepted criteria using flow cytometry for the detection of sur-
face antigens and adipogenic and osteogenic differentiation assays to establish 
multipotency. Surface marker expression was examined after culturing the cells 
for at least 3 passages. Thereafter, the hMSCs were detached using a buffered 
0.05% trypsin-0.02% EDTA solution (TE; Lonza, Vervier, Belgium), suspended in 
phosphate-buffered saline (PBS) containing 1% bovine serum albumin fraction 
V (BSA; Sigma-Aldrich Chemie, Zwijndrecht, the Netherlands) and divided in ali-
quots of 105 cells. Cells were then incubated for 30 min at 4°C with fluorescein iso-
thiocyanate- or phycoerythrin-conjugated monoclonal antibodies (MAbs) directed 
against human CD105 (Ancell, Bayport, MN), CD90, CD73, CD45, CD34 or CD31 
(all from Becton Dickinson). Labeled cells were washed three times with PBS con-
taining 1% BSA and analyzed using a BD LSR II flow cytometer (Becton Dickinson). 
Isotype-matched control MAbs (Becton Dickinson) were used to determine back-
ground fluorescence. At least 104 cells per sample were acquired and data were 
processed using FACSDiva software (Becton Dickinson). Established differentia-
tion assays were used to determine the adipogenic and osteogenic differentiation 
ability of the cells. Briefly, 5×104 hMSCs per well were plated in a 12-well cell culture 
plate (Corning Life Sciences, Amsterdam, the Netherlands) and exposed to adi-
pogenic or osteogenic differentiation medium. Adipogenic differentiation medium 
consisted of MEM-plus (i.e. α-minimum essential medium [Invitrogen] containing 
10% FBS, supplemented with insulin, dexamethason, indomethacin and 3-isobutyl-
1-methylxanthine (all from Sigma-Aldrich Chemie) to final concentrations of 5 μg/
mL, 1 μmol/L, 50 μmol/L and 0.5 μmol/L, respectively, and was refreshed every 
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3-4 days for a period of 3 weeks. Lipid accumulation was assessed by Oil Red O 
(Sigma-Aldrich Chemie) staining of the cultures (15 mg of Oil Red O per mL of 60% 
2-propanol). Osteogenic differentiation medium consisted of MEM-plus containing 
10 mmol/L β-glycerophosphate, 50 μg/mL ascorbic acid and 10 nmol/L dexametha-
son (all from Sigma-Aldrich Chemie) and was refreshed every 3-4 days for a period 
of 3 weeks. Osteogenic differentiation was evaluated by histochemical detection of 
alkaline phosphatase activity and calcium deposition. To measure alkaline phos-
phatase activity, cells were washed with PBS and subsequently incubated for 5 min 
with substrate solution (0.2 mg/mL a-naphthyl-1-phosphate [Sigma-Aldrich Che-
mie] 0.1 mol/L Tris-HCl [pH 8.9], 0.1 mg/mL magnesium sulfate and 0.6 mg/mL 
Fast Blue RR [Sigma-Aldrich Chemie]). Thereafter, calcium deposits were visualized 
by staining of the cells for 5 min with 2% Alizarin Red S (Sigma-Aldrich Chemie) in 
0.5% NH4OH (pH 5.5).
neonatal rat ventricular cardiomyocyte (nrcmc) isolation and culture
All animal experiments were approved by LUMC’s animal experiments commit-
tee and conformed to the Guide for the Care and Use of Laboratory Animals, as 
stated by the US National Institutes of Health2 (permit number: 10236). Isolation of 
nrCMCs from two-day-old neonatal Wistar rats was done essentially as described 
previously.3 In brief, hearts were rapidly excised from isoflurane-anesthetized ani-
mals and minced into small pieces. After two sequential digestion steps with col-
lagenase type I (450 units/mL; Worthington, Lakewood, NJ), a 75-min pre-plating 
step was performed to minimize the number of non-cardiomyocytes in the myo-
cardial cell suspension. Next, the resulting cell suspension was passed through a 
nylon cell strainer with a mesh pore size of 70 µm (Becton Dickinson) to remove 
cell aggregates and, after counting, the cells were plated on fibronectin (Sigma-
Aldrich Chemie)-coated round glass coverslips in 24-well cell culture plates (Corn-
ing Life Sciences, Amsterdam, the Netherlands) at a density of 1-4×105 cells/well 
depending on the experiment. To stop cell proliferation and to maintain the ini-
tial established ratios between cell types, cultures were incubated for 2 h with 10 
µg/mL mitomycin-C (Sigma-Aldrich Chemie) at day 1 of culture. Culture medium 
was refreshed daily, except in experiments investigating paracrine effects. In these 
experiments, cells received fresh medium every 2 days to allow for sufficient expo-
sure to paracrine factors. Cultures were refreshed with DMEM/Ham’s F10 culture 
medium (1:1, v/v; both from Invitrogen) supplemented with 5% horse serum (HS; 
Invitrogen) and cultured in a humidified incubator at 37ºC and 5% CO2.
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186 preparation of co-cultures between nrcmcs and clustered or diffusely 
spread hmscs
To investigate in an ex vivo model system the effects of myocardial engraftment of 
hMSCs in different patterns and doses on arrhythmogeneity, co-cultures of nrC-
MCs and hMSCs were prepared. To mimic a diffuse engraftment pattern, 4.0×105 
nrCMCs with mixed with 2.8×104 (7%) or 1.12×105 (28%) hMSCs and added onto a 
fibronectin-coated glass coverslip in a well of a 24-well cell culture plate. To mimic 
a clustered engraftment pattern, the hMSCs were applied to the center of a glass 
coverslip in a circle with a diameter of 3 mm (2.8×104 cells) or of 6 mm (1.12×105 
cells). To keep the hMSCs centered, rings with an outer diameter of 15 mm and an 
inner diameter of 3 or 6 mm were lasered in Parafilm M (Bemis Flexible Packaging, 
Neenah, WI, USA) using a PLS3.60 laser (Universal Lasersystems. Scottsdale, AZ). 
Next, these rings were sterilized with 70% ethanol and attached to fibronectin-
coated coverslips. A drop of hMSC suspension was then applied to the center of 
each ring and the cells were allowed to adhere for at least 2 h. Finally, the rings of 
Parafilm M were removed and 4.0×105 nrCMCs were plated out on top of the hMSC 
cluster.
electrophysiological measurements in co-cultures of nrcmcs and hmscs
To facilitate the identification of hMSCs in co-cultures with nrCMCs, these cells 
were labeled with enhanced green fluorescent protein (GFP) using the vesicular 
stomatitis virus G protein-pseudotyped, self-inactivating human immunodefi-
ciency virus type 1 vector CMVPRES,4 essentially as described by van Tuyn et al.5 
At day 9 of culture, co-cultures of nrCMCs and GFP-labeled hMSCs in a diffuse or 
clustered pattern were subjected to whole-cell patch-clamp experiments in parallel 
to optical mapping experiments. Whole-cell current-clamp recordings were per-
formed at 25ºC using an L/M-PC patch-clamp amplifier (List Medical, Darmstadt, 
Germany) with 3 kHz filtering. Pipette solution contained (in mmol/L) 10 Na2ATP, 
115 KCl, 1 MgCl2, 5 EGTA, 10 HEPES/KOH (pH 7.4). Tip resistance was 2.0 – 2.5 
MΩ, and seal resistance >1 GΩ. The bath solution contained (in mmol/L) 137 NaCl, 
4 KCl, 1.8 CaCl2, 1 MgCl2, 10 HEPES/KOH (pH 7.4). For data acquisition and analy-
sis pClamp/Clampex8 software (Axon Instruments, Molecular Devices, Sunnyvale, 
CA) was used. Current-clamp recordings were performed in unlabeled nrCMCs 
adjacent to GFP-labeled hMSCs. For partial uncoupling experiments, nrCMCs were 
studied after 20 min of incubation with 2-aminoethoxydiphenyl borate (2-APB; Toc-
ris, Ballwin, MO).
optical mapping
Electrophysiological parameters were determined by optical mapping as described 
previously.6 In brief, nrCMC-hMSC co-cultures were loaded with 6 µmol/L of the 
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voltage-sensitive dye di-4-ANEPPS (Invitrogen) diluted in DMEM/Ham’s F12 cul-
ture medium (Invitrogen) for 10 min at 37ºC in humidified 95% air/5%CO2. Sub-
sequently, the culture medium was replaced by fresh DMEM/Ham’s F12 and the 
cultures were optically mapped using the Micam Ultima-L optical mapping system 
(SciMedia USA, Costa Mesa, CA). Optical signals were recorded and analyzed using 
Brainvision Analyze 1108 (Brainvision, Tokyo, Japan). Cultures were electrically 
stimulated with a 10 ms pulse at ≥1.5× diastolic threshold and paced at 1 Hz (Multi-
channel systems, Reutlingen, Germany) to determine conduction velocity (CV) and 
action potential duration at 90% of full repolarization (APD90), as well as disper-
sion of repolarization. Dispersion of repolarization was calculated as the maximal 
spatial difference in APD90 within the same culture. Areas of dispersion analysis 
were at least 4×4 pixels. Inducibility of reentry was tested by applying a bipolar, 
14-Hz burst stimulation protocol. Reentry was defined as >2 consecutive circular 
activations. For partial uncoupling experiments, cultures were mapped before and 
after 20 min of incubation with 2-APB. The principle of partial uncoupling was 
based on the low connexin 43 (Cx43) plaque density at heterocellular hMSC-nrCMC 
junctions as compared to that at homocellular nrCMC-nrCMC junctions. This ren-
ders the gap junctional communication between nrCMCs and hMSCs more sensi-
tive to uncoupling by 2 µmol/L of 2-APB than that between nrCMCs and nrCMCs. 
Thus, treatment of the co-cultures with 2-APB could effectively uncouple hMSCs 
from nrCMCs while preserving nrCMC reserves of Cx43 necessary for conduction. 
Although 2-APB may have other known effects, these are not expected to be active 
at the used dosages7,8 and are not expected to increase conduction velocity.
To study the effects of fast sodium channel blockade, cultures were succes-
sively exposed to 5, 10, 15 and 20 µmol/L tetrodotoxin (TTX; Alomone Labs, Jeru-
salem, Israel) by stepwise increasing the drug concentration. The influence of APD 
on arrhythmicity was studied using the ATP-sensitive potassium channel opener 
P1075 (10 μmol/L; Tocris).
analysis of markers involved in mechanical and electrical coupling
Alpha smooth muscle actin (αSMA) and N-cadherin, proteins involved in mechani-
cal coupling, were visualized by immunostaining as described previously.1 In short, 
on day 9 after culture initiation, the co-cultures of nrCMCs and adult BM hMSCs 
were fixed on ice with 4% formaldehyde in PBS for 30 min, washed with PBS, per-
meabilized with 0.1% Triton X-100 in PBS for 5 min at 4°C and rinsed again with 
PBS. To decrease non-specific antibody binding, the cells were next incubated at 
room temperature with 0.1% donkey serum (Sigma-Aldrich Chemie) in PBS for 30 
min. Thereafter, the co-cultures were incubated overnight at 4°C with an aSMA-
specific mouse MAb (clone 1A4; A2547; Sigma-Aldrich Chemie) or with an N-cad-
herin-specific mouse MAb (clone ID-7.2.3; C3825; Sigma-Aldrich Chemie) diluted 
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188 1:400 and 1:100, respectively, in PBS containing 0.1% donkey serum. To distinguish 
nrCMCs from hMSCs, co-cultures were stained with a rabbit polyclonal antibody 
(PAb) recognizing the striated muscle-specific protein troponin I (H-170; Santa 
Cruz Biotechnology, Santa Cruz, CA; dilution 1:100). Binding of the primary anti-
bodies to their target antigen was visualized using Alexa Fluor 568-conjugated don-
key anti-mouse IgG and Alexa Fluor 488-conjugated donkey anti-rabbit IgG (both 
from Invitrogen) at dilutions of 1:200. hMSCs in the co-cultures were identified by 
labeling with a human lamin A/C-specific murine MAb (clone 636; Vector Laborato-
ries, Burlingame, CA; dilution 1:200). Lamin A/C staining was visualized with Qdot 
655-streptavidin conjugates (Invitrogen; dilution 1:200) after incubation of the cells 
with biotinylated goat anti-mouse IgG2b secondary antibodies (Santa Cruz Bio-
technology; dilution 1:200). Nuclei were stained by incubating the cells for 10 min 
at room temperature with 10 µg/mL Hoechst 33342 (Invitrogen) in PBS.
The expression of the gap junctional protein Cx43, which plays an important 
role in the electrical coupling of nrCMCs, was also studied by immunocytological 
stainings. Co-cultures of nrCMCs and hMSCs were stained with a Cx43-specific 
rabbit PAb (C6219; Sigma-Aldrich Chemie) and with a mouse MAb recognizing sar-
comeric α-actinin (clone EA53; Sigma-Aldrich Chemie; dilution 1:200). The primary 
antibodies were visualized using Alexa Fluor 568-coupled donkey anti-mouse IgG 
and Alexa Fluor 488-linked donkey anti-rabbit IgG secondary antibodies at dilutions 
of 1:200 (both Invitrogen). Again, the hMSCs in the co-cultures were identified by 
labeling with a human lamin A/C-specific murine MAb as described above. Nuclei 
were stained using a 10 µg/mL solution of Hoechst 33342 in PBS. Cells that went 
through the entire staining procedure but were not exposed to primary antibod-
ies served as negative controls. A fluorescence microscope equipped with a digi-
tal color camera (Nikon Eclipse 80i; Nikon Instruments Europe, Amstelveen, the 
Netherlands) and dedicated software (NIS Elements [Nikon Instruments Europe] 
together with ImageJ [version 1.43; National Institutes of Health, Bethesda, MD]) 
were used for data analysis. ImageJ was used to determine the intensity of the 
Cx43-associated fluorescence in several randomly chosen, equally-sized border 
regions between hMSCs and nrCMCs and between adjoining nrCMCs. Fluorescent 
images of cells stained with the same antibody were always recorded with the same 
exposure time.
analysis of functional coupling
Dye transfer assays were used to directly determine functional heterocellular 
coupling between nrCMCs and GFP-positive hMSCs. Four days after cell isola-
tion, nrCMC cultures with a density of 2×105 cells per well in a 12-well cell cul-
ture plate (Corning Life Sciences) were loaded with dye by incubation for 15 min 
with 4  mmol/L calcein red-orange AM (calcein; Invitrogen) in Hank’s balanced 
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salt  solution ( Invitrogen). Thereafter, the cells were rinsed three times with PBS 
and were kept in the incubator in nrCMC culture medium supplemented with 
2.5 mmol/L Probenecid (Invitrogen) for ³30 min before 2×104 GFP-positive hMSCs 
(n=3 cultures for each of the 4 hMSC isolates) were added. Probenecid blocks 
organic anion transporters located in the plasma membrane thus preventing cal-
cein efflux from the dye-loaded nrCMCs. Fluorescent images (³30 per group) were 
captured after 8 h and evaluated in a blinded manner. In all experimental groups, 
GFP-positive hMSCs surrounded by the same number of nrCMCs were analyzed. 
ImageJ was used to determine the intensity of the calcein-associated fluorescence 
in several randomly chosen, equally-sized subcellular regions for both the GFP-pos-
itive hMSCs and the adjoining nrCMCs. To correct for possible variations in calcein 
loading efficiency, the dye intensity in the GFP-positive hMSCs was expressed as a 
percentage of that in the surrounding nrCMCs. The percentage of calcein-positive 
cells among the GFP-labeled hMSCs was also determined by counting these cells 
in ³60 fields of view per experimental group.
analysis of the influence of paracrine factors on nrcmc cultures
To investigate the influence of hMSC paracrine factors on the electrophysiological 
properties of nrCMC cultures, transwell experiments were conducted. Mitomycin-
C-treated adult hMSCs were seeded in 24-well plate transwell inserts (membrane 
diameter: 6.5 mm, surface area: 0.33 cm2, membrane pore size: 0.4 µm; Corning 
Life Sciences). To allow direct comparison with the previously described co-culture 
experiments, the transwell inserts contained 2.8×104 or 1.12×105 hMSCs, which were 
placed above 4.0×105 mitomycin-C-treated nrCMCs seeded on fibronectin-coated 
coverslips. Control cultures consisted of nrCMC cultures with empty transwells, 
nrCMC cultures without transwells and nrCMC cultures with transwells contain-
ing 1.12×105 nrCMCs. All cultures included in these experiments were refreshed 
with standard nrCMC culture medium every 2 days. To confirm optical mapping 
results, patch-clamp experiments were also performed on nrCMCs exposed to the 
hMSC secretome using the transwell cell culture system and on nrCMCs of control 
cultures.
western blot analyses
To investigate Cav1.2, Kir2.1 and Kv4.3 levels, western blot analyses were performed 
on whole-cell protein extracts obtained from nrCMC layers cultured under transwell 
inserts containing hMSCs or no cells. Proteins were extracted by homogenization 
using RIPA buffer (150 mM NaCl, 1% Nonidet P-40, 0.5% sodium deoxycholate, 
0.1% SDS, 50 mM Tris-HCl [pH 8.0] supplemented with protease inhibitors [cOm-
plete, Mini Protease Inhibitor Cocktail Tablets from Roche Diagnostics Neder-
land, Almere, the Netherlands]). At least 5 samples comprised of ≥2 cultures per 
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190 group were used. Total protein (10 µg/lane) was loaded onto NuPage 10% Bis-Tris 
gels (Invitrogen) and electrophoresis was performed for 2 h at 150 V, after which 
proteins were transferred to Hybond-P polyvinylidene difluoride membranes (GE 
healthcare, Diegem, Belgium) overnight using a wet blotting system. After block-
ing for 1 h at room temperature with 10 mmol/L Tris-HCl (pH7.6), 0.05% Tween-20 
and 150 mmol/L NaCl (TBST) containing 5% BSA, the membranes were incubated 
for 1 h at room temperature with primary antibodies diluted in TBST-5% BSA. The 
primary antibodies were affinity-purified rabbit anti-mouse Cav1.2 (ACC-003; Alo-
mone labs; dilution: 1/500), rabbit anti-human Kir2.1 (APC-026; Alomone labs; 
dilution: 1/1,000) and rabbit anti-rat Kv4.3 (P0358; Sigma-Aldrich Chemie; dilution: 
1/1,000). For normalization purposes, a mouse MAb recognizing the housekeeping 
protein glyceraldehyde-3-phosphate dehydrogenase (GAPDH; clone 6C5; MAB374; 
Merck Millipore, Billerica, MA; dilution 1:50,000) was used. Following three 15-min 
washing steps with TBST, the membranes were incubated with appropriate horse-
radish peroxidase (HRP)-conjugated rabbit or mouse IgG-specific goat secondary 
antibodies (sc-3837 and sc-2005 from Santa Cruz Biotechnology, Santa Cruz, CA) 
diluted 15,000-fold in TBST-5% BSA. Following additional washing steps, blots 
were developed using SuperSignal West Femto Maximum Sensitivity Substrate 
(Thermo Scientific, Rockford, IL). The chemiluminescence signals were captured 
using a ChemiDoc XRS imaging system (Bio-Rad Laboratories, Veenendaal, the 
Netherlands).
exosome experiments
To investigate their pro-arrhythmic effects, exosomes from the hMSC secretome 
were isolated under sterile conditions using previously established procedures.9,10 
Human MSCs were seeded into porcine skin gelatin type A (Sigma-Aldrich Chemie)-
coated cell culture flasks with a surface area of 75 cm2 (1.8 million cells per flask). 
As control, equal-sized gelatin-coated flasks without cells were used. Every 2 days, 
culture medium was collected from the flasks and spun for 10 minutes at 303 × g to 
remove cellular debris. The supernatant was transferred to clean tubes and stored 
shortly at 4°C. Subsequently, supernatants were centrifuged for 30 min at 4°C and 
10,000 × g in a precooled Optima L-70K ultracentrifuge (Beckman Coulter Ned-
erland, Woerden, the Netherlands) for another debris removal step. Next, super-
natants were filtered through Millex 0.45-µm pore size polyethersulfone syringe 
filters (Merck Millipore) and spun for 60 min at 4°C and 100,000 × g to pellet the 
exosomes. Exosomes were resuspended in ice-cold PBS by gentle agitation for 2 h 
at 4°C. Exosomes were stored at -80°C until later use.
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To study the effects of the hMSC-derived exosomes on the electrical properties 
of nrCMCs, 4×105 of these cells were added to single wells of a 24-well cell culture 
plate onto a fibronectin-coated glass coverslip. The resulting nrCMC cultures were 
given fresh medium with or without exosomes every 2 days. Exosomes were added 
to the medium in a quantity calculated to approximate the amount of exosomes 
in the hMSC secretome during the transwell experiments (Amount of hMSCs per 
flask / amount of hMSCs in transwells (i.e. 1.12 x105 cells) = dilution of exosome 
stock needed per nrCMC culture). After 9 days of culture, nrCMC cultures were 
subjected to optical mapping for electrophysiological investigation by a blinded 
researcher.
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Supplemental figure 1. Characterization of adult BM hMSCs. (A) Flow cytometric analy-
ses showed abundant surface expression of the MSC markers CD90, CD73 and CD105 
and hardly any surface expression of the hematopoietic cell markers CD34 and CD45 or 
the endothelial cell marker CD31. Percentages are means of ≥4 measurements. ND is not 
detected. (B) Adipogenic differentiation was visualized by the presence of Oil Red O-stained 
fat vacuoles. (C) Calcium depositions and alkaline phosphatase activity were present after 
osteogenic differentiation of the hMSCs.
Supplemental figure 2. Analyse of markers involved in mechanical coupling. (A) Immuno-
cytological staining showed no expression of alpha smooth muscle actin (aSMA; orange/
red) by adult BM hMSCs in co-culture with nrCMCs. (B) Also, no N-cadherin (indicated as 
N-CAD; orange/red), was detected at contact areas between hMSCs and nrCMCs. hMSCs 
were detected using an antibody directed against human-specific lamin A/C (red), while 
nrCMCs were identified using an antibody directed against cardiac troponin I (cTnI; green). 
Nuclei were stained with the DNA-binding fluorochrome Hoechst 33342.
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194 Summary
The general introduction of this thesis, Chapter I, describes the origins and typical 
characteristics of mesenchymal stem cells (MSCs). Next, the capacity of MSCs to 
undergo cardiac differentiation in vitro and in vivo is discussed with emphasis on 
the criteria and the methods used to determine differentiation into cardiac cell 
types. Finally, an overview is presented of the clinical studies using MSCs to treat 
cardiac diseases, including outcomes and (potential) hurdles.
The aim of this thesis was to study the integration and cardiac differentiation 
of MSCs in cardiac tissue using dedicated in vitro models and molecular interven-
tions.
In Chapter II the cardiac differentiation potential of MSCs derived from human 
(h) embryonic, fetal and adult tissues in co-cultures with neonatal rat ventricular 
cardiomyocytes (nrCMCs) was evaluated. It was shown that the capacity of hMSCs 
to differentiate towards cardiomyocytes, smooth muscle cells and endothelial cells 
declined with the age of the MSC donor. Cardiomyogenic differentiation was most 
efficient in embryonic hMSCs, occurred at a lower frequency in fetal hMSCs and 
could not be detected in hMSCs from adults.
In Chapter III the effects of alignment of neonatal rat MSCs on electrical inte-
gration in nrCMC cultures was studied using multi-electrode arrays. During 9 days 
of co-culture a portion of these MSCs differentiated towards cardiac muscle cells 
and depending on the predefined direction of alignment the degree of electrical 
integration of the MSCs with surrounding cardiomyocytes differed significantly.
The role of gap junctional coupling between cultured cardiomyocytes and 
hMSCs in inducing cardiac differentiation of the hMSCs was studied in Chapter IV. 
Connexin 43 downregulation and subsequent connexin 45 upregulation in fetal 
hMSCs co-cultured with nrCMCs decreased and restored, respectively, their ability 
to differentiate into cardiomyocyte-like cells that could produce action potentials.
In Chapter V, co-cultures between lentiviral vector-modified hMSCs and nrC-
MCs were used to investigate secondary transduction of cardiomyocytes with 
vector particles originating from primary transduced. Secondary transduction of 
native cardiomyocytes under these conditions is a frequent event, thereby seri-
ously disturbing the interpretation of experiments in which cardiac differentiation 
of MSCs is inferred from the co-expression of specific cardiac features together 
with a virally introduced marker gene. However, with some additional measures the 
percentage of falsely labeled cells can be reduced to zero.
Chapter VI shows the results of a study focusing on the role of hMSC engraft-
ment patterns on arrhythmicity in nrCMC cultures. Not only the percentage of 
engrafted cells affected arrhythmia incidence and characteristics but also the pat-
tern in which these cells engrafted (clustered versus diffuse distribution). Electrical 
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coupling between hMSCs and cardiomyocytes as well as secretion of certain freely 
diffusible paracrine factors contributed to the pro-arrhythmic effects observed in 
these co-cultures.
Besides the pro-arrhythmic effects of transplanting unexcitable cells in cardiac 
tissue, also the role of endogenous, unexcitable myofibroblasts in arrhythmogen-
esis was studied. Accordingly, in Chapter VII nrCMC cultures were treated with 
cytostatic agents (i.e. mitomycin-c and paclitaxel) to inhibit the proliferation of the 
(myo)fibroblasts in these cultures. This strongly reduced the incidence of reentrant 
arrhythmias by preserving tissue excitability.
In conclusion, the cardiac differentiation potential of hMSCs negatively correlates 
with donor age, which in its own turn shows a negative relationship with connexin 
43 levels in these cells. However, a causal relationship between connexin 43 expres-
sion levels and cardiomyogenic differentiation potential only exists for hMSCs from 
prenatal sources, i.e. while knockdown of connexin 43 expression in fetal hMSCs 
inhibits their ability to differentiate into cardiomyocytes, connexin 43 overexpres-
sion in adult hMSCs does not endow them with cardiomyogenic differentiation 
capacity. In addition, co-culture studies showed that the alignment and distribu-
tion of MSCs affect their electrical integration into host myocardium and are major 
determinants of their pro-arrhythmic risk. The mechanisms underlying the pro-
arrhythmic effects of hMSCs are to some extent comparable to those of cardiac 
myofibroblasts, cells that are found in fibrotic myocardium.
discussion & future perspectives
Whether and to which extent mesenchymal stem cells (MSCs) are intrinsically 
able, or can be forced, to undergo cardiac differentiation, especially with regard 
to formation of functional cardiomyocytes (CMCs), has been subject of intense 
investigation.1 The incentive for these studies was probably based on the appar-
ent advantageous properties of MSCs following transplantation in damaged myo-
cardium. Their ease with which MSCs can be isolation from a variety of relatively 
easily accessible tissues (e.g. bone marrow and adipose tissue) and subsequently 
expanded in vitro, their favorable immunological effects and indications that these 
cells could differentiate towards cardiac cells contributed to a rapid transition from 
bench to bed.2 However, the initial enthusiasm for MSC therapy to actually regener-
ate myocardial tissue after ischemic damage is now replaced with contemplation, 
while new strategies are being developed to overcome the encountered challenges 
related to cardiac cell therapy.3-5
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Figure 1. Schematic overview of factors that might affect the outcome of studies on cardio-
myogenic differentiation of MSCs using co-culture models. Intrinsic and extrinsic factors 
are indicated by light and dark grey arrows, respectively. These factors probably also affect 
each other, thereby creating a highly complex and dynamic setting in which the outcome is 
determined by the interplay between the various factors.
Before stem cells can undergo cardiomyogenic differentiation specific tran-
scriptional pathways need to be activated. A method from which it is believed to 
deliver the triggers needed to initiate this process involves co-culture with CMCs. 
However, the exact co-culture conditions needed to induce (complete) cardiomyo-
genic differentiation in MSCs, if possible at all, are not fully understood.6 It is there-
fore no surprise that conflicting results have been reported about the potential of 
MSCs to undergo cardiomyogenesis as most of these studies relied on co-cultures 
between MSCs and CMCs.7-9 In fact, there is still little known about the triggers 
for cardiac differentiation in any stem cell type using any model, especially when 
it comes to guiding differentiation towards a specific cardiac cell type.10 In CMC-
MSC co-culture models a number of factors and mechanisms have been identified 
which seem to play a role in inducing cardiomyogenic differentiation. However, 
the degree to which these factors contribute to the underlying mechanism of car-
diomyogenic differentiation is directly influenced by the experimental setup and 
conditions. Basically these factors can be divided into two groups, intrinsic and 
extrinsic factors (Figure 1).
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Intercellular communication between co-cultured cells could be one of these 
intrinsic factors. It has been shown that MSCs derived from human or rodent tissue 
express certain proteins called connexins (Cx).11 These proteins form hemichannels 
called connexons which consist of a ring of 6 connexin molecules with a central 
pore. When connexons in 2 neighboring cells associate with each other, gap junc-
tions are formed. These intercellular channels comprise relatively aselective low-
conductance conduits allowing transmission of electrical and chemical signals 
between MSCs.12 MSCs can also form functional gap junctions with adjacent CMCs, 
thereby establishing heterocellular communication.13 The degree and nature of gap 
junctional communication is determined by several factors, including the extent of 
physical contact between cells, the surface levels of Cxs, the spreading of gap junc-
tions across the plasma membrane, the specific Cx isoforms incorporated in the 
gap junctions and the conductive properties of the connexons, which are regulated 
by chemical, electrical and mechanical signals as well as by posttranslational modi-
fications (e.g. phosphorylation).14 In this thesis it has been shown that functional 
gap junctional coupling between neonatal rat ventricular CMCs (nrCMCs) and co-
cultured adult human MSCs is important for the induction of cardiomyogenic dif-
ferentiation in these stem cells (Chapter IV). Therefore the degree of intercellular 
communication, determined by the factors named above, could directly affect the 
efficiency and extent to which MSCs differentiate into CMCs.
The characteristics of CMCs used in co-culture experiments might also affect the 
propensity of MSCs to acquire a cardiomyogenic phenotype. For practical reasons 
nrCMCs are the primary choice for CMC-MSC co-culture experiments. Such CMCs 
can be kept in culture for many days without losing excitability and contraction.15 
These key properties of CMCs have been linked to induction of cardiomyogenic 
differentiation.16,17 However, during the isolation procedure CMCs might become 
damaged, thereby affecting their characteristics in terms of excitation and con-
traction. Additionally, CMCs are mostly isolated from 2-day old rats, but at this 
stage the heart is still under development with changing CMC characteristics,18 
and a seemingly insignificant difference in age (12 h or 1 day difference for exam-
ple) might therefore affect the outcome of co-culture experiments. Importantly, 
although breeding of rats can be standardized to some degree, the actual time 
point of conception and parturition could create a significant variety in age when 
different nests are put together to create a sufficient supply. Also, intercellular 
communication between hMSCs and non-human CMCs could be suboptimal, but 
obtaining hCMCs in large quantities and keeping them in culture long enough to 
conduct such co-culture experiments does not seem feasible.
Besides culture-related aspects, one also needs to consider that healthy, nrC-
MCs are very different from those found in the target tissue of cardiac cell therapy, 
being a diseased human heart.19 In such a heart, and especially near the border 
Ramkisoensing.indd   197 22-4-2014   11:52:31
chapter viii
198 zone of myocardial infarction, CMCs are often remodeled, exposed to pro-apop-
totic/necrotic signals, inflammatory stimuli and changes in pH, redox balance and 
oxygen tension. Therefore, even if the conditions are fully standardized in CMC-
MSC co-culture experiments and cardiac differentiation can indeed be studied in 
a robust fashion, the data derived from these experiments should always be inter-
preted and presented with great care.
Logically, also the characteristics of MSCs might have an impact on the outcome 
of cardiac differentiation experiments in co-cultures of MSCs and CMCs. Human 
adult MSCs are usually derived from tissues like bone marrow or fat, while human 
MSCs can also be derived from fetal tissues and neonatal sources like amnion, 
placenta and umbilical cords.1 Although some studies suggest that the source of 
MSC could determine their potential to differentiate towards certain cell types,20 
it is now recognized that donor age of MSCs certainly affects their differentiation 
potential, including their ability to form cardiac cells.21,22 This phenomenon can be 
explained by the fact that cellular plasticity in general declines with age.23 In this 
thesis it is shown that Cx43 expression levels in hMSCs also decline with age, which 
is accompanied by a loss of cardiomyogenic differentiation. However, while Cx43 
knockdown fully eliminated the cardiomyogenic differentiation potential of fetal 
human MSCs in co-culture with CMCs, overexpression of Cx43 in adult human 
MSCs did not cause them to become CMCs when coupled to nrCMCs. This shows 
that the potential of stem cells to differentiate into various cell types is constrained 
by other factors and mechanisms besides those related to gap junctions. Impor-
tantly, the recent developments in genetic reprogramming of cells, including those 
involving direct cardiac reprogramming of fibroblasts have further uncovered the 
requirements for cardiomyogenic differentiation.24,25
One of the extrinsic factors in these co-culture experiments that could affect 
the outcome is the CMC to MSC ratio and density at which the cells are plated, as 
this determines the extent of intercellular communication through gap junctions, 
ligand-receptor interactions and vesicle release/uptake as well as the cumulative 
strength of cardiomyogenic cues. Consequently, a relatively high number of adja-
cent CMCs will probably have a greater influence on a MSC than a lower num-
ber of CMCs thereby increasing the likelihood that a suprathreshold stimulus for 
cardiomyogenic differentiation is achieved. Although this thesis (Chapter 4) does 
not provide direct evidence for a role of paracrine factors in inducing cardiac dif-
ferentiation, in other situations and under other conditions such factors could be 
of importance.26 Increasing the supply of paracrine factors could result in a higher 
local concentration of these factors and thereby have a stronger effect. This may, 
for instance, hold true for hypoxia-induced myocardial angiogenesis, which is often 
suggested to represent the major beneficial effect in cardiac cell therapy.27
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It is known that the characteristics of the cell culture supports and coatings used 
in cardiac differentiation experiments can have a strong effect on the induction of 
differentiation.28,29 However, the underlying mechanisms of these in vitro findings 
remain poorly understood. Coatings applied in culture dishes interact with their 
surface and create a substrate on which cells can attach, survive and grow. Such 
coatings are usually based on extracellular matrix components and act as ligand for 
transmembrane receptors called integrins, which ensure attachment. Apparently, 
the degree of attachment, and thereby flattening and spreading of cells, could have 
an effect on the outcome of cardiac differentiation experiments. In the developing 
heart, stem and progenitor cells attach to adjacent cells and extracellular struc-
tures, however, whether inhibition of this process also leads to suboptimal growth 
of heart muscle, as a consequence of disturbed cardiac differentiation, is still not 
fully understood.30
The conditions to which cultured cells are exposed largely depend on the compo-
sition of the culture medium applied onto the cells. Especially serum, which is a key 
ingredient of most culture media and derived from species like bovine and equine, 
is known to affect the outcome of cardiac differentiation experiments, especially 
when using embryonic stem cells.31,32 Serum is rich in proteins, including various 
growth factors. How these or other factors in serum modulate the propensity of 
stem cells to differentiate into cardiac cells is incompletely understood. However, it 
is known that depending on source, concentration and pretreatment e.g. heat treat-
ment to inactivate complement. of serum, the proliferation rate, growth and viabil-
ity of stem cells is changed.33 These changes may have a direct or indirect effect on 
the susceptibility to certain cardiac differentiation-inducing stimuli.
Once stem cells and CMCs are put together in culture and have attached to 
the underlying surface, the duration of co-culture is likely to determine to which 
extent cardiomyogenic differentiation can take place. Based on other cardiac dif-
ferentiation protocols, a 10-day incubation time seems sufficient to allow forma-
tion of cardiac cells.34 Apparently, during this period stem cells are exposed to the 
appropriate stimuli of sufficient duration and (cumulative) strength to activate car-
diac transcriptional pathways. However, if other requirements for cardiomyogenic 
differentiation, which are listed above, are not met, obviously, MSC-derived CMCs 
will not be obtained.
Parallel to extensive in vitro studies, also numerous pre-clinical in vivo stud-
ies,1,35,36 as well as clinical studies have been performed to assess the therapeutic 
potential of cell transplantation in the diseased heart.4,37-39 Although a significant 
number of these clinical trials have studied the effect of transplanted bone marrow 
cells in damaged myocardium, few clinical studies have investigated the effects 
of MSC transplantation on cardiac function.40-42 Nevertheless, most of these 
studies showed a beneficial effect. This effect is often associated with enhanced 
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200  myocardial perfusion,43 although such trials obviously do not allow detailed investi-
gation of the therapeutic mechanisms. As these mechanisms remain poorly under-
stood, there is only a very small basis for the development of strategies to enhance 
the therapeutic effects. As another result, the therapeutic window of cardiac MSC 
therapy in general and the possible (dose-dependent) hazardous effects of MSC 
transplantation are still unknown. While the optimal therapeutic effect could be 
achieved by trial-and-error, such an approach bears the danger of going beyond 
the therapeutic window, resulting in detrimental effects on cardiac function,44 a 
danger that is typical for any new intervention. In this thesis it was shown that the 
alignment of transplanted MSCs determines their degree of spatial and functional 
integration with adjacent CMC fields, which was reflected as changes in conduc-
tion velocity. In the intact heart, the extracellular matrix is the main determinant 
of cell alignment.45 However, in the damaged heart, particularly after myocardium 
infarction, this matrix undergoes extensive changes/remodellng and cellular spatial 
arrangement is disturbed especially in the border zones of the infarcted areas.46 In 
most stem cell studies focusing on myocardial infarction, cells have been injected 
in the border zone and could therefore not be properly guided in their alignment. 
As a result structural and functional heterogeneity may increase locally leading 
to different conduction velocities in specific directions and areas, which could 
increase the pro-arrhythmic risk if the number of misaligned cells is high enough.47 
Additional guidance in the alignment of transplanted cells or tissue engineering 
techniques might overcome these potential dangers.48 Furthermore, in chapter 6 it 
was shown that the number and engraftment patterns of transplanted MSCs affect 
pro-arrhythmic risk by two different mechanisms. While electrotonic interaction 
between MSCs and CMCs lead to partial depolarization of the CMCs, secretion of 
paracrine factors from MSCs results in prolongation of the cardiac action poten-
tial duration. Depending on the extent of these effects, which is directly related to 
the number and engraftment pattern of MSCs, the incidence of arrhythmias was 
strongly increased in MSC-CMC co-cultures. Although in vivo studies are needed 
to proof the relevance of these mechanisms in the intact organism, in vitro stud-
ies like the ones described in this thesis could help us in developing strategies to 
minimize the adverse effects related to MSC therapy for the heart and may also 
help to guide the development/improvement of cardiac cell therapy involving other 
(stem) cell types.
Nevertheless, virtually all current interventions in cardiovascular medicine tar-
get either symptoms or certain disease pathways, but do not actually heal the dam-
aged heart. Despite the existing deficiencies in our knowledge and understanding 
of stem cells and their therapeutic potential, there is no denying in the positive 
impact regenerative medicine could have on patients suffering from cardiovascular 
diseases in either the near or distant future.
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De algemene introductie van dit proefschrift, Hoofdstuk I, geeft de eigenschap-
pen en de oorsprong van mesenchymale stamcellen (MSCs) weer. Tevens wordt 
de in vitro en in vivo capaciteit van MSCs om te differentiëren naar hartspiercellen 
beschreven. Hierbij wordt specifiek ingegaan op hoe differentiatie naar hartspier-
cel gedefiniëerd wordt en op de methoden die gebruikt worden om het proces 
van differentiatie in stamcellen te onderzoeken. Tenslotte, wordt er een overzicht 
gegeven van de klinische studies die gebruikmaken van MSCs om hartziekten te 
behandelen. Hierbij worden tevens de uitkomsten en conclusies van deze studies 
beschreven.
Het hoofddoel van dit proefschrift was dan ook de integratie van MSCs in hart-
spierweefsel en de differentiatie van MSCs naar hartspiercellen in deze omgeving 
kritisch te onderzoeken.
In Hoofdstuk II werd het differentiatie vermogen van MSCs die afkomstig waren 
uit humane (h) embryonale, foetale en volwassen bronnen, met elkaar vergeleken. 
Specifiek werd het vermogen om te differentiëren naar hartspiercel, gladde spiercel 
en endotheelcel onderzocht. Aangetoond werd dat de capaciteit van hMSCs om te 
differentiëren naar deze drie celtypen, direct gerelateerd was aan de leeftijd van de 
weefseldonor, waarbij het differentiatie vermogen van embryonale MSCs superieur 
was ten opzichte van de andere MSCs.
Hoofdstuk III evalueerde de effecten van ruimtelijke oriëntatie van getrans-
planteerde stamcellen op de functionele integratie met gekweekte hartspiercellen 
waarbij gebruik gemaakt werd van micro-electrode arrays. Gedurende 9 dagen co-
cultuur met de hartspiercellen, differentiëerde een deel van de MSCs naar hart-
spiercel en afhankelijk van de vooraf gedefiniëerde ruimtelijke oriëntatie was de 
mate van electrische integratie significant verschillend.
De rol van gap junctie koppeling tussen gekweekte hartspiercellen en hMSCs bij 
het induceren van differentiatie naar hartspiercel van deze hMSCs werd bestudeerd 
in Hoofdstuk IV. Het genetisch blokkeren van de expressie van het gap junctie eiwit 
connexine 43 in hMSCs resulteerde in het verlies van vermogen om te differentië-
ren naar hartspiercel. Wanneer vervolgens de expressie van het connexine 45 eiwit 
in deze hMSCs verhoogd werd, keerde het differentiatie vermogen naar hartspier-
cel van deze cellen terug.
In Hoofdstuk V werd secondaire transductie van neonatale rat hartspiercellen 
onderzocht door deze te kweken in co-cultuur met humane cellen die getransdu-
ceerd werden met een lentivirale vector die codeerde voor een fluorescent eiwit. De 
resultaten toonden dat secondaire transductie in dit soort modellen frequent voor-
komt. Hierdoor wordt de interpretatie van dit soort experimenten, waarbij slechts 
expressie van een fluorescent eiwit door een stamcel gebruikt wordt ter  identificatie 
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van deze cel, sterk verstoord. In deze studie worden echter meerdere mogelijkhe-
den beschreven om het plaatsvinden van secondaire transductie te voorkomen.
Hoofdstuk VI beschrijft de resultaten van een studie die zich gericht heeft op 
de rol van integratie patronen van hMSCs op de incidentie en eigenschappen van 
aritmieën in hartspiercelkweken. Niet alleen het percentage geïntegreerde hMSCs 
beïnvloedt het pro-aritmisch vermogen van de hartspiercelkweken, maar ook het 
integratiepatroon (geclusterd versus diffuus). Electrische koppeling tussen hMSCs 
en hartspiercellen en de secretie van bepaalde paracriene factoren dragen bij aan 
de pro-aritmische effecten die geobserveerd werden in deze co-culturen.
Naast de pro-aritmische effecten van getransplanteerde niet-exciteerbare cellen 
in hartspierweefsel werd bestudeerd maar ook de rol van endogene, niet-exciteer-
bare myofibroblasten. In Hoofdstuk VII werd bestudeerd of en op welke manier 
anti-proliferatieve behandeling van myofibroblasten in hartspiercelkweken het ont-
staan van aritmieën kon voorkomen. De incubatie met cytostatica (mitomycine-c 
en paclitaxel) reduceerde de incidentie van re-entry aritmieën sterk door weefsel 
exciteerbaarheid in stand te houden.
Concluderend, het vermogen van hMSCs te differentiëren tot een hartspiercel 
neemt af met de donorleeftijd, dat op zichzelf ook een negatieve relatie heeft met 
het Cx43 expressie niveau. De expressie van Cx43 is essentieel bij het differentiatie 
proces van MSCs die afkomstig zijn van jonge donoren, maar het is niet een stu-
rende factor bij cardiale differentiatie van MSCs afkomstig uit volwassen donoren. 
Naast de bovenstaande factoren, beïnvloeden ruimtelijke oriëntatie en integratie 
van MSCs de electrische integratie van deze cellen in het myocardiale weefsel. Dit 
kan leiden tot pro-aritmische effecten na stamcel therapie. De onderliggende pro-
aritmische mechanismen zijn deels vergelijkbaar met die van cardiale myofibro-
blasten, die aanwezig zijn in het fibrotische hartspierweefsel.
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